Difference between revisions of "Timeline of brain preservation"

From Timelines
Jump to: navigation, search
m (Mati Roy moved page Timeline of cryonics to Timeline of brain preservation: the article doesn't only discuss cryonics, but brain preservations in general)
(To do: https://www.newsweek.com/back-life-science-reviving-dead-104449)
 
(107 intermediate revisions by 4 users not shown)
Line 1: Line 1:
This is a '''timeline of {{W|cryonics}}'''.
+
This is a '''timeline of brain preservation'''.
  
Cryonics is the attempt to preserve a human or non-human animal using low-temperature with the hope that partial or complete resuscitation may be possible in the future.
+
Brain preservation is the attempt to preserve a human or non-human animal with the hope that partial or complete resuscitation may be possible in the future.
  
While cryonics is currently the most popular brain preservation method, other methods are being used and developed, notably [https://www.gwern.net/plastination plastination]. This page treats all brain preservation methods.
+
{{W|Cryonics}} is the most popular method of brain preservation, and preserves individuals using low-temperature. But other methods are being used and developed as well, notably [http://www.oregoncryo.com/manual/chemicalFixation.html fixation], and a combination of both called [http://www.brainpreservation.org/21cm-aldehyde-stabilized-cryopreservation-eval-page/ aldehyde-stabilized cryopreservation].
  
Similar concepts, or alternative names for cryonics include biostasis, neural archiving, and brain preservation.
+
Alternative names for brain preservation include biostasis and neural archiving.
  
Often confused with cryonics, suspended animation (or anabiosis) is a distinct practice where a patient body would remain biologically intact, and could be reanimated without the need to deeply repair the brain, or transfer its information to another substrate.<ref>{{Cite web|url=http://www.oregoncryo.com/suspendedAnimation.html|title=Oregon Cryonics - Suspended Animation|website=www.oregoncryo.com|access-date=2019-01-24}}</ref>
+
Often confused with cryonics, suspended animation (or anabiosis) is a distinct practice where a patient body would remain biologically intact, and could be reanimated without the need to deeply repair the brain, or transfer its information to another substrate.<ref>{{Cite web|url=http://www.oregoncryo.com/suspendedAnimation.html|title=Oregon Cryonics - Suspended Animation|website=www.oregoncryo.com|access-date=2019-01-24}}</ref> However, improvements in suspended animation would also improve the quality of cryopreservations given a patient could be maintained alive at lower temperature before undergoing the damaging cryonics procedure. So this timeline also includes some important milestones with regards to suspended animation.
  
 
== Trends ==
 
== Trends ==
Line 13: Line 13:
 
==== Interests ====
 
==== Interests ====
  
The following graph shows the relative popularity of web searches on the topic of cryonics on Google.
+
The following graph shows the relative popularity of web searches on the topic of cryonics on Google. For the latest version, check out [https://trends.google.com/trends/explore?date=all&q=cryonics Google Trends].
  
 
[[File:Cryonics_worldwide_popularity_per_month_(Google_Trends).png]]
 
[[File:Cryonics_worldwide_popularity_per_month_(Google_Trends).png]]
  
The following graph shows the number of views the Wikipedia page "[[wikipedia:Cryonics|Cryonics]]" had every day since July 2015. Note that the y-axis is logarithmic, with 5 main peaks.
+
The following graph shows the number of views the Wikipedia page "[[wikipedia:Cryonics|Cryonics]]" had every day since July 2015. Note that the y-axis is logarithmic, with 5 main peaks. For the latest version, check out [https://tools.wmflabs.org/pageviews/?project=en.wikipedia.org&platform=all-access&agent=user&range=all-time&pages=Cryonics WMF Labs]. There were 433,734 views in 2019, 367,632 views in 2018, 352,831 views in 2017, and 544,065 views in 2016.
  
 
[[File:Cryonics_pageviews_wikipedia.png|600px]]
 
[[File:Cryonics_pageviews_wikipedia.png|600px]]
Line 24: Line 24:
 
The first people to start advocating for cryonics emerged in 1962, and the first preservation happened 4 years later. From 1966 until 1973, of the 17 attempts at freezing, only one person remained cryopreserved<ref name="SuspensionFailures"/> (hence the bumps at the beginning of the curve in the graph below). Consequently, the "pay-as-you-go" funding model was abandoned by the cryonics community as relatives had shown to generally eventually lose interest in paying maintenance fees. From then onward, the number of cryopreservations would grow exponentially, but to this day still represent a trivial amount in comparison to the number of burials and cremations. Since cryonics was first publicized, an estimated 2.9 billion people have died,<ref>{{Cite journal|last=Ortiz-Ospina|first=Esteban|last2=Roser|first2=Max|date=2019-01-23|title=World Population Growth|url=https://ourworldindata.org/world-population-growth|journal=Our World in Data}}</ref> which could represent about 2.7% of humans to have ever lived.<ref>{{Cite web|url=https://www.prb.org/howmanypeoplehaveeverlivedonearth/|title=How Many People Have Ever Lived on Earth? – Population Reference Bureau|language=en-US|access-date=2019-01-23}}</ref> As of January 2019, 416 people are known to be cryopreserved.
 
The first people to start advocating for cryonics emerged in 1962, and the first preservation happened 4 years later. From 1966 until 1973, of the 17 attempts at freezing, only one person remained cryopreserved<ref name="SuspensionFailures"/> (hence the bumps at the beginning of the curve in the graph below). Consequently, the "pay-as-you-go" funding model was abandoned by the cryonics community as relatives had shown to generally eventually lose interest in paying maintenance fees. From then onward, the number of cryopreservations would grow exponentially, but to this day still represent a trivial amount in comparison to the number of burials and cremations. Since cryonics was first publicized, an estimated 2.9 billion people have died,<ref>{{Cite journal|last=Ortiz-Ospina|first=Esteban|last2=Roser|first2=Max|date=2019-01-23|title=World Population Growth|url=https://ourworldindata.org/world-population-growth|journal=Our World in Data}}</ref> which could represent about 2.7% of humans to have ever lived.<ref>{{Cite web|url=https://www.prb.org/howmanypeoplehaveeverlivedonearth/|title=How Many People Have Ever Lived on Earth? – Population Reference Bureau|language=en-US|access-date=2019-01-23}}</ref> As of January 2019, 416 people are known to be cryopreserved.
  
The following graph shows an history of the number of bodies preserved (complete or neuro-only). Given that the quality of preservations varies a lot, and it can often take many hours or even days before someone gets preserved from the time of their clinical death,<ref name="AlcorCase"/><ref>{{Cite web|url=https://www.cryonics.org/case-reports/|title=Case Reports {{!}} Cryonics Institute|website=www.cryonics.org|access-date=2019-01-23}}</ref> the graph below represents an upper bound of the number of people that are preserved: some have probably been irreversibly lost, and some might only have been partially preserved. Given that we don't currently know how effective current preservation methods are, the lower bound for the number of people that have been preserved remains 0.
+
The following graph shows a history of the number of bodies preserved (complete or neuro-only). Given that the quality of preservations varies a lot, and it can often take many hours or even days before someone gets preserved from the time of their clinical death,<ref name="AlcorCase"/><ref>{{Cite web|url=https://www.cryonics.org/case-reports/|title=Case Reports {{!}} Cryonics Institute|website=www.cryonics.org|access-date=2019-01-23}}</ref> the graph below represents an upper bound of the number of people that are preserved: some have probably been irreversibly lost, and some might only have been partially preserved. Given that we don't currently know how effective current preservation methods are, the lower bound for the number of people that have been preserved remains 0.
  
 
[[File:Number_of_people_preserved_over_time.png]]
 
[[File:Number_of_people_preserved_over_time.png]]
 +
 +
The following graph shows the number of patients over time for many organizations.
 +
 +
[[File:Cryopreservation_count_per_organisation_over_time.png]]
  
 
==== Members ====
 
==== Members ====
 
Memberships statistics can be tricky to track for a couple of reasons:
 
Memberships statistics can be tricky to track for a couple of reasons:
* Lack of present data: some organisations don't publicize their membership statistics
+
* Lack of present data: some organizations don't publicize their membership statistics
* Lack of historical data: some organisations only started tracking their membership statistics later in their history
+
* Lack of historical data: some organizations only started tracking their membership statistics later in their history
* Lack of cryonics membership data: the Cryonics Institute stopped publicizing the quantity of their members that are fully-funded since 2015, and now only reports the number of members they have; some are also members only for other of their services, such as DNA preservation
+
* Lack of cryonics membership data: the Cryonics Institute stopped publicizing the number of their members that are fully-funded since 2015, and now only reports the number of members they have; some are also members only for other of their services, such as DNA preservation
* Dual memberships: some cryonicists are members of more than one organisation, often to support several organisations, or as a fall-back for themselves if one organisation was to fail in some ways.
+
* Dual memberships: some cryonicists are members of more than one organization, often to support several organizations, or as a fall-back for themselves if one organization was to fail in some ways.
  
Alcor is the only large cryonics organisation that has tracked the number of fully-funded members it has had since its beginnings.<ref>{{Cite web|url=https://alcor.org/AboutAlcor/membershipstats.html|title=Alcor: Membership Statistics|website=alcor.org|access-date=2019-01-23}}</ref> The graph below shows the change in its membership quantity. The recent growth has been pretty linear. However, given that there are more and more cryonics organisations, worldwide cryonics memberships is likely to approach more of an exponential growth.
+
Alcor is the only large cryonics organization that has tracked the number of fully-funded members it has had since its beginnings.<ref>{{Cite web|url=https://alcor.org/AboutAlcor/membershipstats.html|title=Alcor: Membership Statistics|website=alcor.org|access-date=2019-01-23}}</ref> All Alcor members are subscribed to standby services. The Cryonics Institute has tracked the number of members it has signed up with standby services since it started offering it in 2006.<ref>{{Cite web|url=https://www.cryonics.org/ci-landing/member-statistics/|title=Member Statistics {{!}} Cryonics Institute|website=www.cryonics.org|access-date=2019-02-15}}</ref> It also has a lot of members that are signed up but plan to use the services of a funeral director for transport{{snd}}this number is however unknown to the public. The graph below tracks those two numbers. The recent growth has been pretty linear. However, given that there are more and more cryonics organizations, worldwide cryonics memberships is likely growing exponentially.
  
[[File:Number_of_Alcor_members.png]]
+
[[File:Number_of_members_2019-01.png]]
  
 
=== Cost ===
 
=== Cost ===
Alcor and the Cryonics Institute are the main cryonics providers that have existed for decades.<ref group=note>Trans Time has also existed for a long time, but they haven't always been offering cryonics services, and only have 3 patients in storage. The American Cryonics Society has also existed for a long time, but they contract with other cryonics providers.</ref> Alcor has been adjusting their prices according to the Consumer Price Index (which has been lower than medical inflation), while the Cryonics Institute has maintained their initial price. The first graph below shows the [[wikipedia:Real versus nominal value (economics)|nominal cost]] charged by the organisation, while the second graph shows the [[wikipedia:Real versus nominal value (economics)|real cost]] (that is inflation adjusted) of various cryonics services.  
+
Alcor and the Cryonics Institute are the main cryonics providers that have existed for decades.<ref group=note>Trans Time has also existed for a long time, but they haven't always been offering cryonics services, and only have 3 patients in storage. The American Cryonics Society has also existed for a long time, but they contract with other cryonics providers.</ref> Alcor has been adjusting its prices according to the Consumer Price Index (which has been lower than medical inflation), while the Cryonics Institute has maintained its initial price. The first graph below shows the [[wikipedia:Real versus nominal value (economics)|nominal cost]] charged by the organization, while the second graph shows the [[wikipedia:Real versus nominal value (economics)|real cost]] (that is inflation adjusted) of various cryonics services.  
  
While the graphs start in 1976, it is worth nothing that before 1982, Alcor was contracting Trans Time for its storage services, and the Institute for Advanced Biological Studies for its stabilization services. Also, beside Ettinger's mother and wife, the first patient of the Cryonics Institute was preserved in 1991.
+
While the graphs start in 1976, it is worth noting that before 1982, Alcor was contracting Trans Time for its storage services, and the Institute for Advanced Biological Studies for its stabilization services. Also, besides Ettinger's mother and wife, the first patient of the Cryonics Institute was preserved in 1991.
  
A direct comparison between the prices of different organisations is difficult because of the different services provided, and different types of payments. For example, Alcor has an annual membership fee, and has surcharges for late-minute cases. Some of the reason for Alcor's higher price than the Cryonics Institute includes the cost of stabilization and transport, as well as being more financially conservative by putting more money aside in a patient care trust.
+
A direct comparison between the prices of different organizations is difficult because of the different services provided, and different types of payments. For example, Alcor has an annual membership fee and has surcharges for late-minute cases. Some of the reason for Alcor's higher price than the Cryonics Institute includes the cost of stabilization and transport, as well as being more financially conservative by putting more money aside in a patient care trust.
  
 
The graphs below show the price of cryonics for whole-body and / or neuro-only as offered by Alcor<ref>{{Cite web|url=https://alcor.org/Library/html/CryopreservationFundingAndInflation.html|title=Crypreservation Funding and Inflation|website=alcor.org|access-date=2019-01-31}}</ref><ref>{{Cite web|url=https://alcor.org/BecomeMember/|title=Alcor: Membership Info - How to Join|website=alcor.org|access-date=2019-01-31}}</ref>, the Cryonics Institute<ref>{{Cite web|url=https://www.cryonics.org/ci-landing/funding-for-cryostasis/|title=Funding for Cryostasis {{!}} Cryonics Institute|website=www.cryonics.org|access-date=2019-01-31}}</ref>, OregonCryo<ref>{{Cite web|url=http://oregoncryo.com/services.html|title=Oregon Cryonics - Services|website=oregoncryo.com|access-date=2019-01-31}}</ref>, KrioRus<ref>{{Cite web|url=http://kriorus.ru/en/Human-cryopreservation|title=Human cryopreservation {{!}} KrioRus|website=kriorus.ru|access-date=2019-01-31}}</ref>. The second graph has prices inflation adjusted in 2018 USD.
 
The graphs below show the price of cryonics for whole-body and / or neuro-only as offered by Alcor<ref>{{Cite web|url=https://alcor.org/Library/html/CryopreservationFundingAndInflation.html|title=Crypreservation Funding and Inflation|website=alcor.org|access-date=2019-01-31}}</ref><ref>{{Cite web|url=https://alcor.org/BecomeMember/|title=Alcor: Membership Info - How to Join|website=alcor.org|access-date=2019-01-31}}</ref>, the Cryonics Institute<ref>{{Cite web|url=https://www.cryonics.org/ci-landing/funding-for-cryostasis/|title=Funding for Cryostasis {{!}} Cryonics Institute|website=www.cryonics.org|access-date=2019-01-31}}</ref>, OregonCryo<ref>{{Cite web|url=http://oregoncryo.com/services.html|title=Oregon Cryonics - Services|website=oregoncryo.com|access-date=2019-01-31}}</ref>, KrioRus<ref>{{Cite web|url=http://kriorus.ru/en/Human-cryopreservation|title=Human cryopreservation {{!}} KrioRus|website=kriorus.ru|access-date=2019-01-31}}</ref>. The second graph has prices inflation adjusted in 2018 USD.
 +
 +
The raw data of those graphs are available in the Google Sheet [https://docs.google.com/spreadsheets/d/1uEvT8oHOQJOOYzYglkFgrEgKbhbkz1A0jdO5OYZPwEk/edit#gid=339140001 Timeline of brain preservation: cost].
  
 
[[File:Historical_cost_of_cryonics.png]]
 
[[File:Historical_cost_of_cryonics.png]]
Line 58: Line 64:
 
|-
 
|-
 
| 1897-1961 || Early cryobiology research starts, and reaches one of the first important success by cryopreserving human sperms by 1961.
 
| 1897-1961 || Early cryobiology research starts, and reaches one of the first important success by cryopreserving human sperms by 1961.
During that time, the idea of cryonics is conceived by various people; presumably independently from each other. In 1901, Porfiry Ivanovich Bakhmetyev suggests using the phenomenon of anabiosis to prolong human life, to “travel to the future”. In 1931, Neil R. Jones writes a story about someone preserved in orbit because of the cold temperature. In 1948, Robert Ettinger publishes a story explaining the idea of cryonics. In 1962, Evan Cooper publishes "Immortality: Physically, Scientifically, Now" and coins the slogan "freeze, wait, reanimate".
+
During that time, the idea of cryonics is conceived by various people; presumably independently from each other. In 1901, Porfiry Ivanovich Bakhmetyev suggests using the phenomenon of anabiosis to prolong human life, to “travel to the future”. In 1931, Neil R. Jones writes a story about someone preserved in orbit due to the cold temperature. In 1948, Robert Ettinger publishes a story on suspended animation, which addresses various cryonics issues. In 1962, Evan Cooper publishes "Immortality: Physically, Scientifically, Now" and coins the slogan "freeze, wait, reanimate". In the same year, Ettinger privately publishes "The Prospect of Immortality" which would be pivotal for the growth of cryonics.
 
|-
 
|-
| 1960-1966 || The first cryonics activists start grouping, and developping the capabilities to perform cryopreservations. They have difficulty finding a first person interested in receiving the procedure.
+
| 1960-1966 || The first cryonics activists start grouping and developing the capabilities to perform cryopreservations. They have difficulty finding a first person interested in receiving the procedure.
 
|-
 
|-
| 1966-1975 || Early cryonics organisations struggle to maintain their patients in liquid nitrogen. Out of 22 cryopreservations done during that period, only 3 would remain preserved to this day [2019].
+
| 1966-1975 || Early cryonics organizations struggle to maintain their patients in liquid nitrogen. Out of 22 cryopreservations done during that period, only 3 would remain preserved to this day [2020].
 
|-
 
|-
| 1976-1990 || The two cryonics organisations that have provided continuous service for the longest time and have the most members are created in 1976. They would slowly grow during the following years.
+
| 1974-1990 || The two cryonics organizations that have provided continuous service for the longest time and have the most members, Alcor and the Cryonics Institute, are created in 1976. They would slowly grow during the following years. The American Cryonics Society would have patients under its responsibility from 1974 up to this day [2020].
 
|-
 
|-
 
| 1991-2000 || The Cryonics Institute preserves their third patient in 1991{{snd}}the first two being relatives from the founder, {{W|Robert Ettinger}}. Alcor and the Cryonics Institute start getting more members and patients.
 
| 1991-2000 || The Cryonics Institute preserves their third patient in 1991{{snd}}the first two being relatives from the founder, {{W|Robert Ettinger}}. Alcor and the Cryonics Institute start getting more members and patients.
 
|-
 
|-
| 2001-2018 || Alcor starts using a vitrification solution in 2001, and the Cryonics Institute follows in 2004. Some CT scans analyzed in 2018 by Mike Darwin would reveal that Alcor member Fred Chamberlain III, cryopreserved in 2012, was the first patient that was demonstrated to have their brain cryopreserved essentially ice-free. In 2015, {{W|21st Century Medicine}} wins a prize from the {{W|Brain Preservation Foundation}} for having demonstrably preserved the connectome of a pig with a technique combining vitrification and fixation.
+
| 2001-2018 || Alcor starts using a vitrification solution in 2001, and the Cryonics Institute follows in 2004. In 2018, Mike Darwin reports, from CT scans he analyzed, that Alcor member Fred Chamberlain III, cryopreserved in 2012, was the first patient to demonstratively have their brain cryopreserved essentially ice-free. In 2015, {{W|21st Century Medicine}} wins a prize from the {{W|Brain Preservation Foundation}} for having demonstrably preserved the connectome of a pig with a technique combining vitrification and fixation.
 
|}
 
|}
  
 
== Full timeline ==
 
== Full timeline ==
  
The events in the timeline are sometimes classified in the following categories and sub-categories:
+
The events in the timeline are sometimes classified in the following categories, types and sub-types.
* science: paper, observation
+
 
* R&D
+
'''Categories:'''
* technological adoption: cold, cryonics, vitrification, field cryoprotection, fixation, intermediate storage temperature
+
* Brain preservation
* writing: letter, fiction, communication, non-fiction, newsletter
+
* {{W|Cryonics}}
* social: meeting, conference
+
* {{W|Cryobiology}}
* political
+
* {{W|Cryogenics}}
* organisation: pref-founding, founding, first
+
* {{W|Suspended animation}}
* legal: right-to-die
+
* Reanimation
 +
 
 +
'''Types:'''
 +
* General Progress:
 +
** Futurism, fiction
 +
** Science
 +
** Technological development (ie. engineering, research and development)
 +
** Technological adoption (ie. commercialization)
 +
** Quality assessment
 +
* Societal context:
 +
** Social
 +
** Legal
 +
** Risk management
 +
* Organization Progress
 +
 
 +
'''Sub-Types:'''
 +
* Science, technological development, technological assessment: nature, theory, cold, cryonics, cryoprotection, vitrification, toxicity, vitrifixation, field cryoprotection, fixation, intermediate storage temperature, fracturing
 +
* Social:
 +
** Event: festival, meeting, conference
 +
** Writing: newsletter, communication, textbook, journal, paper, open letter, email list, fiction, blog, writeup
 +
** Other: groups, bylaws
 +
* Legal: cryopreservation, life insurance, right-to-die, classification
 +
* Organization: founding, milestone, status
 +
* Risk management: natural catastrophes, economic stability
  
You can click on the header to sort the events by type or subtype.
+
You can click on the header to sort the events by categories, types or subtypes.
  
 
{| class="sortable wikitable"
 
{| class="sortable wikitable"
 
! Date !! Category !! Type !! Subtype !! Organisation or individual !! Event
 
! Date !! Category !! Type !! Subtype !! Organisation or individual !! Event
 
 
|-
 
|-
 
| 1773-04 || cryonics || futurism || || {{W|Benjamin Franklin}} || In a letter to Jacques Dubourg, {{W|Benjamin Franklin}} says: "I wish it were possible&nbsp;...to invent a method of embalming drowned persons, in such a manner that they might be recalled to life at any period, however distant; for having a very ardent desire to see and observe the state of America a hundred years hence, I should prefer to an ordinary death, being immersed with a few friends in a cask of Madeira, until that time, then to be recalled to life by the solar warmth of my dear country! But&nbsp;... in all probability, we live in a century too little advanced, and too near the infancy of science, to see such an art brought in our time to its perfection&nbsp;...".<ref>{{Cite web|url=https://en.wikisource.org/wiki/Page:Works_of_the_Late_Doctor_Benjamin_Franklin_(1793).djvu/233|title=Page:Works of the Late Doctor Benjamin Franklin (1793).djvu/233 - Wikisource, the free online library|website=en.wikisource.org|access-date=2019-01-21}}</ref>
 
| 1773-04 || cryonics || futurism || || {{W|Benjamin Franklin}} || In a letter to Jacques Dubourg, {{W|Benjamin Franklin}} says: "I wish it were possible&nbsp;...to invent a method of embalming drowned persons, in such a manner that they might be recalled to life at any period, however distant; for having a very ardent desire to see and observe the state of America a hundred years hence, I should prefer to an ordinary death, being immersed with a few friends in a cask of Madeira, until that time, then to be recalled to life by the solar warmth of my dear country! But&nbsp;... in all probability, we live in a century too little advanced, and too near the infancy of science, to see such an art brought in our time to its perfection&nbsp;...".<ref>{{Cite web|url=https://en.wikisource.org/wiki/Page:Works_of_the_Late_Doctor_Benjamin_Franklin_(1793).djvu/233|title=Page:Works of the Late Doctor Benjamin Franklin (1793).djvu/233 - Wikisource, the free online library|website=en.wikisource.org|access-date=2019-01-21}}</ref>
Line 93: Line 121:
 
| 1883-04-15 || cryogenics || technological development || cold || {{W|Jagiellonian University}} || Nitrogen is liquefied by {{W|Zygmunt Wróblewski}} and {{W|Karol Olszewski}}.<ref>{{cite book|url=https://books.google.com/books?id=8SKrWdFLEd4C&pg=PA249|page=249|title=A Short History of the Progress of Scientific Chemistry in Our Own Times|author=Tilden, William Augustus |publisher=BiblioBazaar, LLC|year=2009|isbn=1-103-35842-1}}</ref>
 
| 1883-04-15 || cryogenics || technological development || cold || {{W|Jagiellonian University}} || Nitrogen is liquefied by {{W|Zygmunt Wróblewski}} and {{W|Karol Olszewski}}.<ref>{{cite book|url=https://books.google.com/books?id=8SKrWdFLEd4C&pg=PA249|page=249|title=A Short History of the Progress of Scientific Chemistry in Our Own Times|author=Tilden, William Augustus |publisher=BiblioBazaar, LLC|year=2009|isbn=1-103-35842-1}}</ref>
 
|-
 
|-
| 1897 || cryobiology || science || || [https://ru.m.wikipedia.org/wiki/%D0%91%D0%B0%D1%85%D0%BC%D0%B5%D1%82%D1%8C%D0%B5%D0%B2,_%D0%9F%D0%BE%D1%80%D1%84%D0%B8%D1%80%D0%B8%D0%B9_%D0%98%D0%B2%D0%B0%D0%BD%D0%BE%D0%B2%D0%B8%D1%87 Porfiry Ivanovich Bakhmetyev] || [https://ru.m.wikipedia.org/wiki/%D0%91%D0%B0%D1%85%D0%BC%D0%B5%D1%82%D1%8C%D0%B5%D0%B2,_%D0%9F%D0%BE%D1%80%D1%84%D0%B8%D1%80%D0%B8%D0%B9_%D0%98%D0%B2%D0%B0%D0%BD%D0%BE%D0%B2%D0%B8%D1%87 Porfiry Ivanovich Bakhmetyev] starts studying the phenomena of anabiosis during overcooling of animals.
+
| 1897 || cryobiology || science || || {{w|Porfiry Ivanovich Bakhmetyev}} || {{w|Porfiry Ivanovich Bakhmetyev}} starts studying the phenomena of anabiosis during overcooling of animals.
 
|-
 
|-
 
| 1901 || cryonics || futurism || || [https://ru.m.wikipedia.org/wiki/%D0%91%D0%B0%D1%85%D0%BC%D0%B5%D1%82%D1%8C%D0%B5%D0%B2,_%D0%9F%D0%BE%D1%80%D1%84%D0%B8%D1%80%D0%B8%D0%B9_%D0%98%D0%B2%D0%B0%D0%BD%D0%BE%D0%B2%D0%B8%D1%87 Porfiry Ivanovich Bakhmetyev] || In his essay “The Recipe for Survival to the 21st Century” (“Natural Science and Geography”, 1901), [https://ru.m.wikipedia.org/wiki/%D0%91%D0%B0%D1%85%D0%BC%D0%B5%D1%82%D1%8C%D0%B5%D0%B2,_%D0%9F%D0%BE%D1%80%D1%84%D0%B8%D1%80%D0%B8%D0%B9_%D0%98%D0%B2%D0%B0%D0%BD%D0%BE%D0%B2%D0%B8%D1%87 Porfiry Ivanovich Bakhmetyev] suggests using the phenomenon of anabiosis to prolong human life, to “travel to the future”.<ref>{{Cite web|url=http://www.fandom.ru/about_fan/hal_59.htm|title=ЏредвидениЯ ЏорфириЯ Ѓахметьева - ”антаст|website=www.fandom.ru|access-date=2019-02-04}}</ref>
 
| 1901 || cryonics || futurism || || [https://ru.m.wikipedia.org/wiki/%D0%91%D0%B0%D1%85%D0%BC%D0%B5%D1%82%D1%8C%D0%B5%D0%B2,_%D0%9F%D0%BE%D1%80%D1%84%D0%B8%D1%80%D0%B8%D0%B9_%D0%98%D0%B2%D0%B0%D0%BD%D0%BE%D0%B2%D0%B8%D1%87 Porfiry Ivanovich Bakhmetyev] || In his essay “The Recipe for Survival to the 21st Century” (“Natural Science and Geography”, 1901), [https://ru.m.wikipedia.org/wiki/%D0%91%D0%B0%D1%85%D0%BC%D0%B5%D1%82%D1%8C%D0%B5%D0%B2,_%D0%9F%D0%BE%D1%80%D1%84%D0%B8%D1%80%D0%B8%D0%B9_%D0%98%D0%B2%D0%B0%D0%BD%D0%BE%D0%B2%D0%B8%D1%87 Porfiry Ivanovich Bakhmetyev] suggests using the phenomenon of anabiosis to prolong human life, to “travel to the future”.<ref>{{Cite web|url=http://www.fandom.ru/about_fan/hal_59.htm|title=ЏредвидениЯ ЏорфириЯ Ѓахметьева - ”антаст|website=www.fandom.ru|access-date=2019-02-04}}</ref>
 
|-
 
|-
| 1931-07 || cryonics || writing || fiction || {{W|Robert Ettinger}} || {{W|Robert Ettinger}} reads Neil R. Jones' newly published story, "The Jameson Satellite",<ref name="regis87">{{cite book |title= Great Mambo Chicken and the Transhuman Condition: Science Slightly Over The Edge|last= Regis|first= Ed|authorlink=wikipedia:Ed Regis (author) |coauthors= |year= 1991|publisher= Westview Press|location= |isbn= 0-201-56751-2|page= |pages= 87–88|url= }}</ref>, in which a professor has his corpse sent into earth orbit where it would remain preserved indefinitely at near absolute zero (note: this is not scientifically accurate), until millions of years later, when, with humanity extinct, a race of mechanical beings discovers, revives, and repairs him by transferring his brain in a mechanical body.<ref name="RCWE">{{cite web | title = Robert Ettinger | publisher = Cryonics Institute | url = http://www.cryonics.org/bio.html#Robert_Ettinger | accessdate = May 24, 2009 | deadurl = yes | archiveurl = https://www.webcitation.org/6ASYHJ6M9?url=http://www.cryonics.org/bio.html#Robert_Ettinger | archivedate = September 5, 2012 | df = mdy-all }}</ref>
+
| 1931-07 || cryonics || social || fiction || {{W|Robert Ettinger}} || {{W|Robert Ettinger}} reads {{W|Neil R. Jones}}' newly published story, "The Jameson Satellite",<ref name="regis87">{{cite book |title= Great Mambo Chicken and the Transhuman Condition: Science Slightly Over The Edge|last= Regis|first= Ed|authorlink=wikipedia:Ed Regis (author) |coauthors= |year= 1991|publisher= Westview Press|location= |isbn= 0-201-56751-2|page= |pages= 87–88|url= }}</ref>, in which a professor has his corpse sent into earth orbit where it would remain preserved indefinitely at near absolute zero (note: this is not scientifically accurate), until millions of years later, when, with humanity extinct, a race of mechanical beings discovers, revives, and repairs him by transferring his brain in a mechanical body.<ref name="RCWE">{{cite web | title = Robert Ettinger | publisher = Cryonics Institute | url = http://www.cryonics.org/bio.html#Robert_Ettinger | accessdate = May 24, 2009 | deadurl = yes | archiveurl = https://www.webcitation.org/6ASYHJ6M9?url=http://www.cryonics.org/bio.html#Robert_Ettinger | archivedate = September 5, 2012 | df = mdy-all }}</ref>
 
|-
 
|-
| 1936 || reanimatology || organisation || founding || Negovsky || Negovsky founds the first resuscitation research laboratory in the world. In 1986 his laboratory would be renamed Institute of Reanimatology of the USSR (since 1991 of the Russian) Academy of Medical Sciences. This marks the inception of both reanimatology (resuscitation medicine) and critical care medicine both of which would be crucial to the credibility of cryonics paradigm.<ref>{{Cite journal|last=Safar|first=P.|date=June 2001|title=Vladimir A. Negovsky the father of 'reanimatology'|url=https://www.ncbi.nlm.nih.gov/pubmed/11723996|journal=Resuscitation|volume=49|issue=3|pages=223–229|issn=0300-9572|pmid=11723996}}</ref>
+
| 1936 || reanimatology || organization || founding || Negovsky || Negovsky founds the first resuscitation research laboratory in the world. In 1986 his laboratory would be renamed Institute of Reanimatology of the USSR (since 1991 of the Russian) Academy of Medical Sciences. This marks the inception of both reanimatology (resuscitation medicine) and critical care medicine both of which would be crucial to the credibility of cryonics paradigm.<ref name="reanimatology">{{Cite journal|last=Safar|first=P.|date=June 2001|title=Vladimir A. Negovsky the father of 'reanimatology'|url=https://www.ncbi.nlm.nih.gov/pubmed/11723996|journal=Resuscitation|volume=49|issue=3|pages=223–229|issn=0300-9572|pmid=11723996|doi=10.1016/s0300-9572(01)00356-2}}</ref>
 
|-
 
|-
| 1938 || cryobiology || || || || Alexander Goetz and S. Scott Goetz publish a paper discussing vitrification and crystallization of organic cells at low temperatures.
+
| 1938 || cryobiology || science || vitrification || Goetz, Goetz || Alexander Goetz and S. Scott Goetz publish a paper discussing vitrification and crystallization of organic cells at low temperatures.
 
|-
 
|-
| 1940 || cryobiology || writing || book || Basil Luyet, Marie Pierre Gehino || Basil Luyet and Marie Pierre Gehino publish "[https://books.google.ca/books/about/Life_and_Death_at_Low_Temperatures.html?id=a3YMtAEACAAJ Life and Death at Low Temperatures]", the book which marks the beginning of cryobiology as a formal area of study. In this landmark work they document the survival of a wide variety of cells and some tissues after ultra-rapid cooling to -194.5°C providing that ice formation in the tissue is inhibited by vitrification due to the ultra-rapid cooling.<ref>{{Cite book|url=http://worldcat.org/oclc/716713726|title=Life and death at low temperatures|last=J.|first=Luyet, B.|date=1940|publisher=Biodynamica|oclc=716713726}}</ref>
+
| 1940 || cryobiology || science || || Basil Luyet, Marie Pierre Gehino || Basil Luyet and Marie Pierre Gehino publish "[https://books.google.ca/books/about/Life_and_Death_at_Low_Temperatures.html?id=a3YMtAEACAAJ Life and Death at Low Temperatures]", the book which marks the beginning of cryobiology as a formal area of study. In this landmark work, they document the survival of a wide variety of cells and some tissues after ultra-rapid cooling to -194.5°C providing that ice formation in the tissue is inhibited by vitrification due to the ultra-rapid cooling.<ref>{{Cite book|url=http://worldcat.org/oclc/716713726|title=Life and death at low temperatures|last=J.|first=Luyet, B.|date=1940|publisher=Biodynamica|oclc=716713726}}</ref>
 
|-
 
|-
 
| 1940s || cryogenics || technological development || cold || || {{W|Liquid nitrogen}} becomes commercially available.<ref>{{Cite journal|last=Cooper|first=S M|last2=Dawber|first2=R P R|date=April 2001|title=The history of cryosurgery|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1281398/|journal=Journal of the Royal Society of Medicine|volume=94|issue=4|pages=196–201|issn=0141-0768|pmc=1281398|pmid=11317629}}</ref>
 
| 1940s || cryogenics || technological development || cold || || {{W|Liquid nitrogen}} becomes commercially available.<ref>{{Cite journal|last=Cooper|first=S M|last2=Dawber|first2=R P R|date=April 2001|title=The history of cryosurgery|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1281398/|journal=Journal of the Royal Society of Medicine|volume=94|issue=4|pages=196–201|issn=0141-0768|pmc=1281398|pmid=11317629}}</ref>
 
|-
 
|-
| 1947 || cryogenics || || || Polge, Smith, Parkes || {{W|Robert Ettinger}}, while in the hospital for his battle wounds, discovers {{W|Jean Rostand}} research in {{W|cryogenics}}.<ref name="CITimeline">{{Cite web|url=https://www.cryonics.org/ci-landing/history-timeline/|title=History/Timeline {{!}} Cryonics Institute|website=www.cryonics.org|access-date=2019-01-21}}</ref>
+
| 1947 || cryogenics || social || || Polge, Smith, Parkes || {{W|Robert Ettinger}}, while in the hospital for his battle wounds, discovers {{W|Jean Rostand}} research in {{W|cryogenics}}.<ref name="CITimeline">{{Cite web|url=https://www.cryonics.org/ci-landing/history-timeline/|title=History/Timeline {{!}} Cryonics Institute|website=www.cryonics.org|access-date=2019-01-21}}</ref>
 
|-
 
|-
| 1948 || cryobiology || technological development || vitrification || || Polge, Smith and Parkes discover the cryoprotective effects of glycerol and publish a paper documenting the successful hatching of chicks from fowl sperm cryopreserved with glycerol.<ref>{{Cite journal|last=POLGE|first=C.|date=June 1951|title=Functional Survival of Fowl Spermatozoa after Freezing at −79° C.|url=http://dx.doi.org/10.1038/167949b0|journal=Nature|volume=167|issue=4258|pages=949–950|doi=10.1038/167949b0|issn=0028-0836}}</ref>
+
| 1948 || cryobiology || technological development || vitrification || || Polge, Smith, and Parkes discover the cryoprotective effects of glycerol and publish a paper documenting the successful hatching of chicks from fowl sperm cryopreserved with glycerol.<ref>{{Cite journal|last=POLGE|first=C.|date=June 1951|title=Functional Survival of Fowl Spermatozoa after Freezing at −79° C.|url=http://dx.doi.org/10.1038/167949b0|journal=Nature|volume=167|issue=4258|pages=949–950|doi=10.1038/167949b0|issn=0028-0836}}</ref>
 
|-
 
|-
| 1948-03 || cryonics || writing || fiction || {{W|Robert Ettinger}} || {{W|Robert Ettinger}} publishes the story [https://archive.is/20120801065253/http://www.cryonics.org/Trump.html The Penultimate Trump], in which the explicit idea of cryopreservation of legally dead people for future repair is promulgated. This story was written in 1947.<ref>{{Cite web|url=http://www.isfdb.org/cgi-bin/title.cgi?80014|title=Title: The Penultimate Trump|website=www.isfdb.org|access-date=2019-01-21}}</ref>
+
| 1948-03 || cryonics || social || fiction || {{W|Robert Ettinger}} || {{W|Robert Ettinger}} publishes the story [http://translatedby.com/you/the-penultimate-trump/original/ The Penultimate Trump] in the March 1948 issue of the magazine Startling Stories. This story was written in 1947. This is a suspended animation story where many of the questions and problems also common to cryonics are discussed.<ref>{{Cite web|url=http://www.isfdb.org/cgi-bin/title.cgi?80014|title=Title: The Penultimate Trump|website=www.isfdb.org|access-date=2019-01-21}}</ref>
 
|-
 
|-
 
| 1950-05 || cryobiology || technological development || vitrification || Luyet, Gonzales || Luyet and Gonzales achieve successful vitrification of chicken embryo hearts using ethylene glycol.<ref>{{Cite journal|last=Gonzales|first=F.|last2=Luyet|first2=B.|date=May 1950|title=Resumption of heart-beat in chick embryo frozen in liquid nitrogen|url=https://www.ncbi.nlm.nih.gov/pubmed/15426631|journal=Biodynamica|volume=7|issue=126-128|pages=1–5|issn=0006-3010|pmid=15426631}}</ref>
 
| 1950-05 || cryobiology || technological development || vitrification || Luyet, Gonzales || Luyet and Gonzales achieve successful vitrification of chicken embryo hearts using ethylene glycol.<ref>{{Cite journal|last=Gonzales|first=F.|last2=Luyet|first2=B.|date=May 1950|title=Resumption of heart-beat in chick embryo frozen in liquid nitrogen|url=https://www.ncbi.nlm.nih.gov/pubmed/15426631|journal=Biodynamica|volume=7|issue=126-128|pages=1–5|issn=0006-3010|pmid=15426631}}</ref>
 
|-
 
|-
| 1954-06 || suspended animation || science || nature || Smith et al. || Smith et al., demonstrate the ability of golden hamsters to recover and survive long term following freezing of ~60% of the water in their brains and the survival a full recovery of hamsters cooled to -5°C.<ref>{{Cite journal|last=Parkes|first=A. S.|last2=Lovelock|first2=J. E.|last3=Smith|first3=A. U.|date=June 1954|title=Resuscitation of Hamsters after Supercooling or Partial Crystallization at Body Temperatures Below 0° C.|url=https://www.nature.com/articles/1731136a0|journal=Nature|language=en|volume=173|issue=4415|pages=1136–1137|doi=10.1038/1731136a0|issn=1476-4687}}</ref>
+
| 1954-06 || suspended animation || science || nature || Smith et al. || Smith et al., demonstrate the ability of golden hamsters to recover and survive long term following the freezing of ~60% of the water in their brains and the survival a full recovery of hamsters cooled to -5°C.<ref>{{Cite journal|last=Parkes|first=A. S.|last2=Lovelock|first2=J. E.|last3=Smith|first3=A. U.|date=June 1954|title=Resuscitation of Hamsters after Supercooling or Partial Crystallization at Body Temperatures Below 0° C.|url=https://www.nature.com/articles/1731136a0|journal=Nature|language=en|volume=173|issue=4415|pages=1136–1137|doi=10.1038/1731136a0|issn=1476-4687}}</ref><ref>{{Cite journal |date=1956-07-24 |title=Studies on golden hamsters during cooling to and rewarming from body temperatures below 0° C. III. Biophysical aspects and general discussion |url=https://royalsocietypublishing.org/doi/10.1098/rspb.1956.0054 |journal=Proceedings of the Royal Society of London. Series B - Biological Sciences |language=en |volume=145 |issue=920 |pages=427–442 |doi=10.1098/rspb.1956.0054 |issn=2053-9193}}</ref> Related YouTube video: [https://www.youtube.com/watch?v=2tdiKTSdE9Y I promise this story about microwaves is interesting.].
 
|-
 
|-
 
| 1959-05 || cryobiology || technological development || vitrification || Lovelock, Bishop || Lovelock and Bishop discover the cryoprotective properties of dimethyl sulfoxide (Me2SO). Me2SO would subsequently become a mainstay of most experimental vitrification solutions used in organ preservation.<ref>{{Cite journal|last=LOVELOCK|first=J. E.|last2=BISHOP|first2=M. W. H.|date=May 1959|title=Prevention of Freezing Damage to Living Cells by Dimethyl Sulphoxide|url=http://dx.doi.org/10.1038/1831394a0|journal=Nature|volume=183|issue=4672|pages=1394–1395|doi=10.1038/1831394a0|issn=0028-0836}}</ref>
 
| 1959-05 || cryobiology || technological development || vitrification || Lovelock, Bishop || Lovelock and Bishop discover the cryoprotective properties of dimethyl sulfoxide (Me2SO). Me2SO would subsequently become a mainstay of most experimental vitrification solutions used in organ preservation.<ref>{{Cite journal|last=LOVELOCK|first=J. E.|last2=BISHOP|first2=M. W. H.|date=May 1959|title=Prevention of Freezing Damage to Living Cells by Dimethyl Sulphoxide|url=http://dx.doi.org/10.1038/1831394a0|journal=Nature|volume=183|issue=4672|pages=1394–1395|doi=10.1038/1831394a0|issn=0028-0836}}</ref>
 
|-
 
|-
| 1960 || cryonics || writing || communication || {{W|Robert Ettinger}} || {{W|Robert Ettinger}} expected other scientists to advocate for cryonics. Given that this still hasn't happened, Ettinger finally makes the scientific case for cryonics. He sends this to approximately 200 people whom he selected from ''Who's Who in America'', but got little response.<ref name="regis87"/>
+
| 1960 || cryonics || social || communication || {{W|Robert Ettinger}} || {{W|Robert Ettinger}} expected other scientists to advocate for cryonics. Given that this still hasn't happened, Ettinger finally makes the scientific case for cryonics. He sends this to approximately 200 people whom he selected from ''Who's Who in America'', but got little response.<ref name="regis87"/>
 
|-
 
|-
| 1960s || cryonics || organisation || founding || Cryo-Care Equipment Corporation || Cryo-Care Equipment Corporation in Phoenix, Arizona is founded by Ed Hope (not the same as the California organization with similar name). Unlike the others, it would build its own capsules, horizontal units on wheels for easy transport.
+
| 1960s || cryonics || organization || founding || Cryo-Care Equipment Corporation || Cryo-Care Equipment Corporation<ref group=note>not the same as the California organization with similar name</ref> in [[wikipedia:Phoenix, Arizona|Phoenix, Arizona]] is founded by Ed Hope. These freezings would be advertised as being for cosmetic purposes rather than eventual reanimation, though the cryonics issue would naturally arise.<ref group=note>Cryo-Care would not use cryoprotectants or perfusion with its patients but would only do straight freezes to liquid nitrogen temperature.</ref><ref name="SuspensionFailures"/>
 
 
Cryo-Care would not use cryoprotectants or perfusion with its patients but would only do straight freezes to liquid nitrogen temperature. These freezings would be advertised as being for cosmetic purposes rather than eventual reanimation, though the cryonics issue would naturally arise. <ref name="SuspensionFailures"/>
 
 
|-
 
|-
 
| 1961 || cryobiology || technological development || cryoprotection || Lovelock, Bishop || By 1961 the work of Lovelock and Bishop is rapidly extended to other animal sperm, including human sperm, and glycerol is also shown to be an effective cryoprotectant for both red cells and many nucleated mammalian cells.<ref>{{Cite book|url=http://worldcat.org/oclc/1027485685|title=Biological effects of freezing and supercooling|last=Ursula|first=Smith, Audrey|oclc=1027485685}}</ref>
 
| 1961 || cryobiology || technological development || cryoprotection || Lovelock, Bishop || By 1961 the work of Lovelock and Bishop is rapidly extended to other animal sperm, including human sperm, and glycerol is also shown to be an effective cryoprotectant for both red cells and many nucleated mammalian cells.<ref>{{Cite book|url=http://worldcat.org/oclc/1027485685|title=Biological effects of freezing and supercooling|last=Ursula|first=Smith, Audrey|oclc=1027485685}}</ref>
 
|-
 
|-
| 1962 || reanimatology || writing || book || Vladimir A. Negovsky || Vladimir A. Negovsky publishes his landmark book, "Resuscitation and Artificial Hypothermia".<ref>{{Cite book|title=Resuscitation and Artificial Hypothermia (USSR)|last=Negovsky|first=Vladimir|publisher=Consultants Bureau|year=1962|isbn=|location=New York|pages=}}</ref><ref>{{Cite journal|last=Safar|first=Peter|date=2001-06|title=Vladimir A. Negovsky the father of ‘reanimatology’|url=http://dx.doi.org/10.1016/s0300-9572(01)00356-2|journal=Resuscitation|volume=49|issue=3|pages=223–229|doi=10.1016/s0300-9572(01)00356-2|issn=0300-9572}}</ref>
+
| 1962 || reanimatology || science || || Vladimir A. Negovsky || Vladimir A. Negovsky publishes his landmark book, "Resuscitation and Artificial Hypothermia".<ref>{{Cite book|title=Resuscitation and Artificial Hypothermia (USSR)|last=Negovsky|first=Vladimir|publisher=Consultants Bureau|year=1962|isbn=|location=New York|pages=}}</ref><ref name="reanimatology"/>
 
|-
 
|-
| 1962 || cryonics || writing || non-fiction || Evan Cooper || Evan Cooper publishes "Immortality: Physically, Scientifically, Now" under the pseudonym Nathan Duhring.<ref name="cryonics9208">{{Cite journal|last=Perry|first=Michael|date=August 1992|title=Unity and Disunity in Cryonics|url=https://www.alcor.org/cryonics/cryonics9208.txt|journal=Cryonics|volume=13|issue=145|pages=5|via=}}</ref> He coins the immortal "freeze, wait, reanimate" slogan.<ref name="cryonet23124">{{Cite web|url=http://www.cryonet.org/cgi-bin/dsp.cgi?msg=23124|title=Ev Cooper|website=www.cryonet.org|access-date=2019-01-21}}</ref><ref name="EvCooperClassic">{{Cite web|url=https://www.biostasis.com/ev-coopers-cryonics-classic-published-online/|title=Ev Cooper's cryonics classic published online – Biostasis|language=en-US|access-date=2019-01-21}}</ref>
+
| 1962 || cryonics || social || book || Evan Cooper || Evan Cooper publishes "Immortality: Physically, Scientifically, Now" under the pseudonym Nathan Duhring.<ref name="cryonics9208">{{Cite journal|last=Perry|first=Michael|date=August 1992|title=Unity and Disunity in Cryonics|url=https://www.alcor.org/cryonics/cryonics9208.txt|journal=Cryonics|volume=13|issue=145|pages=5|via=}}</ref> He coins the immortal "freeze, wait, reanimate" slogan.<ref name="cryonet23124">{{Cite web|url=http://www.cryonet.org/cgi-bin/dsp.cgi?msg=23124|title=Ev Cooper|website=www.cryonet.org|access-date=2019-01-21}}</ref><ref name="EvCooperClassic">{{Cite web|url=https://www.biostasis.com/ev-coopers-cryonics-classic-published-online/|title=Ev Cooper's cryonics classic published online – Biostasis|language=en-US|access-date=2019-01-21}}</ref>
 
|-
 
|-
 
| 1962 || cryonics || futurism || || {{W|Robert Ettinger}} || Ettinger privately publishes a preliminary version of ''The Prospect of Immortality'', in which he makes the case for cryonics.<ref name="regis87"/>
 
| 1962 || cryonics || futurism || || {{W|Robert Ettinger}} || Ettinger privately publishes a preliminary version of ''The Prospect of Immortality'', in which he makes the case for cryonics.<ref name="regis87"/>
Line 135: Line 161:
 
| 1962 || cryonics || social || meeting || || About 20 people attend the first informal cryonics meeting.<ref name="cryonics9208"/>
 
| 1962 || cryonics || social || meeting || || About 20 people attend the first informal cryonics meeting.<ref name="cryonics9208"/>
 
|-
 
|-
| 1962 || cryonics || social || || Evan Cooper || After the first cryonics meeting, Cooper and a few other individuals form the Immortality Communication Exchange (ICE), an informal, "special-interest group" for the "freeze and wait" idea that would later be known as cryonics.<ref name="cryonics9208"/>
+
| 1962 || cryonics || social || group || Evan Cooper || After the first cryonics meeting, Cooper and a few other individuals form the Immortality Communication Exchange (ICE), an informal, "special-interest group" for the "freeze and wait" idea that would later be known as cryonics.<ref name="cryonics9208"/>
 
|-
 
|-
| 1963 || cryonics || organisation || founding || {{W|Life Extension Society}} || During the conference, the {{W|Life Extension Society}}, the first cryonics organization, is founded by Evan Cooper. It would be situated in Washington, D.C.<ref name="EvCooperClassic"/>
+
| 1964 || cryonics || organization || founding || {{W|Life Extension Society}} || During the conference, the {{W|Life Extension Society}}, the first cryonics organization, is founded by Evan Cooper. It would be situated in Washington, D.C.<ref name="EvCooperClassic"/>
 
|-
 
|-
 
| 1963-12-29 || cryonics || social || conference || || The first cryonics conference happens.<ref name="cryonics9208"/><ref name="firstNewsletter">{{Cite web|url=http://www.evidencebasedcryonics.org/2011/01/19/the-first-cryonics-newsletter/|title=The First Cryonics Newsletter|last=Perry|first=Mike|date=2011-01-19|website=Evidence Based Cryonics|archive-url=https://web.archive.org/web/20161126064131/http://www.evidencebasedcryonics.org/2011/01/19/the-first-cryonics-newsletter/|archive-date=2016-11-26|dead-url=|access-date=}}</ref>
 
| 1963-12-29 || cryonics || social || conference || || The first cryonics conference happens.<ref name="cryonics9208"/><ref name="firstNewsletter">{{Cite web|url=http://www.evidencebasedcryonics.org/2011/01/19/the-first-cryonics-newsletter/|title=The First Cryonics Newsletter|last=Perry|first=Mike|date=2011-01-19|website=Evidence Based Cryonics|archive-url=https://web.archive.org/web/20161126064131/http://www.evidencebasedcryonics.org/2011/01/19/the-first-cryonics-newsletter/|archive-date=2016-11-26|dead-url=|access-date=}}</ref>
 
|-
 
|-
| 1964 || cryonics || futurism || || {{W|Robert Ettinger}} || {{W|Robert Ettinger}}'s ''The Prospect of Immortality'' finally attracts attention of a major publisher, Doubleday, which sends a copy to [[wikipedia:Isaac Asimov|Isaac Asimov]]; Asimov says that the science behind cryonics is sound, so the book is published. The book becomes a selection of the Book of the Month Club and is published in nine languages. Ettinger becomes a media celebrity, discussed in many periodicals, television shows, and radio programs.<ref name="regis87"/>
+
| 1964 || cryonics || futurism || || {{W|Robert Ettinger}} || {{W|Robert Ettinger}}'s ''The Prospect of Immortality'' finally attracts the attention of a major publisher, Doubleday, which sends a copy to [[wikipedia:Isaac Asimov|Isaac Asimov]]; Asimov says that the science behind cryonics is sound, so the book is published. The book becomes a selection of the Book of the Month Club and is published in nine languages. Ettinger becomes a media celebrity, discussed in many periodicals, television shows, and radio programs.<ref name="regis87"/>
 
|-
 
|-
| 1964-01 || cryonics || writing || newsletter || || The first issue of the {{W|Life Extension Society}} Newsletter is published.<ref name="cryonics9208"/><ref name="firstNewsletter"/>
+
| 1964-01 || cryonics || social || newsletter || Life Extension Society || The first issue of the {{W|Life Extension Society}} Newsletter is published.<ref name="cryonics9208"/><ref name="firstNewsletter"/>
 
|-
 
|-
| 1965 || cryonics || || || Karl Werner || Karl Werner coins the word "{{W|cryonics}}".<ref name="BenBestCryonicsHistory">{{Cite web|url=http://www.benbest.com/cryonics/history.html|title=A HISTORY OF CRYONICS|website=www.benbest.com|access-date=2019-01-22}}</ref>
+
| 1965 || cryonics || social || || Karl Werner || Karl Werner coins the word "{{W|cryonics}}".<ref name="BenBestCryonicsHistory">{{Cite web|url=http://www.benbest.com/cryonics/history.html|title=A HISTORY OF CRYONICS|website=www.benbest.com|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1965 || cryonics || organisation || founding || Cryonics Society of New York || The Cryonics Society of New York (CSNY) is founded by {{W|Saul Kent}}, {{W|Curtis Henderson}} and Karl Werner. CSNY is a non-profit organisation contracting with the for-profit organisation Cryospan for cryonics freezing and storage.<ref name="BenBestCryonicsHistory"/><ref>{{Cite news|url=https://www.theguardian.com/science/2009/nov/07/cryonics-british-dads-army|title=The Dad's Army of British cryonics|last=Hattenstone|first=Simon|date=2009-11-07|work=The Guardian|access-date=2019-01-22|language=en-GB|issn=0261-3077}}</ref>
+
| 1965 || cryonics || organization || founding || Cryonics Society of New York || The Cryonics Society of New York (CSNY) is founded by {{W|Saul Kent}}, {{W|Curtis Henderson}} and Karl Werner. CSNY is a non-profit organization contracting with the for-profit organization Cryospan for cryonics freezing and storage.<ref name="BenBestCryonicsHistory"/><ref>{{Cite news|url=https://www.theguardian.com/science/2009/nov/07/cryonics-british-dads-army|title=The Dad's Army of British cryonics|last=Hattenstone|first=Simon|date=2009-11-07|work=The Guardian|access-date=2019-01-22|language=en-GB|issn=0261-3077}}</ref>
 
|-
 
|-
| 1965-03 || cryobiology || technological development || cryoprotection || James Farrant || James Farrant shows that viable ice free cryopreservation of a highly organized tissue is possible and that eliminating ice formation, even at -79 °C, eliminates virtually all of the extensive mechanical (histological) and ultrastructural disruption observed with conventional cryoprotection and freezing of complex tissues.<ref>{{Cite journal|last=FARRANT|first=J.|date=March 1965|title=Mechanism of Cell Damage During Freezing and Thawing and its Prevention|url=http://dx.doi.org/10.1038/2051284a0|journal=Nature|volume=205|issue=4978|pages=1284–1287|doi=10.1038/2051284a0|issn=0028-0836}}</ref>
+
| 1965-03 || cryobiology || technological development || cryoprotection || James Farrant || James Farrant shows that viable ice-free cryopreservation of a highly organized tissue is possible and that eliminating ice formation, even at -79 °C, eliminates virtually all of the extensive mechanical (histological) and ultrastructural disruption observed with conventional cryoprotection and freezing of complex tissues.<ref>{{Cite journal|last=FARRANT|first=J.|date=March 1965|title=Mechanism of Cell Damage During Freezing and Thawing and its Prevention|url=http://dx.doi.org/10.1038/2051284a0|journal=Nature|volume=205|issue=4978|pages=1284–1287|doi=10.1038/2051284a0|issn=0028-0836}}</ref>
 
|-
 
|-
 
| 1965-05-20 || cryonics || || || {{W|Life Extension Society}} || Wilma Jean McLaughlin of Springfield, Ohio dies from heart and circulatory problems. Ev Cooper would fill a report the following day "The woman who almost became the first person frozen for a possible reanimation in the future died yesterday." The attempt to freeze her is abandoned. While reports on this event would vary, many would mention the lack of preparation, cooperation from various people, and explicit consent as obstacles to the freezing.<ref name="BedfordSuspension">{{Cite web|url=https://alcor.org/Library/html/BedfordSuspension.html|title=The First Cryonic Suspension|website=alcor.org|access-date=2019-01-22}}</ref>
 
| 1965-05-20 || cryonics || || || {{W|Life Extension Society}} || Wilma Jean McLaughlin of Springfield, Ohio dies from heart and circulatory problems. Ev Cooper would fill a report the following day "The woman who almost became the first person frozen for a possible reanimation in the future died yesterday." The attempt to freeze her is abandoned. While reports on this event would vary, many would mention the lack of preparation, cooperation from various people, and explicit consent as obstacles to the freezing.<ref name="BedfordSuspension">{{Cite web|url=https://alcor.org/Library/html/BedfordSuspension.html|title=The First Cryonic Suspension|website=alcor.org|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1965-06 || cryonics || organisation || || {{W|Life Extension Society}} || The {{W|Life Extension Society}} offers to freeze the first person for free: "The {{W|Life Extension Society}} now has primitive facilities for emergency short term freezing and storing our friend the large homeotherm (man). LES offers to freeze free of charge the first person desirous and in need of cryogenic suspension." No one would take them on their offer.<ref name="BedfordSuspension"/>
+
| 1965-06 || cryonics || organization || milestone || {{W|Life Extension Society}} || The {{W|Life Extension Society}} offers to freeze the first person for free: "The {{W|Life Extension Society}} now has primitive facilities for emergency short term freezing and storing our friend the large homeotherm (man). LES offers to freeze free of charge the first person desirous and in need of cryogenic suspension." No one would take them on their offer.<ref name="BedfordSuspension"/>
 
|-
 
|-
| 1965-10-30 || cryonics || || || Dandridge M. Cole || Dandridge M. Cole suffers a fatal heart attack. Cole had read ''The Prospect of Immortality'' in 1963. In his more recent book, ''Beyond Tomorrow'', he had devoted several pages to the subject. He had expressed a wish to be frozen after death. After some delay a call was placed to Ettinger, who later would write, "I was consulted by long-distance telephone several hours after he died, but in the end the family did what was to be expected {{snd}} nothing."<ref name="BedfordSuspension"/>
+
| 1966 || cryonics || organization || founding || Immortalist Soceity || The Cryonics Society of Michigan (later renamed the Cryonics Association, and then, in 1985, the {{W|Immortalist Society}}) is founded with Ettinger elected as its president.<ref name="CorpSummary">{{Cite web|url=https://cofs.lara.state.mi.us/CorpWeb/CorpSearch/CorpSummary.aspx?ID=800832595&SEARCH_TYPE=1|title=Search Summary State of Michigan Corporations Division|website=cofs.lara.state.mi.us|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1966 || cryonics || organisation || founding || Immortalist Soceity || The Cryonics Society of Michigan (later renamed the Cryonics Association, and then, in 1985, the {{W|Immortalist Society}}) is founded with Ettinger elected as its president.<ref name="CorpSummary">{{Cite web|url=https://cofs.lara.state.mi.us/CorpWeb/CorpSearch/CorpSummary.aspx?ID=800832595&SEARCH_TYPE=1|title=Search Summary State of Michigan Corporations Division|website=cofs.lara.state.mi.us|access-date=2019-01-22}}</ref>
+
| 1966 || cryonics || organization || founding || Cryonics Society of California || The Cryonics Society of California (CSC) is founded by Robert Nelson. CSC is a non-profit organization contracting with the for-profit organization Cryonic Interment for cryonics freezing and storage. Cryonics Interment would later be renamed General Fluidics by Robert Nelson and Marshal Neel.<ref name="SuspensionFailures"/><ref name="CorpSummary"/>
 
|-
 
|-
| 1966 || cryonics || organisation || founding || Cryonics Society of California || The Cryonics Society of California (CSC) is founded by Robert Nelson. CSC is a non-profit organisation contracting with the for-profit organisation Cryonic Interment for cryonics freezing and storage. Cryonics Interment would later be renamed General Fluidics by Robert Nelson and Marshal Neel.<ref name="SuspensionFailures"/><ref name="CorpSummary"/>
+
| 1966 || cryobiology || science || fracturing || Kroener and Luyet || Kroener and Luyet observe fracturing in vitrified glycerol solutions.<ref name="IntermediateTemperatureStorage">{{Cite web|url=https://alcor.org/Library/html/IntermediateTemperatureStorage.html|title=Systems for Intermediate Temperature Storage for Fracture Reduction and Avoidance|website=alcor.org|access-date=2019-01-22}}</ref><ref>{{Cite journal|last=Kroener|first=C.|last2=Luyet|first2=B.|date=1966|title=Formation of cracks during the vitrification of glycerol solutions and disappearance of the cracks during rewarming|url=|journal=Biodynamica|volume=10|pages=47-52|via=}}</ref>
 
|-
 
|-
| 1966 || cryobiology || science || paper || Kroener and Luyet || Kroener and Luyet observe fracturing in vitrified glycerol solutions.<ref name="IntermediateTemperatureStorage">{{Cite web|url=https://alcor.org/Library/html/IntermediateTemperatureStorage.html|title=Systems for Intermediate Temperature Storage for Fracture Reduction and Avoidance|website=alcor.org|access-date=2019-01-22}}</ref><ref>{{Cite journal|last=Kroener|first=C.|last2=Luyet|first2=B.|date=1966|title=Formation of cracks during the vitrification of glycerol solutions and disappearance of the cracks during rewarming|url=|journal=Biodynamica|volume=10|pages=47-52|via=}}</ref>
+
| 1966-04-22 || cryonics || || milestone || Cryo-Care Equipment Corporation || An elderly woman (probably from Los Angeles{{snd}}never identified) who has been embalmed for two months and maintained slightly above-freezing temperature is straight-frozen.<ref name="BedfordSuspension"/> There is some thought of the cryonics premise of eventual reanimation, but within a year she would be thawed and buried by relatives.<ref>{{Cite book|title=We Froze the First Man|last=F. Nelson|first=Robert|last2=Stanley|first2=Sandra|publisher=Dell|year=1968|isbn=|location=New York|pages=17-20}}</ref><ref>{{Cite journal|last=Kraver|first=Ted|date=March 1989|title=Notes on the First Human Freezing|url=|journal=Cryonics|volume=|pages=11-21|via=}}</ref>
 
|-
 
|-
| 1966-04-22 || cryonics || || || Cryo-Care Equipment Corporation || An elderly woman (probably from Los Angeles{{snd}}never identified) who has been embalmed for two months and maintained slightly above-freezing temperature is straight-frozen.<ref name="BedfordSuspension"/> There is some thought of the cryonics premise of eventual reanimation, but within a year she would be thawed and buried by relatives.<ref>{{Cite book|title=We Froze the First Man|last=F. Nelson|first=Robert|last2=Stanley|first2=Sandra|publisher=Dell|year=1968|isbn=|location=New York|pages=17-20}}</ref><ref>{{Cite journal|last=Kraver|first=Ted|date=March 1989|title=Notes on the First Human Freezing|url=|journal=Cryonics|volume=|pages=11-21|via=}}</ref>
+
| 1966-10-15 || cryonics || science || || Adachi, et al. || Recovery of brain electrical activity after freezing to −20 °C is demonstrated.<ref>{{Cite journal|last=Adachi|first=C.|last2=Kito|first2=K.|last3=Suda|first3=I.|date=1966-10-15|title=Viability of Long Term Frozen Cat Brain In Vitro|url=https://www.nature.com/articles/212268a0|journal=Nature|language=en|volume=212|issue=5059|pages=268–270|doi=10.1038/212268a0|issn=1476-4687}}</ref>
|-
 
| 1966-10-15 || cryonics || science || paper || || The first paper showing recovery of brain electrical activity after freezing to −20 °C is published.<ref>{{Cite journal|last=Adachi|first=C.|last2=Kito|first2=K.|last3=Suda|first3=I.|date=1966-10-15|title=Viability of Long Term Frozen Cat Brain In Vitro|url=https://www.nature.com/articles/212268a0|journal=Nature|language=en|volume=212|issue=5059|pages=268–270|doi=10.1038/212268a0|issn=1476-4687}}</ref>
 
 
|-
 
|-
 
| 1967-01-12 || cryonics || technological adoption || cryonics || Cryonics Society of California || {{W|James Bedford}} is the first human to be cryopreserved.
 
| 1967-01-12 || cryonics || technological adoption || cryonics || Cryonics Society of California || {{W|James Bedford}} is the first human to be cryopreserved.
Line 171: Line 195:
 
The freezing is carried out by affiliates of the newly-formed Cryonics Society of California: {{W|Robert Prehoda}}, author and cryobiological researcher; Dante Brunol, physician and biophysicist; and Robert Nelson, President of the Society. Also assisting is Bedford's physician, Renault Able.
 
The freezing is carried out by affiliates of the newly-formed Cryonics Society of California: {{W|Robert Prehoda}}, author and cryobiological researcher; Dante Brunol, physician and biophysicist; and Robert Nelson, President of the Society. Also assisting is Bedford's physician, Renault Able.
  
6 days later, relatives would move Bedford to the Cryo-Care facility in Phoenix. Later, his son would store him, and finally on September 22, 1987, Bedford would be moved to Alcor.<ref name="BedfordSuspension"/><ref name="AlcorCase">{{Cite web|url=https://alcor.org/cases.html|title=Alcor Cases|website=alcor.org|access-date=2019-01-22}}</ref>
+
6 days later, relatives would move Bedford to the Cryo-Care facility in Phoenix. Later, his son would store him, and finally, on September 22, 1987, Bedford would be moved to Alcor.<ref name="BedfordSuspension"/><ref name="AlcorCase">{{Cite web|url=https://alcor.org/cases.html|title=Alcor Cases|website=alcor.org|access-date=2019-01-22}}</ref><ref>{{Cite news|url=https://www.nytimes.com/1997/01/12/magazine/still-frozen-after-all-these-years.html|title=Still Frozen After All These Years|date=1997-01-12|work=The New York Times|access-date=2019-02-15|language=en-US|issn=0362-4331}}</ref>
 
|-
 
|-
| 1968 || cryonics || organisation || || Cryo-Care Equipment Corporation || Ed Hope closes Cryo-Care Equipment Corporation after seeing it wouldn't turn a profit. The remaining patients are turn over to other organizations or to relatives.<ref name="SuspensionFailures">{{Cite web|url=https://www.alcor.org/Library/html/suspensionfailures.html|title=Suspension Failures - Lessons from the Early Days|website=www.alcor.org|access-date=2019-01-21}}</ref>
+
| 1968 || cryonics || organization || status || Cryo-Care Equipment Corporation || Ed Hope closes Cryo-Care Equipment Corporation after seeing it wouldn't turn a profit. The remaining patients are turned over to other organizations or to relatives.<ref name="SuspensionFailures">{{Cite web|url=https://www.alcor.org/Library/html/suspensionfailures.html|title=Suspension Failures - Lessons from the Early Days|website=www.alcor.org|access-date=2019-01-21}}</ref>
 
|-
 
|-
 
| 1968 || cryobiology || technological development || cryoprotection || || Dog kidneys are cryopreserved using Farrant's technique resulting in no ice formation and with excellent structural preservation, and the ability to tolerate reperfusion with blood in the animal without immediate failure.<ref>{{Cite journal|last=Kemp|first=E.|last2=Clark|first2=P. B.|last3=Anderson|first3=C. K.|last4=Laursen|first4=T.|last5=Parsons|first5=F. M.|date=1968|title=Low temperature preservation of mammalian kidneys|url=https://www.ncbi.nlm.nih.gov/pubmed/4893380|journal=Scandinavian Journal of Urology and Nephrology|volume=2|issue=3|pages=183–190|issn=0036-5599|pmid=4893380}}</ref>
 
| 1968 || cryobiology || technological development || cryoprotection || || Dog kidneys are cryopreserved using Farrant's technique resulting in no ice formation and with excellent structural preservation, and the ability to tolerate reperfusion with blood in the animal without immediate failure.<ref>{{Cite journal|last=Kemp|first=E.|last2=Clark|first2=P. B.|last3=Anderson|first3=C. K.|last4=Laursen|first4=T.|last5=Parsons|first5=F. M.|date=1968|title=Low temperature preservation of mammalian kidneys|url=https://www.ncbi.nlm.nih.gov/pubmed/4893380|journal=Scandinavian Journal of Urology and Nephrology|volume=2|issue=3|pages=183–190|issn=0036-5599|pmid=4893380}}</ref>
 
|-
 
|-
| 1968 || cryonics || writing || non-fiction || Robert Nelson || Robert Nelson publishes the book ''We Froze the First Man'' telling the story of Bedford's cryopreservation. However, his description is largely inaccurate. A more accurate description would be written later on [https://alcor.org/Library/html/BedfordLetter.htm DEAR DR. BEDFORD (and those who will care for you after I do)].<ref>{{Cite book|url=http://worldcat.org/oclc/434744|title=We froze the first man|last=Nelson|first=Robert F.,|date=1968|publisher=[Dell Pub. Co.]|oclc=434744}}</ref>
+
| 1968-02 || reanimatology || science || || Ames, et al. || Ames, et al., discover the cerebral no-re-flow phenomenon which prevents adequate reperfusion of the brain after ~10 minutes of global cerebral ischemia and identifies this as the likely cause of failure to achieve brain resuscitation after 6-10 minutes of normothermic ischemia rather than the acute death of brain cells as the supposed cause.<ref>{{Cite journal|last=Ames|first=A.|last2=Wright|first2=R. L.|last3=Kowada|first3=M.|last4=Thurston|first4=J. M.|last5=Majno|first5=G.|date=Feb 1968|title=Cerebral ischemia. II. The no-reflow phenomenon.|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2013326/|journal=The American Journal of Pathology|volume=52|issue=2|pages=437–453|issn=0002-9440|pmc=2013326|pmid=5635861}}</ref>
 
|-
 
|-
| 1968-02 || cryonics || science || resuscitation || Ames, et al. || Ames, et al., discover the cerebral no-re-flow phenomenon which prevents adequate reperfusion of the brain after ~10 minutes of global cerebral ischemia and identifies this as the likely cause of failure to achieve brain resuscitation after 6-10 minutes of normothermic ischemia rather than the acute death of brain cells as the supposed cause.<ref>{{Cite journal|last=Ames|first=A.|last2=Wright|first2=R. L.|last3=Kowada|first3=M.|last4=Thurston|first4=J. M.|last5=Majno|first5=G.|date=Feb 1968|title=Cerebral ischemia. II. The no-reflow phenomenon.|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2013326/|journal=The American Journal of Pathology|volume=52|issue=2|pages=437–453|issn=0002-9440|pmc=2013326|pmid=5635861}}</ref>
+
| 1969 || cryonics || social || magazine || Immortalist Soceity || The Cryonics Society of Michigan publishes the first issue of the Long Life magazine, which is still published to this day [2020].<ref>{{Cite web|url=https://www.cryonics.org/resources/long-life-magazine|title=Resources {{!}} Cryonics Institute|website=www.cryonics.org|access-date=2020-01-28}}</ref>
 
|-
 
|-
| 1969 || cryonics || organisation || founding || {{W|American Cryonics Society}} || The Bay Area Cryonics Society is founded by two physicians, prominent allergist and editor of [[wikipedia:Annals of Allergy, Asthma & Immunology|Annals of Allergy]], Dr. M. Coleman Harris, and Dr. Grace Talbot. It would be renamed to the {{W|American Cryonics Society}} in 1985.<ref name="BenBestCryonicsHistory"/><ref>{{Cite web|url=https://businesssearch.sos.ca.gov/CBS/SearchResults?SearchType=NUMBER&SearchCriteria=C0587199|title=Business Search - Business Entities - Business Programs {{!}} California Secretary of State|website=businesssearch.sos.ca.gov|access-date=2019-01-22}}</ref><ref>{{Cite web|url=http://www.americancryonics.org/|title=American Cryonics Society - Human Cryopreservation Services for the 21st Century|website=www.americancryonics.org|access-date=2019-01-22}}</ref>
+
| 1969 || cryonics || organization || founding || {{W|American Cryonics Society}} || The Bay Area Cryonics Society is founded by two physicians, the prominent allergist and editor of [[wikipedia:Annals of Allergy, Asthma & Immunology|Annals of Allergy]], Dr. M. Coleman Harris, and Dr. Grace Talbot, alongside with 5 other founders, including Jerry White and Edgar Swank, both of which are now cryopreserved under the ACS program.<ref>Private conversation between Mati Roy and Jim Yount</ref> The organization would be renamed to the {{W|American Cryonics Society}} in 1985.<ref name="BenBestCryonicsHistory"/><ref>{{Cite web|url=https://businesssearch.sos.ca.gov/CBS/SearchResults?SearchType=NUMBER&SearchCriteria=C0587199|title=Business Search - Business Entities - Business Programs {{!}} California Secretary of State|website=businesssearch.sos.ca.gov|access-date=2019-01-22}}</ref><ref>{{Cite web|url=http://www.americancryonics.org/|title=American Cryonics Society - Human Cryopreservation Services for the 21st Century|website=www.americancryonics.org|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1969 || cryonics || || || Evan Cooper || Cooper ends his involvement in cryonics. He feels overloaded and burned-out, and thinks cryonics is not going to be a viable option for himself for practical (political, social, economic) reasons and that he is not going to spend the time he had left trying to obtain the impossible. He is also concerned with the commercial and political aspects within cryonics.<ref name="cryonet23124"/>
+
| 1969 || cryonics || social || || Evan Cooper || Cooper ends his involvement in cryonics. He feels overloaded and burned-out, and thinks cryonics is not going to be a viable option for himself for practical (political, social, economic) reasons and that he is not going to spend the time he had left trying to obtain the impossible. He is also concerned with the commercial and political aspects within cryonics.<ref name="cryonet23124"/>
 
|-
 
|-
 
| 1969-04-11 || cryonics || futurism || || Jerome White || Jerome White, one of the founders of the Bay Area Cryonics Society, proposes the use of specially engineered viruses to effect repair of cells that are damaged by freezing and compromised by aging.<ref>{{Cite journal|last=White|first=J. B.|date=1969-04-11|title=Viral Induced Repair of Damaged Neurons with Preservation of Long-Term Information Content,|url=https://alcor.org/Library/pdfs/White1969.pdf|journal=Second Annual Cryonics Conference|volume=|pages=|via=|location=Ann Arbor, Michigan}}</ref>
 
| 1969-04-11 || cryonics || futurism || || Jerome White || Jerome White, one of the founders of the Bay Area Cryonics Society, proposes the use of specially engineered viruses to effect repair of cells that are damaged by freezing and compromised by aging.<ref>{{Cite journal|last=White|first=J. B.|date=1969-04-11|title=Viral Induced Repair of Damaged Neurons with Preservation of Long-Term Information Content,|url=https://alcor.org/Library/pdfs/White1969.pdf|journal=Second Annual Cryonics Conference|volume=|pages=|via=|location=Ann Arbor, Michigan}}</ref>
Line 189: Line 213:
 
| 1970 || cryonics || science || || Hossmann, Sato || Hossmann and Sato demonstrate that, contrary to decades of biomedical dogma, it is possible to restore robust electrical activity and demonstrate evoked potentials in cat brains that had been subjected to 1 hour of normothermic ischemia. This marks the beginning of the debunking of 3-6 minute limit on brain viability under conditions of normothermic ischemia. It also shows that brain cells do not undergo autolysis after ~10 minutes of normothermic ischemia, a view that was commonly held by both many physicians and neurologists prior to this time.<ref>{{Cite journal|last=Hossmann|first=K. -A.|last2=Sato|first2=K.|date=1970|title=The effect of ischemia on sensorimotor cortex of cat|url=http://dx.doi.org/10.1007/bf00316134|journal=Zeitschrift für Neurologie|volume=198|issue=1|pages=33–45|doi=10.1007/bf00316134|issn=0340-5354}}</ref>
 
| 1970 || cryonics || science || || Hossmann, Sato || Hossmann and Sato demonstrate that, contrary to decades of biomedical dogma, it is possible to restore robust electrical activity and demonstrate evoked potentials in cat brains that had been subjected to 1 hour of normothermic ischemia. This marks the beginning of the debunking of 3-6 minute limit on brain viability under conditions of normothermic ischemia. It also shows that brain cells do not undergo autolysis after ~10 minutes of normothermic ischemia, a view that was commonly held by both many physicians and neurologists prior to this time.<ref>{{Cite journal|last=Hossmann|first=K. -A.|last2=Sato|first2=K.|date=1970|title=The effect of ischemia on sensorimotor cortex of cat|url=http://dx.doi.org/10.1007/bf00316134|journal=Zeitschrift für Neurologie|volume=198|issue=1|pages=33–45|doi=10.1007/bf00316134|issn=0340-5354}}</ref>
 
|-
 
|-
| 1970 || cryonics || organisation || founding || Cryonics Society of America || The Cryonics Society of America (CSA) is incorporated.
+
| 1970 || cryonics || organization || founding || Cryonics Society of America || The Cryonics Society of America (CSA) is incorporated.
  
 
The purpose of the CSA is to establish “standards and practices” of operations for all of the cryonics societies, to mandate validation of human freezing by requiring the submission of photographic proof along with a death certificate, and a description of the procedure used and the location where the patient was being stored (essentially establishing a registry of cryonics patients). It is also created to allow for the creation of a Scientific Advisory Board which would, in fact, formed in March of 1968. CSA itself never got off the ground due to noncompliance with the "standards and practices" by the Cryonics Society of California.<ref>{{Cite web|url=https://appext20.dos.ny.gov/corp_public/CORPSEARCH.ENTITY_INFORMATION?p_token=7361B53D067A654A76A77C3D820968CE25ADADB428A2F2B69B4B1B434D5CDC52D3EF5B4A61760545D791DA3D1A8E4D7F&p_nameid=4A504BB578548E78&p_corpid=A70384D2E44B2C90&p_captcha=11476&p_captcha_check=7361B53D067A654A76A77C3D820968CE25ADADB428A2F2B69B4B1B434D5CDC527922A9872C775310E6F079882FB316C3&p_entity_name=cryonics%20society&p_name_type=A&p_search_type=BEGINS&p_srch_results_page=0|title=Informational Message|website=appext20.dos.ny.gov|access-date=2019-01-22}}</ref>
 
The purpose of the CSA is to establish “standards and practices” of operations for all of the cryonics societies, to mandate validation of human freezing by requiring the submission of photographic proof along with a death certificate, and a description of the procedure used and the location where the patient was being stored (essentially establishing a registry of cryonics patients). It is also created to allow for the creation of a Scientific Advisory Board which would, in fact, formed in March of 1968. CSA itself never got off the ground due to noncompliance with the "standards and practices" by the Cryonics Society of California.<ref>{{Cite web|url=https://appext20.dos.ny.gov/corp_public/CORPSEARCH.ENTITY_INFORMATION?p_token=7361B53D067A654A76A77C3D820968CE25ADADB428A2F2B69B4B1B434D5CDC52D3EF5B4A61760545D791DA3D1A8E4D7F&p_nameid=4A504BB578548E78&p_corpid=A70384D2E44B2C90&p_captcha=11476&p_captcha_check=7361B53D067A654A76A77C3D820968CE25ADADB428A2F2B69B4B1B434D5CDC527922A9872C775310E6F079882FB316C3&p_entity_name=cryonics%20society&p_name_type=A&p_search_type=BEGINS&p_srch_results_page=0|title=Informational Message|website=appext20.dos.ny.gov|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1970-05-15 || cryonics || organisation || || Cryonics Society of California || Nelson moves the 4 patients from the Cryonics Society of California into an underground vault he recently had designed and build under the aegis of Cryonics Interment. The vault is located in Oakwood Cemetery in {{W|Chatsworth, Los Angeles}}.<ref name="SuspensionFailures"/>
+
| 1970-05-15 || cryonics || organization || status || Cryonics Society of California || Nelson moves the 4 patients from the Cryonics Society of California into an underground vault he recently had designed and built under the aegis of Cryonics Interment. The vault is located in Oakwood Cemetery in {{W|Chatsworth, Los Angeles}}.<ref name="SuspensionFailures"/>
 
|-
 
|-
| 1970-05-22 || cryobiology || science || theory || Peter Mazur || Peter Mazur publishes his “two factor theory” elucidating the basic mechanisms of freezing damage to living cells: solution effects injury and/or intracellular freezing. This insight facilitates more rational design of freezing and thawing protocols allowing the development of freezing techniques for animal embryos.<ref>{{Cite journal|last=Mazur|first=P.|date=1970-05-22|title=Cryobiology: the freezing of biological systems|url=https://www.ncbi.nlm.nih.gov/pubmed/5462399|journal=Science (New York, N.Y.)|volume=168|issue=3934|pages=939–949|issn=0036-8075|pmid=5462399}}</ref>
+
| 1970-05-22 || cryobiology || science || theory || Peter Mazur || Peter Mazur publishes his “two-factor theory” elucidating the basic mechanisms of freezing damage to living cells: solution effects injury and/or intracellular freezing. This insight facilitates a more rational design of freezing and thawing protocols allowing the development of freezing techniques for animal embryos.<ref>{{Cite journal|last=Mazur|first=P.|date=1970-05-22|title=Cryobiology: the freezing of biological systems|url=https://www.ncbi.nlm.nih.gov/pubmed/5462399|journal=Science (New York, N.Y.)|volume=168|issue=3934|pages=939–949|issn=0036-8075|pmid=5462399}}</ref>
 
|-
 
|-
| 1971 || resuscitation || science || || Hossmann || Hossmann demonstrate possible recovery of the cat brain after complete ischemia for 1 hour. The field of cerebral resuscitation is born.<ref>{{Cite journal|last=Hossmann|first=K.-A.|last2=Lechtape-Grüter|first2=H.|date=1971|title=Blood Flow and Recovery of the Cat Brain after Complete Ischemia for 1 Hour|url=http://dx.doi.org/10.1159/000114515|journal=European Neurology|volume=6|issue=1-6|pages=318–322|doi=10.1159/000114515|issn=0014-3022}}</ref>
+
| 1971 || resuscitation || science || || Hossmann || Hossmann demonstrates the possible recovery of the cat brain after complete ischemia for 1 hour. The field of cerebral resuscitation is born.<ref>{{Cite journal|last=Hossmann|first=K.-A.|last2=Lechtape-Grüter|first2=H.|date=1971|title=Blood Flow and Recovery of the Cat Brain after Complete Ischemia for 1 Hour|url=http://dx.doi.org/10.1159/000114515|journal=European Neurology|volume=6|issue=1-6|pages=318–322|doi=10.1159/000114515|issn=0014-3022}}</ref>
  
 
|-
 
|-
 
| 1971 || cryonics || futurism || || Martin || Cryonics by neuropreservation is proposed.<ref>{{Cite journal|last=Martin|first=George M.|date=1971|title=On Immortality: An Interim Solution|url=https://muse.jhu.edu/article/404700/summary|journal=Perspectives in Biology and Medicine|language=en|volume=14|issue=2|pages=339–340|doi=10.1353/pbm.1971.0015|issn=1529-8795}}</ref>
 
| 1971 || cryonics || futurism || || Martin || Cryonics by neuropreservation is proposed.<ref>{{Cite journal|last=Martin|first=George M.|date=1971|title=On Immortality: An Interim Solution|url=https://muse.jhu.edu/article/404700/summary|journal=Perspectives in Biology and Medicine|language=en|volume=14|issue=2|pages=339–340|doi=10.1353/pbm.1971.0015|issn=1529-8795}}</ref>
 
|-
 
|-
| 1971-08 || cryonics || writing || journal || Manrise Technical Review || Fred and Linda Chamberlain begin publishing a bi-monthly technical journal, Manrise Technical Review and in 1972 they publish the first comprehensive technical manual of human cryopreservation procedures. This marks the beginning of a biomedically informed and rigorously scientific approach to cryonics. In this manual the Chamberlains suggest apoplication of the Farrant technique to cryonics patients.<ref>{{Cite journal|last=Chamberlain|first=FR|last2=Chamberlain|first2=LL|date=1972|title=Instructions for the Induction of Solid State Hypothermia|url=|journal=Manrise Corporation|location=La Canada, CA|volume=|pages=|via=}}</ref>
+
| 1971-08 || cryonics || social || journal || Manrise Technical Review || Fred and Linda Chamberlain begin publishing a bi-monthly technical journal, Manrise Technical Review and in 1972 they publish the first comprehensive technical manual of human cryopreservation procedures. This marks the beginning of a biomedically informed and rigorously scientific approach to cryonics. In this manual, the Chamberlains suggest application of the Farrant technique to cryonics patients.<ref>{{Cite journal|last=Chamberlain|first=FR|last2=Chamberlain|first2=LL|date=1972|title=Instructions for the Induction of Solid State Hypothermia|url=|journal=Manrise Corporation|location=La Canada, CA|volume=|pages=|via=}}</ref>
 +
|-
 +
| 1971 (end of) - 1979-04 || cryonics || organization || status || Cryonics Society of California || 9 patients are thawed by the Cryonics Society of California. This would become known as the Chatsworth Scandal because the patients were stored in an underground vault at a cemetery in Chatsworth.<ref name="SuspensionFailures"/>
 
|-
 
|-
| 1971 (end of) - 1979-04 || cryonics || organisation || || Cryonics Society of California || 9 patients are thawed by the Cryonics Society of California. This would become known as the Chatsworth Scandal, because the patients were stored in an underground vault at a cemetery in Chatsworth.<ref name="SuspensionFailures"/>
+
| 1972 || cryonics || technological adoption || || Trans Time || A collaborative working group led by Trans Time President Art Quaife and consisting of Gregory Fahy, Peter Gouras, M.D., Fred, and Linda Chamberlain and Mike Darwin begin working on a standardized protocol for the cryoprotection of cryonics patients. Quaife publishes the first results of this effort, a modification of Collins’ organ preservation solution for use as the carrier solution for Me2SO during cryoprotective perfusion. This marks the first attempt at creating a standardized, science-based human cryopreservation protocol.<ref>{{Cite journal|last=Quaife|first=A.|date=1972|title=Recommended modification to Collins’ solution for use as the base perfusate for inducing SSH|url=|journal=Manrise Technical Review|volume=2|pages=3-9|via=}}</ref>
 
|-
 
|-
| 1972 || cryonics || technological adoption || || Trans Time || A collaborative working group led by Trans Time President Art Quaife and consisting of Gregory Fahy, Peter Gouras, M.D., Fred and Linda Chamberlain and Mike Darwin begin working on a standardized protocol for the cryoprotection of cryonics patients. Quaife publishes the first results of this effort, a modification of Collins’ organ preservation solution for use as the carrier solution for Me2SO during cryoprotective perfusion. This marks the first attempt at creating a standardized, science-based human cryopreservation protocol.<ref>{{Cite journal|last=Quaife|first=A.|date=1972|title=Recommended modification to Collins’ solution for use as the base perfusate for inducing SSH|url=|journal=Manrise Technical Review|volume=2|pages=3-9|via=}}</ref>
+
| 1972 || cryonics || organization || founding || Trans Time || Trans Time, Inc., (TT) a cryonics service provider, is founded by Art Quaife, along with John Day and other cryonicists. It is a for-profit organization. It's initially a perfusion service-provider for the Bay Area Cryonics Society. They buy the perfusion equipment from Manrise Corporation.<ref name="BenBestCryonicsHistory"/> They would be the first to undertake the effort of clarifying legal issues around cryonics, and to actively market cryonics.<ref name="BenBestCryonicsHistory"/> The name "Trans Time" is inspired by Trans World Airlines, a prominent airline.<ref>{{Cite web|url=https://hpluspedia.org/wiki/History_of_cryonics#Chatsworth_Scandal|title=History of cryonics - H+Pedia|website=hpluspedia.org|access-date=2019-01-22}}</ref><ref>{{Cite web|url=https://businesssearch.sos.ca.gov/CBS/SearchResults?SearchType=NUMBER&SearchCriteria=C0647293|title=Business Search - Business Entities - Business Programs {{!}} California Secretary of State|website=businesssearch.sos.ca.gov|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1972 || cryonics || organisation || founding || Trans Time || Trans Time, Inc., (TT) a cryonics service provider, is founded by Art Quaife, along with John Day, Paul Segall and other cryonicists. It is a for-profit organisation. It's initially a perfusion service-provider for the Bay Area Cryonics Society. They buy the perfusion equipment from Manrise Corporation.<ref name="BenBestCryonicsHistory"/> They would be the first to undertake the effort of clarifying legal issues around cryonics, and to actively market cryonics.<ref name="BenBestCryonicsHistory"/> The name "Trans Time" is inspired by Trans World Airlines, a prominent airline.<ref>{{Cite web|url=https://hpluspedia.org/wiki/History_of_cryonics#Chatsworth_Scandal|title=History of cryonics - H+Pedia|website=hpluspedia.org|access-date=2019-01-22}}</ref><ref>{{Cite web|url=https://businesssearch.sos.ca.gov/CBS/SearchResults?SearchType=NUMBER&SearchCriteria=C0647293|title=Business Search - Business Entities - Business Programs {{!}} California Secretary of State|website=businesssearch.sos.ca.gov|access-date=2019-01-22}}</ref>
+
| 1972 || cryonics || social || book || {{W|Robert Ettinger}} || Robert Ettinger publishes [https://www.cryonics.org/resources/man-into-superman Man Into Superman]. The book expands on the implications and possibilities of cryonics from his previous book, "The Prospect of Immortality".<ref>{{Cite web|url=https://www.cryonics.org/resources/man-into-superman|title=Resources {{!}} Cryonics Institute|website=www.cryonics.org|access-date=2020-01-28}}</ref>
 
|-
 
|-
 
| 1972 || cryonics || || || {{W|Mike Darwin}} || {{W|Mike Darwin}} is the first full-time cryonics researcher. He would work at Alcor for a year.<ref name="BenBestCryonicsHistoryImmortalist">{{Cite web|url=http://www.cryonics.org/immortalist/november08/History.pdf|title=A History of Cryonics|last=Best|first=Ben|date=2008-11-08|website=Cryonics Institute|archive-url=https://web.archive.org/web/20130628112826/http://www.cryonics.org/immortalist/november08/History.pdf|archive-date=2013-06-28|dead-url=|access-date=}}</ref>
 
| 1972 || cryonics || || || {{W|Mike Darwin}} || {{W|Mike Darwin}} is the first full-time cryonics researcher. He would work at Alcor for a year.<ref name="BenBestCryonicsHistoryImmortalist">{{Cite web|url=http://www.cryonics.org/immortalist/november08/History.pdf|title=A History of Cryonics|last=Best|first=Ben|date=2008-11-08|website=Cryonics Institute|archive-url=https://web.archive.org/web/20130628112826/http://www.cryonics.org/immortalist/november08/History.pdf|archive-date=2013-06-28|dead-url=|access-date=}}</ref>
 
|-
 
|-
| 1972-01-12 || suspended animation || technological adoption || || Klebanoff || Klebanoff reports survival of the first human after blood washout and induction of profound hypothermia with full recovery of heath and normal mentation, Air Force Seargent Tor Olsen who, as of 2018, would still be alive and well.<ref>{{Cite journal|last=Klebanoff|first=G.|last2=Hollander|first2=D.|last3=Cosimi|first3=A. B.|last4=Stanford|first4=W.|last5=Kemmerer|first5=W. T.|date=January 1972|title=Asanguineous hypothermic total body perfusion (TBW) in the treatment of stage IV hepatic coma|url=https://www.ncbi.nlm.nih.gov/pubmed/5058015|journal=The Journal of Surgical Research|volume=12|issue=1|pages=1–7|issn=0022-4804|pmid=5058015}}</ref>
+
| 1972-01-12 || suspended animation || technological adoption || || Klebanoff || Klebanoff reports survival of the first human after blood washout and induction of profound hypothermia with full recovery of health and normal mentation, Air Force Seargent Tor Olsen who, as of 2018, would still be alive and well.<ref>{{Cite journal|last=Klebanoff|first=G.|last2=Hollander|first2=D.|last3=Cosimi|first3=A. B.|last4=Stanford|first4=W.|last5=Kemmerer|first5=W. T.|date=January 1972|title=Asanguineous hypothermic total body perfusion (TBW) in the treatment of stage IV hepatic coma|url=https://www.ncbi.nlm.nih.gov/pubmed/5058015|journal=The Journal of Surgical Research|volume=12|issue=1|pages=1–7|issn=0022-4804|pmid=5058015}}</ref>
 
|-
 
|-
| 1972-02-23 || cryonics || organisation || founding || {{W|Alcor Life Extension Foundation}} || The {{W|Alcor Life Extension Foundation}}, a cryonics service provider, is founded by {{W|Fred and Linda Chamberlain}} in the State of California. The organisation is named after a star in the Big Dipper used in ancient times as a test of visual acuity. It would serve as a response team for the Cryonics Society of California. Alcor is initially incorporated as the Alcor Society for Solid State Hypothermia, but would change its name to the "{{W|Alcor Life Extension Foundation}}" in 1977.<ref name="BenBestCryonicsHistory"/><ref>{{Cite web|url=https://businesssearch.sos.ca.gov/CBS/SearchResults?SearchType=NUMBER&SearchCriteria=C0645886|title=Business Search - Business Entities - Business Programs {{!}} California Secretary of State|website=businesssearch.sos.ca.gov|access-date=2019-01-22}}</ref>
+
| 1972-02-23 || cryonics || organization || founding || {{W|Alcor Life Extension Foundation}} || The {{W|Alcor Life Extension Foundation}}, a cryonics service provider, is founded by {{W|Fred and Linda Chamberlain}} in the State of California. The organization is named after a star in the Big Dipper used in ancient times as a test of visual acuity. It would serve as a response team for the Cryonics Society of California. Alcor is initially incorporated as the Alcor Society for Solid State Hypothermia, but would change its name to the "{{W|Alcor Life Extension Foundation}}" in 1977.<ref name="BenBestCryonicsHistory"/><ref>{{Cite web|url=https://businesssearch.sos.ca.gov/CBS/SearchResults?SearchType=NUMBER&SearchCriteria=C0645886|title=Business Search - Business Entities - Business Programs {{!}} California Secretary of State|website=businesssearch.sos.ca.gov|access-date=2019-01-22}}</ref>
 
|-
 
|-
 
| 1973-08 || cryobiology || technological development || cryoprotection, re-warming || Hamilton, Lehr || Hamilton and Lehr demonstrate successful preservation of canine small intestine allografts using Me2SO as the cryoprotectant, and cooling and warming using vascular perfusion with helium gas suggesting that even controlled cooling and emptying of the vasculature's fluid/ice are beneficial in organ freezing. The organ is successfully transplanted.<ref>{{Cite journal|last=LaRossa|first=D.|last2=Hamilton|first2=R.|last3=Ketterer|first3=F.|last4=Lehr|first4=H. B.|date=August 1973|title=Preservation of structure and function in canine small intestinal autografts after freezing|url=https://www.ncbi.nlm.nih.gov/pubmed/4722678|journal=Plastic and Reconstructive Surgery|volume=52|issue=2|pages=174–177|issn=0032-1052|pmid=4722678}}</ref><ref>{{Cite web|url=https://www.journalofsurgicalresearch.com/action/captchaChallenge?redirectUri=%2Farticle%2F0022-4804%2873%2990033-4%2Fpdf|title=Journal of Surgical Research|website=www.journalofsurgicalresearch.com|doi=10.1016/0022-4804(73)90033-4|access-date=2019-01-22}}</ref>
 
| 1973-08 || cryobiology || technological development || cryoprotection, re-warming || Hamilton, Lehr || Hamilton and Lehr demonstrate successful preservation of canine small intestine allografts using Me2SO as the cryoprotectant, and cooling and warming using vascular perfusion with helium gas suggesting that even controlled cooling and emptying of the vasculature's fluid/ice are beneficial in organ freezing. The organ is successfully transplanted.<ref>{{Cite journal|last=LaRossa|first=D.|last2=Hamilton|first2=R.|last3=Ketterer|first3=F.|last4=Lehr|first4=H. B.|date=August 1973|title=Preservation of structure and function in canine small intestinal autografts after freezing|url=https://www.ncbi.nlm.nih.gov/pubmed/4722678|journal=Plastic and Reconstructive Surgery|volume=52|issue=2|pages=174–177|issn=0032-1052|pmid=4722678}}</ref><ref>{{Cite web|url=https://www.journalofsurgicalresearch.com/action/captchaChallenge?redirectUri=%2Farticle%2F0022-4804%2873%2990033-4%2Fpdf|title=Journal of Surgical Research|website=www.journalofsurgicalresearch.com|doi=10.1016/0022-4804(73)90033-4|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1973-03 || cryonics || || || Cryonics Society of New York || Fahy and Darwin publish the first technical case report documenting the procedures, problems and responses of a human patient (Clara Dostal) to cryoprotective perfusion and freezing. The report is severely critical of the way cryonics patients are being treated and suggests many reform and inprovements.<ref>{{Cite journal|last=Federowicz|first=MD|date=1973|title=Perfusion and freezing of a 60-year-old woman|url=http://www.lifepact.com/images/MTRV3N1.pdf|journal=Manrise Technical Review|volume=3(1)|pages=9-32|access-date=2010-08-31|via=}}</ref>
+
| 1973-03 || cryonics || science || || Cryonics Society of New York || Fahy and Darwin publish the first technical case report documenting the procedures, problems, and responses of a human patient (Clara Dostal) to cryoprotective perfusion and freezing. The report is severely critical of the way cryonics patients are being treated and suggests many reform and improvements.<ref>{{Cite journal|last=Federowicz|first=MD|date=1973|title=Perfusion and freezing of a 60-year-old woman|url=http://www.lifepact.com/images/MTRV3N1.pdf|journal=Manrise Technical Review|volume=3(1)|pages=9-32|access-date=2010-08-31|via=}}</ref>
 
|-
 
|-
| 1974 || cryonics || organisation || || Trans Time || Due to the closure of the storage facility in New York, the Bay Area Cryonics Society and the {{W|Alcor Life Extension Foundation}} change their plan to preserve their patients to the Trans Time facility instead of the New York one, and would do so until the 1980s.<ref name="BenBestCryonicsHistory"/>
+
| 1974 || cryonics || organization || status || Trans Time || Due to the closure of the storage facility in New York, the Bay Area Cryonics Society and the {{W|Alcor Life Extension Foundation}} change their plan to preserve their patients to the Trans Time facility instead of the New York one, and would do so until the 1980s.<ref name="BenBestCryonicsHistory"/> In February 1974, 2 patients are accepted by the Bay Area Cryonics Society as anatomical donations and kept by Trans Time.
 
|-
 
|-
| 1974 || cryonics || science || || || The first paper showing partial recovery of brain electrical activity after 7 years of frozen storage is published.<ref>{{Cite journal|last=Suda|first=Isamu|last2=Kito|first2=Kyoko|last3=Adachi|first3=Chizuko|date=1974-04-26|title=Bioelectric discharges of isolated cat brain after revival from years of frozen storage|url=http://www.sciencedirect.com/science/article/pii/0006899374902637|journal=Brain Research|volume=70|issue=3|pages=527–531|doi=10.1016/0006-8993(74)90263-7|issn=0006-8993}}</ref>
+
| 1974 || cryonics || science || || Suda, et al. || Partial recovery of brain electrical activity after 7 years of frozen storage is demonstrated.<ref>{{Cite journal|last=Suda|first=Isamu|last2=Kito|first2=Kyoko|last3=Adachi|first3=Chizuko|date=1974-04-26|title=Bioelectric discharges of isolated cat brain after revival from years of frozen storage|url=http://www.sciencedirect.com/science/article/pii/0006899374902637|journal=Brain Research|volume=70|issue=3|pages=527–531|doi=10.1016/0006-8993(74)90263-7|issn=0006-8993}}</ref>
 
|-
 
|-
| 1974 || cryonics || organisation || || Cryonics Society of New York || {{W|Curtis Henderson}}, who has been maintaining three cryonics patients for the Cryonics Society of New York, is told by the New York Department of Public Health that he must close down his cryonics facility. The three cryonics patients are returned to their families, and would later be thawed.<ref name="BenBestCryonicsHistory"/>
+
| 1974 || cryonics || organization || status || Cryonics Society of New York || {{W|Curtis Henderson}}, who has been maintaining three cryonics patients for the Cryonics Society of New York, is told by the New York Department of Public Health that he must close down his cryonics facility. The three cryonics patients are returned to their families, and would later be thawed.<ref name="BenBestCryonicsHistory"/>
 
|-
 
|-
| 1975-07 || suspended animation || technological development || || Gerald Klebanoff || Gerald Klebanoff demonstrates recovery of dogs from total blood washout and profound hypothermia with no neurological deficit using a defined asanguineous solution. Klebanoff documents the critical importance of adequate amounts of colloid in the perfusate to prevent death from pulmonary edema.<ref>{{Cite journal|last=Haff|first=R. C.|last2=Klebanoff|first2=G.|last3=Brown|first3=B. G.|last4=Koreski|first4=W. R.|date=July 1975|title=Asanguineous hypothermic perfusion as a means of total organism preservation|url=https://www.ncbi.nlm.nih.gov/pubmed/1142760|journal=The Journal of Surgical Research|volume=19|issue=1|pages=13–19|issn=0022-4804|pmid=1142760}}</ref>
+
| 1974<ref group=note>Jim Yount thinks it was in September from memory</ref> || cryonics || organization || milestone || American Cryonics Society || John Day, Jerry White, Art Quaife and Jim Yount freeze and place into liquid nitrogen a dog from a member of the Bay Area Cryonics Society. This is the first companion animal to be cryopreserved.<ref>Private conversation between Mati Roy and Jim Yount</ref>
 
|-
 
|-
| 1976 || cryonics || R&D || || {{W|Alcor Life Extension Foundation}} || Manrise Corporation provides initial funding to Alcor for cryonics research.
+
| 1975-07 || suspended animation || technological development || || Gerald Klebanoff || Gerald Klebanoff demonstrates the recovery of dogs from total blood washout and profound hypothermia with no neurological deficit using a defined asanguineous solution. Klebanoff documents the critical importance of adequate amounts of colloid in the perfusate to prevent death from pulmonary edema.<ref>{{Cite journal|last=Haff|first=R. C.|last2=Klebanoff|first2=G.|last3=Brown|first3=B. G.|last4=Koreski|first4=W. R.|date=July 1975|title=Asanguineous hypothermic perfusion as a means of total organism preservation|url=https://www.ncbi.nlm.nih.gov/pubmed/1142760|journal=The Journal of Surgical Research|volume=19|issue=1|pages=13–19|issn=0022-4804|pmid=1142760}}</ref>
 
|-
 
|-
| 1976-04-28 || cryonics || organisation || founding || Cryonics Institute || Cryonics Institute is founded, and starts offering cryonics services: preparation, cooling, and long term storage.<ref>{{Cite web|url=https://cofs.lara.state.mi.us/CorpWeb/CorpSearch/CorpSummary.aspx?ID=800830993&SEARCH_TYPE=1|title=Search Summary State of Michigan Corporations Division|website=cofs.lara.state.mi.us|access-date=2019-01-22}}</ref>
+
| 1976 || cryonics || technological development || || {{W|Alcor Life Extension Foundation}} || Manrise Corporation provides initial funding to Alcor for cryonics research.
 
|-
 
|-
| 1976-07-16 || cryonics || technological adoption || || {{W|Alcor Life Extension Foundation}} || Alcor carries out the first human cryopreservation where cardiopulmonary support is initiated immediately post pronouncement and is continued until the patient is cooled to 15°C (~400 minutes) and where a scientifically designed custom perfusion machine with heat exchanger was used to carry out cryoprotective perfusion (as opposed to an embalming pump) with control over flow, pressure and temperature and incorporating a bubble trap was used. This is also the first neurocryopreservation (head only) patient. The patient was the father of Fred Chamberlain, the co-founder of the organisation.<ref>{{Cite journal|last=Chamberlain|first=FRC|last2=Chamberlain|first2=LLC|date=July 16-17, 1976|title=Alcor patient A-1001 Case Notes|url=|journal=Alcor Foundation|volume=|pages=|via=}}</ref><ref name="BenBestCryonicsHistoryImmortalist"/>
+
| 1976-04-28 || cryonics || organization || founding || {{W|Cryonics Institute}} || Cryonics Institute is founded by the directors of the Cryonics Association<ref>Private conversation between Mati Roy and Jim Yount</ref>, and starts offering cryonics services: preparation, cooling, and long term storage.<ref>{{Cite web|url=https://cofs.lara.state.mi.us/CorpWeb/CorpSearch/CorpSummary.aspx?ID=800830993&SEARCH_TYPE=1|title=Search Summary State of Michigan Corporations Division|website=cofs.lara.state.mi.us|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1977 || cryonics || organisation || || Institute for Advanced Biological Studies || The Institute for Advanced Biological Studies (IABS) is incorporated by Steve Bridge. IABS is a nonprofit research startup.<ref name="IABS">{{Cite journal|last=|first=|date=1981-03-08|title=The Newsletter of The Institute For Advanced Biological Studies, Inc.|url=https://www.alcor.org/cryonics/cryonics8103.txt|journal=Cryonics|volume=|pages=|via=}}</ref>
+
| 1976-07-16 || cryonics || technological adoption || || {{W|Alcor Life Extension Foundation}} || Alcor carries out the first human cryopreservation where cardiopulmonary support is initiated immediately post pronouncement and is continued until the patient is cooled to 15°C (~400 minutes) and where a scientifically designed custom perfusion machine with heat exchanger was used to carry out cryoprotective perfusion (as opposed to an embalming pump) with control over flow, pressure and temperature and incorporating a bubble trap was used. This is also the first neurocryopreservation (head only) patient. The patient was the father of Fred Chamberlain, the co-founder of the organization.<ref>{{Cite journal|last=Chamberlain|first=FRC|last2=Chamberlain|first2=LLC|date=July 16-17, 1976|title=Alcor patient A-1001 Case Notes|url=|journal=Alcor Foundation|volume=|pages=|via=}}</ref><ref name="BenBestCryonicsHistoryImmortalist"/>
 
|-
 
|-
| 1977 || cryonics || organisation || || Soma, Inc. || Soma, Inc. is incorporated. Soma is intended as a for-profit organization to provide cryopreservation and human storage services. Its president is {{W|Mike Darwin}}.
+
| 1977 || cryonics || organization || founding || Institute for Advanced Biological Studies || The Institute for Advanced Biological Studies (IABS) is incorporated by Steve Bridge. IABS is a nonprofit research startup.<ref name="IABS">{{Cite journal|last=|first=|date=1981-03-08|title=The Newsletter of The Institute For Advanced Biological Studies, Inc.|url=https://www.alcor.org/cryonics/cryonics8103.txt|journal=Cryonics|volume=|pages=|via=}}</ref>
 
|-
 
|-
| 1977 || cryonics || organisation || || Cryonics Institute || The Cryonics Institute preserves its first patient, Rhea Ettinger. She would be preserved in dry ice for 10 years, and then switch to liquid nitrogen.
+
| 1977 || cryonics || organization || founding || Soma, Inc. || Soma, Inc. is incorporated. Soma is intended as a for-profit organization to provide cryopreservation and human storage services. Its president is {{W|Mike Darwin}}.
 
|-
 
|-
| 1977(?) - 1986 || cryonics || social || || Life Extension Festival || The Life Extension Festival is run by {{W|Fred and Linda Chamberlain}}.<ref>{{Cite journal|last=|first=|date=July 1983|title=Report on the Lake Tahoe Life Extension Festival|url=https://www.alcor.org/cryonics/cryonics8307.txt|journal=Cryonics|volume=|issue=36|pages=7-13|via=}}</ref>
+
| 1977 || cryonics || organization || milestone || {{W|Cryonics Institute}} || The Cryonics Institute preserves its first patient, Rhea Ettinger. She would be preserved in dry ice for 10 years, and then switch to liquid nitrogen.
 
|-
 
|-
| 1977-07 || cryonics || futurism || || Darwin || Darwin is the first to conceive of the idea of an autonomous, bioengineered cell repair and replacement device to reverse cryo-injury and aging, which he called the “anabolocyte”.<ref>{{Cite journal|last=Darwin|first=MG|date=July 1977|title=The anabolocyte: a biological approach to repairing cryoinjury|url=http://www.nanomedicine.com/NMI/1.3.2.1.htm|journal=Life Extension Magazine: A Journal of the Life Extension Sciences|volume=1|pages=|via=}}</ref>
+
| 1977(?) - 1986 || cryonics || social || festival || Life Extension Festival || The Life Extension Festival is run by {{W|Fred and Linda Chamberlain}}.<ref>{{Cite journal|last=|first=|date=July 1983|title=Report on the Lake Tahoe Life Extension Festival|url=https://www.alcor.org/cryonics/cryonics8307.txt|journal=Cryonics|volume=|issue=36|pages=7-13|via=}}</ref>
 
|-
 
|-
| 1978 || cryonics || organisation || founding || Cryovita Laboratories || Cryovita Laboratories is founded by {{W|Jerry Leaf}}<ref>{{Cite web|url=https://businesssearch.sos.ca.gov/CBS/SearchResults?SearchType=NUMBER&SearchCriteria=C0849138|title=Business Search - Business Entities - Business Programs {{!}} California Secretary of State|website=businesssearch.sos.ca.gov|access-date=2019-01-22}}</ref>, who had been teaching surgery at the {{W|University of California, Los Angeles}}. Cryovita is a for-profit organization which would provide cryopreservation services for Alcor and Trans Time in the 1980s.<ref name="BenBestCryonicsHistory"/>
+
| 1977-07 || cryonics || futurism || || {{W|Mike Darwin}} || Darwin is the first to conceive of the idea of an autonomous, bioengineered cell repair and replacement device to reverse cryo-injury and aging, which he called the “anabolocyte”.<ref>{{Cite journal|last=Darwin|first=MG|date=July 1977|title=The anabolocyte: a biological approach to repairing cryoinjury|url=http://www.nanomedicine.com/NMI/1.3.2.1.htm|journal=Life Extension Magazine: A Journal of the Life Extension Sciences|volume=1|pages=|via=}}</ref>
 
|-
 
|-
| 1978-07 || cryonics || technological adoption || || Cryovita Laboratories || Jerry Leaf of Cryovita Laboratories introduces the principles and equipment of extracorporeal medicine into cryonics with the cryopreservation of Samuel Berkowitz. This included the use the heart-lung machine, closed circuit perfusion, 40µ arterial filtration and sterile technique and Universal Precautions to protect the staff caring for the patient:<ref>{{Cite journal|last=Leaf|first=JD|date=March-April 1979|title=Cryonic Suspension of Sam Berkowitz,|url=|journal=Long Life Magazine|volume=|pages=30-35|via=}}</ref>
+
| 1978 || cryonics || organization || founding || Cryovita Laboratories || Cryovita Laboratories is founded by {{W|Jerry Leaf}}<ref>{{Cite web|url=https://businesssearch.sos.ca.gov/CBS/SearchResults?SearchType=NUMBER&SearchCriteria=C0849138|title=Business Search - Business Entities - Business Programs {{!}} California Secretary of State|website=businesssearch.sos.ca.gov|access-date=2019-01-22}}</ref>, who had been teaching surgery at the {{W|University of California, Los Angeles}}. Cryovita is a for-profit organization which would provide cryopreservation services for Alcor and Trans Time in the 1980s.<ref name="BenBestCryonicsHistory"/>
 
|-
 
|-
| 1979 || cryonics || || || Institute for Advanced Biological Studies || Darwin et al., place the first long term storage marker animal into cryopreservation at the Institute for Advanced Biological Studies in Indianapolis, IN, using glycerol cryoprotection. This animal’s cephalon was subsequently transferred to Alcor where it remains in cryopreservation through the present. This was also the first cryopreservation of a companion animal, which was M. Darwin’s childhood dog “Mitzi”.<ref>{{Cite journal|last=Darwin|first=M.|date=1979|title=Glycerol perfusion and extended storage of the canine central nervous system|url=|journal=Institute for Advanced Biological Studies, Inc|location=Indpls, IN|volume=|pages=|via=}}</ref>
+
| 1978-07 || cryonics || technological adoption || || Cryovita Laboratories || Jerry Leaf of Cryovita Laboratories introduces the principles and equipment of extracorporeal medicine into cryonics with the cryopreservation of Samuel Berkowitz. This included the use of the heart-lung machine, closed-circuit perfusion, 40µ arterial filtration, and sterile technique and Universal Precautions to protect the staff caring for the patient:<ref>{{Cite journal|last=Leaf|first=JD|date=March-April 1979|title=Cryonic Suspension of Sam Berkowitz,|url=|journal=Long Life Magazine|volume=|pages=30-35|via=}}</ref>
 
|-
 
|-
| 1979 || cryonics || || || Institute for Advanced Biological Studies || The Institute for Advanced Biological Studies (IABS) puts Mitzi into cryopreservation, the first companion animal to receive the procedure. Alcor would later store the animal starting in 1982.
+
| 1979 || cryonics || || milestone || Institute for Advanced Biological Studies || The Institute for Advanced Biological Studies (IABS) puts Mitzi into cryopreservation, the first companion animal to receive the procedure. Alcor would later store the animal starting in 1982.
 
|-
 
|-
| 1980 || cryonics || technological development || || Leaf et al. || Leaf et al., carry out the first closed circuit perfusions with stepped increase in cryoprotectant concentration under well controlled conditions with physiological and biochemical monitoring of the patients in real-time. This is also the first case where remote standby and stabilization using continuous heart-lung resuscitator support is carried out.<ref>{{Cite journal|last=Leaf|first=JD|last2=Federowicz|first2=Hixon|last3=H.|first3=|date=1985|title=Case report: two consecutive suspensions, a comparative study in experimental human suspended animation|url=http://www.alcor.org/Library/html/casereport8511.html|journal=Cryonics|volume=6(11)|pages=13-38|via=}}</ref>
+
| 1980 || cryonics || technological development || || Leaf, et al. || Leaf et al., carry out the first closed circuit perfusions with stepped increases in cryoprotectant concentration under well-controlled conditions with physiological and biochemical monitoring of the patients in real-time. This is also the first case where remote standby and stabilization using continuous heart-lung resuscitator support is carried out.<ref>{{Cite journal|last=Leaf|first=JD|last2=Federowicz|first2=Hixon|last3=H.|first3=|date=1985|title=Case report: two consecutive suspensions, a comparative study in experimental human suspended animation|url=http://www.alcor.org/Library/html/casereport8511.html|journal=Cryonics|volume=6(11)|pages=13-38|via=}}</ref>
 
|-
 
|-
| 1980 || cryonics || organisation || founding || Life Extension Foundation || The Life Extension Foundation (LEF) is founded. It would later helped fund various cryonics organisations, notably Alcor, {{W|21st Century Medicine}}, Critical Care Research, and {{W|Suspended Animation, Inc}}.<ref name="BenBestCryonicsHistory"/>
+
| 1980 || cryonics || organization || founding || Life Extension Foundation || The Life Extension Foundation (LEF) is founded. It would later help fund various cryonics organizations, notably Alcor, {{W|21st Century Medicine}}, Critical Care Research, and {{W|Suspended Animation, Inc}}.<ref name="BenBestCryonicsHistory"/>
 
|-
 
|-
| 1980 || cryonics || organisation || founding || Institute for Cryobiological Extension || The Institute for Cryobiological Extension is founded, and would soon published its first volume of ICE Proceedings.
+
| 1980 || cryonics || organization || founding || Institute for Cryobiological Extension || The Institute for Cryobiological Extension is founded, and would soon publish its first volume of ICE Proceedings.
 
|-
 
|-
| 1981 || cryonics || futurism || || || The first paper suggesting that nanotechnology could reverse freezing injury is published.<ref>{{Cite journal|last=Drexler|first=K. Eric|date=1981-09-01|title=Molecular engineering: An approach to the development of general capabilities for molecular manipulation|url=https://www.pnas.org/content/78/9/5275|journal=Proceedings of the National Academy of Sciences|language=en|volume=78|issue=9|pages=5275–5278|doi=10.1073/pnas.78.9.5275|issn=0027-8424|pmid=16593078}}</ref>
+
| 1981 || cryonics || futurism || || {{W|K. Eric Drexler}} || The first paper suggesting that nanotechnology could reverse freezing injury is published.<ref>{{Cite journal|last=Drexler|first=K. Eric|date=1981-09-01|title=Molecular engineering: An approach to the development of general capabilities for molecular manipulation|url=https://www.pnas.org/content/78/9/5275|journal=Proceedings of the National Academy of Sciences|language=en|volume=78|issue=9|pages=5275–5278|doi=10.1073/pnas.78.9.5275|issn=0027-8424|pmid=16593078}}</ref>
 
|-
 
|-
| 1981 || cryonics || organisation || || Cryovita Laboratories || Soma, Inc. merges with Cryovita Laboratories.
+
| 1981 || cryonics || organization || status || Cryovita Laboratories || Soma, Inc. merges with Cryovita Laboratories.
 
|-
 
|-
| 1981-03 || cryonics || writing || journal || Darwin, Bridge || Michael Darwin and Stephen Bridge begin publication of the monthly magazine Cryonics which, for the next 10 years, would be the principle vehicle for publication of technical and scientific papers in cryonics.<ref>{{Cite web|url=https://www.alcor.org/CryonicsMagazine/archive.html|title=Cryonics Magazine|website=www.alcor.org|access-date=2019-02-01}}</ref>
+
| 1981-03 || cryonics || social || journal || Darwin, Bridge || Michael Darwin and Stephen Bridge begin publication of the monthly magazine Cryonics which, for the next 10 years, would be the principal vehicle for publication of technical and scientific papers in cryonics.<ref>{{Cite web|url=https://www.alcor.org/CryonicsMagazine/archive.html|title=Cryonics Magazine|website=www.alcor.org|access-date=2019-02-01}}</ref>
 
|-
 
|-
| 1982 || cryobiology || science || toxicity || Fahy, et al. || Fahy, et al., publish papers which extensively documents the role of cryoprotectant toxicity as a barrier to tissue and organ cryopreservation suggest possible molecular mechanisms.<ref>{{Citation|last=Fahy|first=G. M.|title=Prospects for organ preservation by vitrification|date=1982|url=http://dx.doi.org/10.1007/978-94-011-6267-8_60|work=Organ Preservation|pages=399–404|publisher=Springer Netherlands|isbn=9789401162692|access-date=2019-02-01|last2=Hirsch|first2=A.}}</ref><ref>{{Cite journal|last=Fahy|first=Gregory M.|last2=Lilley|first2=Terence H.|last3=Linsdell|first3=Helen|last4=Douglas|first4=Mary St.John|last5=Meryman|first5=Harold T.|date=June 1990|title=Cryoprotectant toxicity and cryoprotectant toxicity reduction: In search of molecular mechanisms|url=http://dx.doi.org/10.1016/0011-2240(90)90025-y|journal=Cryobiology|volume=27|issue=3|pages=247–268|doi=10.1016/0011-2240(90)90025-y|issn=0011-2240}}</ref>
+
| 1982 || cryobiology || science || toxicity || [[wikipedia:Greg Fahy|Fahy]], et al. || Fahy, et al., publish papers which extensively documents the role of cryoprotectant toxicity as a barrier to tissue and organ cryopreservation suggest possible molecular mechanisms.<ref>{{Citation|last=Fahy|first=G. M.|title=Prospects for organ preservation by vitrification|date=1982|url=http://dx.doi.org/10.1007/978-94-011-6267-8_60|work=Organ Preservation|pages=399–404|publisher=Springer Netherlands|isbn=9789401162692|access-date=2019-02-01|last2=Hirsch|first2=A.}}</ref><ref>{{Cite journal|last=Fahy|first=Gregory M.|last2=Lilley|first2=Terence H.|last3=Linsdell|first3=Helen|last4=Douglas|first4=Mary St.John|last5=Meryman|first5=Harold T.|date=June 1990|title=Cryoprotectant toxicity and cryoprotectant toxicity reduction: In search of molecular mechanisms|url=http://dx.doi.org/10.1016/0011-2240(90)90025-y|journal=Cryobiology|volume=27|issue=3|pages=247–268|doi=10.1016/0011-2240(90)90025-y|issn=0011-2240}}</ref>
 
|-
 
|-
| 1982 || cryonics || organisation || || {{W|Alcor Life Extension Foundation}} || Alcor begins storing its own patients. It was previously storing its patients with Trans Time, Inc.
+
| 1982 || cryonics || organization || milestone || {{W|Alcor Life Extension Foundation}} || Alcor begins storing its own patients. It was previously storing its patients with Trans Time, Inc.
 
|-
 
|-
| 1982 || cryonics || organisation || || {{W|Alcor Life Extension Foundation}} || The Institute for Advanced Biological Studies merges with Alcor.
+
| 1982 || cryonics || organization || status || {{W|Alcor Life Extension Foundation}} || The Institute for Advanced Biological Studies merges with Alcor.
 
|-
 
|-
| 1982-09-15 || cryonics || social || || {{W|Society for Cryobiology}} || The {{W|Society for Cryobiology}} adopts new bylaws denying membership to organizations or individuals supporting cryonics.<ref>{{Cite web|url=http://blog.ciphergoth.org/blog/2010/02/12/society-for-cryobiology-statements-on-cryonic/|title=Paul Crowley's Blog - Society for Cryobiology statements on cryonics|website=blog.ciphergoth.org|access-date=2019-01-22}}</ref><ref>{{Cite web|url=https://www.alcor.org/Library/html/coldwar.html|title=Cold War: The Conflict Between Cryonicists and Cryobiologists|website=www.alcor.org|access-date=2019-01-22}}</ref>
+
| 1982-09-15 || cryonics || social || bylaws || {{W|Society for Cryobiology}} || The {{W|Society for Cryobiology}} adopts new bylaws denying membership to organizations or individuals supporting cryonics.<ref>{{Cite web|url=http://blog.ciphergoth.org/blog/2010/02/12/society-for-cryobiology-statements-on-cryonic/|title=Paul Crowley's Blog - Society for Cryobiology statements on cryonics|website=blog.ciphergoth.org|access-date=2019-01-22}}</ref><ref>{{Cite web|url=https://www.alcor.org/Library/html/coldwar.html|title=Cold War: The Conflict Between Cryonicists and Cryobiologists|website=www.alcor.org|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1983-01 || cryonics || technological development || || Darwin, et al. || Darwin, et al. carry out an extensive study to evaluate the efficacy of a human cryopreservation protocol on whole mammals (rabbits). This research discloses extensive ultrastructural disruption of the brain even when freezing in the presence of 3 M glycerol is employed. This work also documentes the extremely adverse effects of prolonged cold ischemia on cryoprotective perfusion.<ref>{{Cite web|url=http://www.cryonet.org/cgi-bin/dsp.cgi?msg=1389|title=Cryoprotective perfusion and freezing of the ischemic and nonischemic cat|last=Darwin|first=M|last2=Leaf|first2=JD|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref><ref>{{Cite web|url=http://www.cryonet.org/cgi-bin/dsp.cgi?msg=1390|title=CRYONICS: Freezing Damage (Darwin) Part 2|website=www.cryonet.org|access-date=2019-02-01}}</ref><ref>{{Cite web|url=http://www.cryonet.org/cgi-bin/dsp.cgi?msg=1391|title=CRYONICS: Freezing Damage (Darwin) Part 3|website=www.cryonet.org|access-date=2019-02-01}}</ref><ref>{{Cite web|url=http://www.cryonet.org/cgi-bin/dsp.cgi?msg=1392|title=CRYONICS: Freezing Damage (Darwin) Part 4|website=www.cryonet.org|access-date=2019-02-01}}</ref><ref>{{Cite journal|last=Federowicz|first=MG|last2=Leaf|first2=JD|date=January 1983|title=Tahoe Research Proposals|url=http://www.alcor.org/cryonics/cryonics8301.txt|journal=Cryonics|volume=|issue=30|pages=14|via=}}</ref><ref>{{Cite web|url=http://chronopause.com/index.php/2012/02/13/the-effects-of-cryopreservation-on-the-cat-part-1/|title=THE EFFECTS OF CRYOPRESERVATION ON THE CAT, Part 1|last=chronopause|website=CHRONOSPHERE|language=en-US|access-date=2019-02-01}}</ref><ref>{{Cite web|url=http://chronopause.com/index.php/2012/02/14/the-effects-of-cryopreservation-on-the-cat-part-2/|title=THE EFFECTS OF CRYOPRESERVATION ON THE CAT, Part 2|last=chronopause|website=CHRONOSPHERE|language=en-US|access-date=2019-02-01}}</ref><ref>{{Cite web|url=http://chronopause.com/index.php/2012/02/21/the-effects-of-cryopreservation-on-the-cat-part-3/|title=THE EFFECTS OF CRYOPRESERVATION ON THE CAT, Part 3|last=chronopause|website=CHRONOSPHERE|language=en-US|access-date=2019-02-01}}</ref>
+
| 1983-01 || cryonics || technological development || || [[wikipedia:Mike Darwin|Darwin]], et al. || Darwin, et al. carry out an extensive study to evaluate the efficacy of a human cryopreservation protocol on whole mammals (rabbits). This research discloses extensive ultrastructural disruption of the brain even when freezing in the presence of 3 M glycerol is employed. This work also documents the extremely adverse effects of prolonged cold ischemia on cryoprotective perfusion.<ref>{{Cite web|url=http://www.cryonet.org/cgi-bin/dsp.cgi?msg=1389|title=Cryoprotective perfusion and freezing of the ischemic and nonischemic cat|last=Darwin|first=M|last2=Leaf|first2=JD|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref><ref>{{Cite web|url=http://www.cryonet.org/cgi-bin/dsp.cgi?msg=1390|title=CRYONICS: Freezing Damage (Darwin) Part 2|website=www.cryonet.org|access-date=2019-02-01}}</ref><ref>{{Cite web|url=http://www.cryonet.org/cgi-bin/dsp.cgi?msg=1391|title=CRYONICS: Freezing Damage (Darwin) Part 3|website=www.cryonet.org|access-date=2019-02-01}}</ref><ref>{{Cite web|url=http://www.cryonet.org/cgi-bin/dsp.cgi?msg=1392|title=CRYONICS: Freezing Damage (Darwin) Part 4|website=www.cryonet.org|access-date=2019-02-01}}</ref><ref>{{Cite journal|last=Federowicz|first=MG|last2=Leaf|first2=JD|date=January 1983|title=Tahoe Research Proposals|url=http://www.alcor.org/cryonics/cryonics8301.txt|journal=Cryonics|volume=|issue=30|pages=14|via=}}</ref><ref>{{Cite web|url=http://chronopause.com/index.php/2012/02/13/the-effects-of-cryopreservation-on-the-cat-part-1/|title=THE EFFECTS OF CRYOPRESERVATION ON THE CAT, Part 1|last=chronopause|website=CHRONOSPHERE|language=en-US|access-date=2019-02-01}}</ref><ref>{{Cite web|url=http://chronopause.com/index.php/2012/02/14/the-effects-of-cryopreservation-on-the-cat-part-2/|title=THE EFFECTS OF CRYOPRESERVATION ON THE CAT, Part 2|last=chronopause|website=CHRONOSPHERE|language=en-US|access-date=2019-02-01}}</ref><ref>{{Cite web|url=http://chronopause.com/index.php/2012/02/21/the-effects-of-cryopreservation-on-the-cat-part-3/|title=THE EFFECTS OF CRYOPRESERVATION ON THE CAT, Part 3|last=chronopause|website=CHRONOSPHERE|language=en-US|access-date=2019-02-01}}</ref>
 
|-
 
|-
| 1983 || cryonics || organisation || || Institute for Cryobiological Extension || Leaf changes hats to President of the Institute for Cryobiological Extension (ICE) with the intention to devise a new project with the goal of having animal heads frozen, thawed, and reattached to a new body in such a way that would allow for neurocognitive evaluation. The project would later be deemed impractical. <ref>{{Cite journal|last=|first=|date=July 1983|title=Report on the Lake Tahoe Life Extension Festival|url=https://www.alcor.org/cryonics/cryonics8307.txt|journal=Cryonics|volume=|issue=36|pages=7-13|via=}}</ref>
+
| 1983 || cryonics || organization || status || Institute for Cryobiological Extension || Leaf changes hats to President of the Institute for Cryobiological Extension (ICE) with the intention to devise a new project with the goal of having animal heads frozen, thawed, and reattached to a new body in such a way that would allow for neurocognitive evaluation. The project would later be deemed impractical. <ref>{{Cite journal|last=|first=|date=July 1983|title=Report on the Lake Tahoe Life Extension Festival|url=https://www.alcor.org/cryonics/cryonics8307.txt|journal=Cryonics|volume=|issue=36|pages=7-13|via=}}</ref>
 
|-
 
|-
| 1984 || cryonics || science || || Darwin et al. || Darwin et al., publish the first paper documenting the effects of cryopreservation protocols on human patients. This paper documents the presence of extensive macro-tissue fracturing in all three patients examined and shows relatively good histological preservation in the patient treated with 3 M glycerol.<ref>{{Cite journal|last=Federowicz|first=M.|last2=Hixon|first2=H.|last3=Leaf|first3=J.|date=1984|title=Post-mortem examination of three cryonic suspension patients|url=http://www.alcor.org/cryonics/cryonics8409.txt|journal=Cryonics|volume=5|issue=9|pages=16-28|access-date=2010-08-31|via=}}</ref>
+
| 1984 || cryonics || science || || [[wikipedia:Mike Darwin|Darwin]], et al. || Darwin et al. publish the first paper documenting the effects of cryopreservation protocols on human patients. This paper documents the presence of extensive macro-tissue fracturing in all three patients examined and shows relatively good histological preservation in the patient treated with 3 M glycerol.<ref>{{Cite journal|last=Federowicz|first=M.|last2=Hixon|first2=H.|last3=Leaf|first3=J.|date=1984|title=Post-mortem examination of three cryonic suspension patients|url=http://www.alcor.org/cryonics/cryonics8409.txt|journal=Cryonics|volume=5|issue=9|pages=16-28|access-date=2010-08-31|via=}}</ref>
 
|-
 
|-
| 1984 || suspended animation || technological development || || Leaf, Darwin, Hixon || Leaf, Darwin and Hixon complete 3-years of research demonstrating successful 4-hour asanguineous perfusion of dogs at 5°C with full recovery of health, mentation and long term memory. The paper documenting this work is rejected by the Society for Cryobiology because the work was conducted by cryonicists. The perfusate developed during this research, MHP-2 continues to be used for total body washout through the present.<ref>{{Cite web|url=http://www.alcor.org/Library/html/tbwcanine.html|title=A mannitol-based perfusate for reversible 5-hour asanguineous ultraprofound hypothermia in canines (Report on work performed from 1984-87)|last=Leaf|first=JD|last2=Darwin|first2=M.|date=|website=1986|archive-url=|archive-date=|dead-url=|access-date=2010-08-31|last3=Hixon|first3=H.}}</ref>
+
| 1984 || suspended animation || technological development || || Leaf, Darwin, Hixon || Leaf, Darwin and Hixon complete 3-years of research demonstrating successful 4-hour asanguineous perfusion of dogs at 5°C with full recovery of health, mentation, and long term memory. The paper documenting this work is rejected by the Society for Cryobiology because the work was conducted by cryonicists. The perfusate developed during this research, MHP-2 continues to be used for total body washout through the present.<ref>{{Cite web|url=http://www.alcor.org/Library/html/tbwcanine.html|title=A mannitol-based perfusate for reversible 5-hour asanguineous ultraprofound hypothermia in canines (Report on work performed from 1984-87)|last=Leaf|first=JD|last2=Darwin|first2=M.|date=|website=1986|archive-url=|archive-date=|dead-url=|access-date=2010-08-31|last3=Hixon|first3=H.}}</ref>
 
|-
 
|-
| 1984 || cryobiology || science || paper || || The first paper showing that large organs can be cryopreserved without structural damage from ice is published.<ref>{{Cite journal|last=Fahy|first=G. M.|last2=MacFarlane|first2=D. R.|last3=Angell|first3=C. A.|last4=Meryman|first4=H. T.|date=1984-08-01|title=Vitrification as an approach to cryopreservation|url=http://www.sciencedirect.com/science/article/pii/0011224084900798|journal=Cryobiology|volume=21|issue=4|pages=407–426|doi=10.1016/0011-2240(84)90079-8|issn=0011-2240}}</ref>
+
| 1984 || cryobiology || science || cryoprotection || [[wikipedia:Greg Fahy|Fahy]], et al. || The first paper showing that large organs can be cryopreserved without structural damage from ice is published.<ref>{{Cite journal|last=Fahy|first=G. M.|last2=MacFarlane|first2=D. R.|last3=Angell|first3=C. A.|last4=Meryman|first4=H. T.|date=1984-08-01|title=Vitrification as an approach to cryopreservation|url=http://www.sciencedirect.com/science/article/pii/0011224084900798|journal=Cryobiology|volume=21|issue=4|pages=407–426|doi=10.1016/0011-2240(84)90079-8|issn=0011-2240}}</ref>
 
|-
 
|-
| 1984 || cryonics || science || observation || {{W|Alcor Life Extension Foundation}} || Alcor observes fractures in human cryopreservation patients. <ref name="IntermediateTemperatureStorage"/><ref>{{Cite journal|last=Federowicz|first=M.|last2=Hixon|first2=H.|last3=Leaf|first3=J.|date=1984|title=Postmortem Examination of Three Cryonic Suspension Patients|url=https://alcor.org/Library/html/postmortemexamination.html|journal=Cryonics|volume=|pages=16-28|via=}}</ref>
+
| 1984 || cryonics || science || fracturing || {{W|Alcor Life Extension Foundation}} || Alcor observes fractures in human cryopreservation patients. <ref name="IntermediateTemperatureStorage"/><ref>{{Cite journal|last=Federowicz|first=M.|last2=Hixon|first2=H.|last3=Leaf|first3=J.|date=1984|title=Postmortem Examination of Three Cryonic Suspension Patients|url=https://alcor.org/Library/html/postmortemexamination.html|journal=Cryonics|volume=|pages=16-28|via=}}</ref>
 
|-
 
|-
| 1985 || cryonics || technological adoption || remote stabilization || || For the first time, a cryonics patient is given remote standby with in-field total body washout. Cardiopulmonary support (CPS) is initiated within 2 minutes following monitored cardiac arrest. This is also the first case where anesthesia is used to inhibit consciousness during cardiopulmonary arrest (CPA) and external cooling.<ref>{{Cite journal|last=Federowicz|first=MG|last2=Leaf|first2=JD|last3=Hixon|first3=H.|date=1986|title=Case report: neuropreservation of Alcor patient A-1068 (1 of 2)|url=http://www.alcor.org/cryonics/cryonics8602.txt|journal=Cryonics|volume=7|issue=2|pages=17-32|via=}}</ref><ref>{{Cite journal|last=Federowicz|first=MG|last2=Leaf|first2=JD|last3=Hixon|first3=H.|date=1986|title=Case report: neuropreservation of Alcor patient A-1068 (2 of 2)|url=http://www.alcor.org/cryonics/cryonics8603.txt|journal=Cryonics|volume=7|issue=3|pages=15-29|via=}}</ref><ref>{{Cite web|url=http://www.cryocare.org/index.cgi?subdir=bpi&url=tech21.txt|title=Securing anesthesia in the human cryopreservation patient|last=Darwin|first=M.|date=18 January 1997|website=CryoNet|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
+
| 1985 || cryonics || technological adoption || remote stabilization || Federowicz, et al. || For the first time, a cryonics patient is given remote standby with in-field total body washout. Cardiopulmonary support (CPS) is initiated within 2 minutes following monitored cardiac arrest. This is also the first case where anesthesia is used to inhibit consciousness during cardiopulmonary arrest (CPA) and external cooling.<ref>{{Cite journal|last=Federowicz|first=MG|last2=Leaf|first2=JD|last3=Hixon|first3=H.|date=1986|title=Case report: neuropreservation of Alcor patient A-1068 (1 of 2)|url=http://www.alcor.org/cryonics/cryonics8602.txt|journal=Cryonics|volume=7|issue=2|pages=17-32|via=}}</ref><ref>{{Cite journal|last=Federowicz|first=MG|last2=Leaf|first2=JD|last3=Hixon|first3=H.|date=1986|title=Case report: neuropreservation of Alcor patient A-1068 (2 of 2)|url=http://www.alcor.org/cryonics/cryonics8603.txt|journal=Cryonics|volume=7|issue=3|pages=15-29|via=}}</ref><ref>{{Cite web|url=http://www.cryocare.org/index.cgi?subdir=bpi&url=tech21.txt|title=Securing anesthesia in the human cryopreservation patient|last=Darwin|first=M.|date=18 January 1997|website=CryoNet|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
 
|-
 
|-
| 1985 || cryobiology || vitrification || vitrification || Fahy, Rall || Fahy and Rall successfully apply vitrification to embryo preservation introducing the technique to mainstream medicine and highlighting its potential utility in solid organ cryopreservation.<ref>{{Cite journal|last=Rall|first=W. F.|last2=Fahy|first2=G. M.|date=14 Feb 1985|title=Ice-free cryopreservation of mouse embryos at -196 degrees C by vitrification|url=https://www.ncbi.nlm.nih.gov/pubmed/3969158|journal=Nature|volume=313|issue=6003|pages=573–575|issn=0028-0836|pmid=3969158}}</ref>
+
| 1985 || cryobiology || technological development || vitrification || [[wikipedia:Greg Fahy|Fahy]], Rall || Fahy and Rall successfully apply vitrification to embryo preservation introducing the technique to mainstream medicine and highlighting its potential utility in solid organ cryopreservation.<ref>{{Cite journal|last=Rall|first=W. F.|last2=Fahy|first2=G. M.|date=14 Feb 1985|title=Ice-free cryopreservation of mouse embryos at -196 degrees C by vitrification|url=https://www.ncbi.nlm.nih.gov/pubmed/3969158|journal=Nature|volume=313|issue=6003|pages=573–575|issn=0028-0836|pmid=3969158}}</ref>
 
|-
 
|-
| 1980s (mid) || cryonics || legal || || Jackson National || Jackson National is the first life insurance company to definitively state that it acknowledges that cryonics arrangements constitute a legitimate insurable interest.<ref>{{Cite web|url=https://groups.yahoo.com/|title=Yahoo! Groups|website=groups.yahoo.com|language=en-US|access-date=2019-01-22}}</ref>
+
| 1980s (mid) || cryonics || legal || life insurance || Jackson National || Jackson National is the first life insurance company to definitively state that it acknowledges that cryonics arrangements constitute a legitimate insurable interest.<ref>{{Cite web|url=https://groups.yahoo.com/|title=Yahoo! Groups|website=groups.yahoo.com|language=en-US|access-date=2019-01-22}}</ref>
 
|-
 
|-
 
| 1980s (mid) || cryobiology || technological adoption || vitrification || {{W|Greg Fahy}} and William F. Rall || Researchers {{W|Greg Fahy}} and William F. Rall help introduce {{W|vitrification}} to reproductive cryopreservation.
 
| 1980s (mid) || cryobiology || technological adoption || vitrification || {{W|Greg Fahy}} and William F. Rall || Researchers {{W|Greg Fahy}} and William F. Rall help introduce {{W|vitrification}} to reproductive cryopreservation.
 
|-
 
|-
| 1986 || cryonics || writing || textbook || Darwin || M. Darwin publishes the first textbook on acute stabilization of human cryopreservation patients.<ref>{{Cite web|url=http://www.alcor.org/Library/html/1990manual.html|title=Transport Protocol for Cryonic suspension of Humans|last=Darwin|first=MG|date=1986|website=Alcor Life Extension Foundation|location=Fullerton, CA|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
+
| 1986 || cryonics || social || textbook || {{W|Mike Darwin}} || M. Darwin publishes the first textbook on acute stabilization of human cryopreservation patients.<ref>{{Cite web|url=http://www.alcor.org/Library/html/1990manual.html|title=Transport Protocol for Cryonic suspension of Humans|last=Darwin|first=MG|date=1986|website=Alcor Life Extension Foundation|location=Fullerton, CA|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
 
|-
 
|-
| 1986 || cryobiology || science || vitrification || Fahy || Greg Fahy proposes vitrification as a mean of achieving viable parenchymatous organ preservation.<ref>{{Cite journal|last=Fahy|first=G. M.|date=1986|title=Vitrification: a new approach to organ cryopreservation|url=https://www.ncbi.nlm.nih.gov/pubmed/3540994|journal=Progress in Clinical and Biological Research|volume=224|pages=305–335|issn=0361-7742|pmid=3540994}}</ref>
+
| 1986 || cryobiology || science || vitrification || {{W|Greg Fahy}} || Greg Fahy proposes vitrification as a mean of achieving viable parenchymatous organ preservation.<ref>{{Cite journal|last=Fahy|first=G. M.|date=1986|title=Vitrification: a new approach to organ cryopreservation|url=https://www.ncbi.nlm.nih.gov/pubmed/3540994|journal=Progress in Clinical and Biological Research|volume=224|pages=305–335|issn=0361-7742|pmid=3540994}}</ref>
 
|-
 
|-
 
| 1986 || cryonics || futurism || || {{W|K. Eric Drexler}} || {{W|K. Eric Drexler}} publishes ''Engines of Creation''<ref>{{Cite book|title=Engines of creation|last=K. Eric|first=Drexler|publisher=Anchor Press/Doubleday|year=1986|isbn=0385199724|location=Garden City, N.Y|pages=}}</ref> -- the first book on molecular nanotechnology --. The book has a chapter on cryonics. It creates a surge in growth in cryonics interest and membership.
 
| 1986 || cryonics || futurism || || {{W|K. Eric Drexler}} || {{W|K. Eric Drexler}} publishes ''Engines of Creation''<ref>{{Cite book|title=Engines of creation|last=K. Eric|first=Drexler|publisher=Anchor Press/Doubleday|year=1986|isbn=0385199724|location=Garden City, N.Y|pages=}}</ref> -- the first book on molecular nanotechnology --. The book has a chapter on cryonics. It creates a surge in growth in cryonics interest and membership.
 
|-
 
|-
| 1986 || suspended animation || science || paper || || The first paper showing that large mammals can be recovered after three hours of total circulatory arrest (“clinical death”) at +3°C (37°F) is published. This supports the reversibility of the hypothermic phase of cryonics.<ref>{{Cite journal|last=Haneda|first=Kiyoshi|last2=Thomas|first2=Robert|last3=Sands|first3=Murray P.|last4=Breazeale|first4=Donald G.|last5=Dillard|first5=David H.|date=1986-12-01|title=Whole body protection during three hours of total circulatory arrest: An experimental study|url=http://www.sciencedirect.com/science/article/pii/001122408690057X|journal=Cryobiology|volume=23|issue=6|pages=483–494|doi=10.1016/0011-2240(86)90057-X|issn=0011-2240}}</ref>
+
| 1986 || suspended animation || science || || Haneda, et al. || The first paper showing that large mammals can be recovered after three hours of total circulatory arrest (“clinical death”) at +3°C (37°F) is published. This supports the reversibility of the hypothermic phase of cryonics.<ref>{{Cite journal|last=Haneda|first=Kiyoshi|last2=Thomas|first2=Robert|last3=Sands|first3=Murray P.|last4=Breazeale|first4=Donald G.|last5=Dillard|first5=David H.|date=1986-12-01|title=Whole body protection during three hours of total circulatory arrest: An experimental study|url=http://www.sciencedirect.com/science/article/pii/001122408690057X|journal=Cryobiology|volume=23|issue=6|pages=483–494|doi=10.1016/0011-2240(86)90057-X|issn=0011-2240}}</ref>
  
 
|-
 
|-
| 1986 || cryonics || organisation || organisation's first || {{W|Alcor Life Extension Foundation}} || Alcor cryopreserves a member's companion animal for the first time.
+
| 1986 || cryonics || organization || milestone || {{W|Alcor Life Extension Foundation}} || Alcor cryopreserves a member's companion animal for the first time.
 
|-
 
|-
| 1986 || cryonics || futurism || || Drexler || Aldehyde-stabilized cryopreservation is proposed under the name of "fixation and vitrification".<ref>{{Cite book|title=Engines of Creation: The Coming Era of Nanotechnology|last=Drexler|first=K. Eric|publisher=|year=1986|isbn=|location=|pages=|chapter=9|url=http://e-drexler.com/d/06/00/EOC/EOC_Chapter_9.html}}</ref>
+
| 1986 || cryonics || futurism || || {{W|K. Eric Drexler}} || Aldehyde-stabilized cryopreservation is proposed under the name of "fixation and vitrification".<ref>{{Cite book|title=Engines of Creation: The Coming Era of Nanotechnology|last=Drexler|first=K. Eric|publisher=|year=1986|isbn=|location=|pages=|chapter=9|url=http://e-drexler.com/d/06/00/EOC/EOC_Chapter_9.html}}</ref>
 
|-
 
|-
| 1987 || cryonics || organisation || founding || Cryonics Society of Canada || Douglas Quinn launches the Cryonics Society of Canada and Canadian Cryonics News.<ref>{{Cite web|url=http://www.cryocdn.org/cdnhist.html|title=Cryonics Society of Canada -- The Story of the Organization and Its People|website=www.cryocdn.org|access-date=2019-01-22}}</ref>
+
| 1987 || cryonics || organization || founding || Cryonics Society of Canada || Douglas Quinn launches the Cryonics Society of Canada and Canadian Cryonics News.<ref>{{Cite web|url=http://www.cryocdn.org/cdnhist.html|title=Cryonics Society of Canada -- The Story of the Organization and Its People|website=www.cryocdn.org|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1987 || cryonics || technological adoption || cold || Cryonics Institute || The Cryonics Institute starts using liquid nitrogen instead of dry ice.<ref name="BenBestCryonicsHistory"/>
+
| 1987 || cryonics || technological adoption || cold || {{W|Cryonics Institute}} || The Cryonics Institute starts using liquid nitrogen instead of dry ice.<ref name="BenBestCryonicsHistory"/>
 
|-
 
|-
| 1987-06 || cryonics || technological development || [[wikipedia:extracorporeal membrane oxygenation|extracorporeal membrane oxygenation]] || Leaf, Darwin, Hixon || Leaf, Darwin and Hixon develop a mobile [[wikipedia:extracorporeal membrane oxygenation|extracorporeal membrane oxygenation]] (ECMO) cart which is capable of providing acute, in-field extracorporeal life support and cooling providing the first truly adequate method of maintaining viability and achieving rapid induction of hypothermia in cryonics patients.<ref>{{Cite journal|last=Leaf|first=Jerry D|last2=Hixon|first2=Hugh|last3=Hugh|first3=Mike|date=1987|title=Development of a mobile advanced life support system for human biostasis operations|url=https://www.alcor.org/cryonics/cryonics8703.txt|journal=Cryonics|volume=8|issue=3|pages=23-40|via=}}</ref><ref>{{Cite web|url=https://alcor.org/Library/pdfs/AlcorCaseA1133.pdf|title=Cryonic suspension case report: A-1133|last=Darwin|first=Michael G.|last2=Leaf|first2=Jerry D.|date=|website=Alcor Life Extension Foundation|archive-url=|archive-date=|dead-url=|access-date=|last3=Hixon|first3=Hugh L.}}</ref>
+
| 1987-06 || cryonics || technological development || [[wikipedia:extracorporeal membrane oxygenation|extracorporeal membrane oxygenation]] || Leaf, Darwin, Hixon || Leaf, Darwin, and Hixon develop a mobile [[wikipedia:extracorporeal membrane oxygenation|extracorporeal membrane oxygenation]] (ECMO) cart which is capable of providing acute, in-field extracorporeal life support and cooling providing the first truly adequate method of maintaining viability and achieving rapid induction of hypothermia in cryonics patients.<ref>{{Cite journal|last=Leaf|first=Jerry D|last2=Hixon|first2=Hugh|last3=Hugh|first3=Mike|date=1987|title=Development of a mobile advanced life support system for human biostasis operations|url=https://www.alcor.org/cryonics/cryonics8703.txt|journal=Cryonics|volume=8|issue=3|pages=23-40|via=}}</ref><ref>{{Cite web|url=https://alcor.org/Library/pdfs/AlcorCaseA1133.pdf|title=Cryonic suspension case report: A-1133|last=Darwin|first=Michael G.|last2=Leaf|first2=Jerry D.|date=|website=Alcor Life Extension Foundation|archive-url=|archive-date=|dead-url=|access-date=|last3=Hixon|first3=Hugh L.}}</ref>
 
|-
 
|-
| 1987-06-08 || cryonics || technological adoption || [[wikipedia:extracorporeal membrane oxygenation|extracorporeal membrane oxygenation]] || || First use of extracorporeal membrane oxygenation (ECMO) support on a cryonics patient.<ref>{{Cite web|url=https://alcor.org/Library/pdfs/AlcorCaseA1133.pdf|title=Cryonic suspension case report: A-1133|last=Darwin|first=M.|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
+
| 1987-06-08 || cryonics || technological adoption || [[wikipedia:extracorporeal membrane oxygenation|extracorporeal membrane oxygenation]] || {{W|Mike Darwin}} || The first use of extracorporeal membrane oxygenation (ECMO) support on a cryonics patient.<ref>{{Cite web|url=https://alcor.org/Library/pdfs/AlcorCaseA1133.pdf|title=Cryonic suspension case report: A-1133|last=Darwin|first=M.|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
 
|-
 
|-
| 1987-12 || cryonics || legal || || {{W|Alcor Life Extension Foundation}} || {{W|Saul Kent}} brings his terminally ill mother ({{W|Dora Kent}}) into the Alcor facility where she deanimates. Her head would be cryopreserved.
+
| 1987-12 || cryonics || legal || cryopreservation || {{W|Alcor Life Extension Foundation}} || {{W|Saul Kent}} brings his terminally ill mother ({{W|Dora Kent}}) into the Alcor facility where she deanimates. Her head would be cryopreserved.
  
 
The rest of the body would be given to a coroner. The coroner's office wouldn't understand that circulation would be artificially restarted after legal death, and that barbiturate would be given to slow down the brain metabolism. Seeing the distributed barbiturate throughout the body, they would change the cause of death from natural causes to homicide.
 
The rest of the body would be given to a coroner. The coroner's office wouldn't understand that circulation would be artificially restarted after legal death, and that barbiturate would be given to slow down the brain metabolism. Seeing the distributed barbiturate throughout the body, they would change the cause of death from natural causes to homicide.
  
In January 1988, Alcor would be raided by coroner's deputies, a SWAT team, and UCLA police. The Alcor staff would be taken to the police station in handcuffs and the Alcor facility would be ransacked, with computers and records being seized. The coroner's office would want to seize {{W|Dora Kent}}'s head for autopsy, but the head would be removed from the Alcor facility and taken to a location that would never be disclosed. Alcor would later sue for false arrest and for illegal seizures, and would win both cases.<ref name="BenBestCryonicsHistory"/>
+
In January 1988, Alcor would be raided by coroner's deputies, a SWAT team, and UCLA police. The Alcor staff would be taken to the police station in handcuffs and the Alcor facility would be ransacked, with computers and records being seized. The coroner's office would want to seize {{W|Dora Kent}}'s head for autopsy, but the head would be removed from the Alcor facility and taken to a location that would never be disclosed. Alcor would later sue for false arrest and for illegal seizures, and would win both cases.<ref name="BenBestCryonicsHistory"/><ref>{{Cite web|url=https://alcor.org/Library/html/DoraKentCase.html|title=The Dora Kent Case|website=alcor.org|access-date=2019-02-15}}</ref>
|-
 
| 1988 || cryonics || social || || || The Cryonet email list starts.<ref>{{Cite web|url=http://www.cryonet.org/cgi-bin/dsp.cgi?msg=1|title=administrivia|website=www.cryonet.org|access-date=2019-01-22}}</ref>
 
 
|-
 
|-
| 1988 || cryonics || legal || || Dick Clair || Alcor member Dick Clair (who is dying of AIDS) sues for, and ultimately wins for everyone, the right to be cryopreserved in the State of California.<ref>{{Cite web|url=https://www.alcor.org/Library/html/CaliforniaAppellateCourtDecison.html|title=California Appellate Court Decision on Legality of Cryonics|website=www.alcor.org|access-date=2019-01-22}}</ref>
+
| 1988 || cryonics || social || email list || Cryonet || The [http://www.cryonet.org/ Cryonet] email list starts.<ref>{{Cite web|url=http://www.cryonet.org/cgi-bin/dsp.cgi?msg=1|title=administrivia|website=www.cryonet.org|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1989 || cryonics || technological development || cooling rate || Darwin || M. Darwin creates the portable ice bath (PIB) to substantially increase the efficacy of external cooling with Fred Chamberlain subsequently developing a surface convective cooling device to further improve heat exchange doubling the rate of cooling during external cooling for induction of hypothermia.<ref>{{Cite journal|last=Pizer|first=David|date=1989|title=Alcor outstanding support award nominee|url=https://www.alcor.org/cryonics/cryonics8907.txt|journal=Cryonics|volume=17|issue=7|pages=10|via=}}</ref>
+
| 1988 || cryonics || legal || cryopreservation || Dick Clair || Alcor member Dick Clair{{snd}}who is dying of AIDS{{snd}}sues for, and ultimately wins for everyone, the right to be cryopreserved in the State of California.<ref name="BenBestCryonicsHistory"/><ref>{{Cite web|url=https://www.alcor.org/Library/html/CaliforniaAppellateCourtDecison.html|title=California Appellate Court Decision on Legality of Cryonics|website=www.alcor.org|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1989 || cryonics || technological adoption || || Darwin || M. Darwin introduces high impulse [[wikipedia:cardiopulmonary resuscitation|cardiopulmonary resuscitation]] (CPR) improving cardiac output during cardiopulmonary support (CPS).<ref>{{Cite journal|last=Darwin|first=M.|date=1989|title=A major advance in suspension patient support|url=http://www.alcor.org/cryonics/cryonics8908.txt|journal=Cryonics|volume=10|issue=8|pages=7-14|access-date=2010-09-29|via=}}</ref>
+
| 1989 || cryonics || technological development || cooling rate || {{W|Mike Darwin}} || M. Darwin creates the portable ice bath (PIB) to substantially increase the efficacy of external cooling with Fred Chamberlain subsequently developing a surface convective cooling device to further improve heat exchange doubling the rate of cooling during external cooling for induction of hypothermia.<ref>{{Cite journal|last=Pizer|first=David|date=1989|title=Alcor outstanding support award nominee|url=https://www.alcor.org/cryonics/cryonics8907.txt|journal=Cryonics|volume=17|issue=7|pages=10|via=}}</ref>
 
|-
 
|-
| 1989-02 || cryonics || writing || textbook || Wowk, Darwin || Wowk and Darwin author the first comprehensive textbook on cryonics, "Cryonics: Reaching for Tomorrow", designed for use in recruiting new members to Alcor. It would be published in 1991.<ref>{{Cite web|url=http://cryoeuro.eu:8080/download/attachments/425990/AlcorReachingForTomorrow1989.pdf|title=Cryonics: Reaching for Tomorrow,|last=Wowk|first=B.|last2=Darwin|first2=M.|date=1990|website=Alcor Life Extension Foundation|location=Riverside, CA|isbn=1880209004|archive-url=|archive-date=|dead-url=|access-date=2010-10-09}}</ref>
+
| 1989 || cryonics || technological adoption || || {{W|Mike Darwin}} || M. Darwin introduces high impulse [[wikipedia:cardiopulmonary resuscitation|cardiopulmonary resuscitation]] (CPR) improving cardiac output during cardiopulmonary support (CPS).<ref>{{Cite journal|last=Darwin|first=M.|date=1989|title=A major advance in suspension patient support|url=http://www.alcor.org/cryonics/cryonics8908.txt|journal=Cryonics|volume=10|issue=8|pages=7-14|access-date=2010-09-29|via=}}</ref>
 
|-
 
|-
| 1980s (late) || cryonics || legal || || {{W|Alcor Life Extension Foundation}} || Alcor Member Dick Clair{{snd}}who was dying of AIDS{{snd}}fights in court for the legal right to practice cryonics in California, a battle that would ultimately be won.<ref name="BenBestCryonicsHistory"/>
+
| 1989-02 || cryonics || social || textbook || Wowk, [[wikipedia:Mike Darwin|Darwin]] || Wowk and Darwin author the first comprehensive textbook on cryonics, "Cryonics: Reaching for Tomorrow", designed for use in recruiting new members to Alcor. It would be published in 1991.<ref>{{Cite web|url=http://cryoeuro.eu:8080/download/attachments/425990/AlcorReachingForTomorrow1989.pdf|title=Cryonics: Reaching for Tomorrow,|last=Wowk|first=B.|last2=Darwin|first2=M.|date=1990|website=Alcor Life Extension Foundation|location=Riverside, CA|isbn=1880209004|archive-url=|archive-date=|dead-url=|access-date=2010-10-09}}</ref>
 
|-
 
|-
| 1990 || cryonics || technological development || pre-medication || Darwin || M. Darwin publishes the first pre-medication protocol to minimize ischemia reperfusion injury in cryonics patients.<ref>{{Cite journal|last=Darwin|first=M.|date=1991|title=Reducing ischemic damage in cryonic suspension patients by premedication|url=http://www.alcor.org/cryonics/cryonics9104.txt|journal=Cryonics|volume=12|pages=13-15|access-date=2010-09-29|via=}}</ref>
+
| 1990 || cryonics || technological development || pre-medication || {{W|Mike Darwin}} || M. Darwin publishes the first pre-medication protocol to minimize ischemia-reperfusion injury in cryonics patients.<ref>{{Cite journal|last=Darwin|first=M.|date=1991|title=Reducing ischemic damage in cryonic suspension patients by premedication|url=http://www.alcor.org/cryonics/cryonics9104.txt|journal=Cryonics|volume=12|pages=13-15|access-date=2010-09-29|via=}}</ref>
 
|-
 
|-
| 1990 || cryonics || quality assessment || || Darwin || M. Darwin introduces end-tidal CO2 monitoring to cryonics and sets out a comprehensive set of guidelines for determining the efficacy of in-field cardiopulmonary support.<ref>{{Cite journal|last=Darwin|first=M.|date=1990|title=Cardiopulmonary support: Evaluation and intervention|url=http://www.alcor.org/cryonics/cryonics9004.txt|journal=Cryonics|volume=11|issue=4|pages=26-31|access-date=2010-09-29|via=}}</ref>
+
| 1990 || cryonics || quality assessment || || {{W|Mike Darwin}} || M. Darwin introduces end-tidal CO2 monitoring to cryonics and sets out a comprehensive set of guidelines for determining the efficacy of in-field cardiopulmonary support.<ref>{{Cite journal|last=Darwin|first=M.|date=1990|title=Cardiopulmonary support: Evaluation and intervention|url=http://www.alcor.org/cryonics/cryonics9004.txt|journal=Cryonics|volume=11|issue=4|pages=26-31|access-date=2010-09-29|via=}}</ref>
 
|-
 
|-
 
| 1990 || cryonics || legal || right-to-die || {{W|Thomas K. Donaldson}} || {{W|Thomas K. Donaldson}}, after being diagnosed with terminal brain cancer, petitions the California courts, seeking a declaration that he has a constitutional right to achieve cryonic suspension before his natural death. Donaldson and his doctors build their argument in light of the recent right-to-die legislation where patients could have life-sustaining medical treatment withdrawn. The trial court would dismiss the complaint for failure to state a cause of action, and Donaldson would then appeal. The court holds that he does not have a constitutional right to assisted death because the cryonic process would necessarily involve physician-assisted death, or the aiding, advising, or encouraging of another to commit suicide.<ref>{{Cite web|url=https://www.alcor.org/Library/html/Donaldson-VanDeKampAbstract.html|title=Donaldson v. Van de Kamp (Abstract)|website=www.alcor.org|access-date=2019-01-22}}</ref>
 
| 1990 || cryonics || legal || right-to-die || {{W|Thomas K. Donaldson}} || {{W|Thomas K. Donaldson}}, after being diagnosed with terminal brain cancer, petitions the California courts, seeking a declaration that he has a constitutional right to achieve cryonic suspension before his natural death. Donaldson and his doctors build their argument in light of the recent right-to-die legislation where patients could have life-sustaining medical treatment withdrawn. The trial court would dismiss the complaint for failure to state a cause of action, and Donaldson would then appeal. The court holds that he does not have a constitutional right to assisted death because the cryonic process would necessarily involve physician-assisted death, or the aiding, advising, or encouraging of another to commit suicide.<ref>{{Cite web|url=https://www.alcor.org/Library/html/Donaldson-VanDeKampAbstract.html|title=Donaldson v. Van de Kamp (Abstract)|website=www.alcor.org|access-date=2019-01-22}}</ref>
Line 339: Line 363:
 
| 1990 || cryobiology || science || intermediate storage temperature || {{W|Greg Fahy}} || Fahy publishes a detailed study of fracturing in large volumes of {{W|vitrification}} solution.<ref name="IntermediateTemperatureStorage"/><ref name="Fahy1990">{{Cite journal|last=Fahy|first=Gregory M.|last2=Saur|first2=Joseph|last3=Williams|first3=Robert J.|date=October 1990|title=Physical problems with the vitrification of large biological systems|url=http://dx.doi.org/10.1016/0011-2240(90)90038-6|journal=Cryobiology|volume=27|issue=5|pages=492–510|doi=10.1016/0011-2240(90)90038-6|issn=0011-2240}}</ref>
 
| 1990 || cryobiology || science || intermediate storage temperature || {{W|Greg Fahy}} || Fahy publishes a detailed study of fracturing in large volumes of {{W|vitrification}} solution.<ref name="IntermediateTemperatureStorage"/><ref name="Fahy1990">{{Cite journal|last=Fahy|first=Gregory M.|last2=Saur|first2=Joseph|last3=Williams|first3=Robert J.|date=October 1990|title=Physical problems with the vitrification of large biological systems|url=http://dx.doi.org/10.1016/0011-2240(90)90038-6|journal=Cryobiology|volume=27|issue=5|pages=492–510|doi=10.1016/0011-2240(90)90038-6|issn=0011-2240}}</ref>
 
|-
 
|-
| 1990 || cryonics || || || Trygve Bauge || Trygve Bauge, a member of the {{W|American Cryonics Society}}, brings his deceased grandfather from Norvegia to the United States.
+
| 1990 || cryonics || organization || status || Trygve Bauge || Trygve Bauge, a member of the {{W|American Cryonics Society}}, brings his deceased grandfather from Norvegia to the United States.
  
 
He would store his body at Trans Time from 1990 to 1993.
 
He would store his body at Trans Time from 1990 to 1993.
Line 348: Line 372:
 
|-
 
|-
 
| 1990-06 || cryonics || technological adoption || remote stabilization || {{W|Alcor Life Extension Foundation}} || Alcor patient A-1239 receives a field cryoprotection with glycerol in Australia before being transported on dry ice to Alcor.<ref name="fieldcryoprotection"/>
 
| 1990-06 || cryonics || technological adoption || remote stabilization || {{W|Alcor Life Extension Foundation}} || Alcor patient A-1239 receives a field cryoprotection with glycerol in Australia before being transported on dry ice to Alcor.<ref name="fieldcryoprotection"/>
 +
|-
 +
| 1990-06 || cryonics ||  || VSED || Alcor || Arlene Fried does voluntary stopping of eating and drinking (VSED) for approximately 12 days<ref>{{Cite web|url=https://www.quora.com/Have-cryonicists-considered-preemptively-getting-cryopreserved|title=Have cryonicists considered preemptively getting cryopreserved? - Quora|website=www.quora.com|access-date=2020-01-23}}</ref>, until clinical death would occur, in order to hasten her cryopreservation, hence reducing damages caused by her cancer which had metastasized to the brain.<ref>{{Cite web|url=https://alcor.org/Library/html/ElectiveCryopreservation.html|title=Options for Elective Cryopreservation|website=alcor.org|access-date=2020-01-22}}</ref><ref group=note>This is the earliest example of VSED used for identity preservation purposes that could be found online.</ref>
 
|-
 
|-
 
| 1990-06-09 || cryonics || quality assessment || || Alcor || First evaluation of viability in a cryonics patient using Na+/K+ ratio in the renal cortex demonstrating good tissue viability following application of the Alcor Transport Protocol, including rapid post-arrest in-field washout and rapid air transport of the patient to the cryoprotective perfusion facility.<ref>{{Cite web|url=http://www.alcor.org/Library/html/fried.html|title=Cryopreservation case report: Arlene Francis Fried, A-1049|last=Darwin|first=MG|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
 
| 1990-06-09 || cryonics || quality assessment || || Alcor || First evaluation of viability in a cryonics patient using Na+/K+ ratio in the renal cortex demonstrating good tissue viability following application of the Alcor Transport Protocol, including rapid post-arrest in-field washout and rapid air transport of the patient to the cryoprotective perfusion facility.<ref>{{Cite web|url=http://www.alcor.org/Library/html/fried.html|title=Cryopreservation case report: Arlene Francis Fried, A-1049|last=Darwin|first=MG|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
 
|-
 
|-
| 1990-10 || cryobiology || technological development || re-warming || Ruggera, Fahy || Ruggera and Fahy demonstrate uniform radio frequency re-warming of vitrified solution in volumes compsarable to those of the rabbit kidney without thermal runaway and at rates of re-warming sufficient to inhibit devitrification in their model system.<ref>{{Cite journal|last=Ruggera|first=P. S.|last2=Fahy|first2=G. M.|date=October 1990|title=Rapid and uniform electromagnetic heating of aqueous cryoprotectant solutions from cryogenic temperatures|url=https://www.ncbi.nlm.nih.gov/pubmed/2249450|journal=Cryobiology|volume=27|issue=5|pages=465–478|issn=0011-2240|pmid=2249450}}</ref>
+
| 1990-10 || cryobiology || technological development || re-warming || Ruggera, Fahy || Ruggera and Fahy demonstrate uniform radio frequency re-warming of a vitrified solution in volumes comparable to those of the rabbit kidney without thermal runaway and at rates of re-warming sufficient to inhibit devitrification in their model system.<ref>{{Cite journal|last=Ruggera|first=P. S.|last2=Fahy|first2=G. M.|date=October 1990|title=Rapid and uniform electromagnetic heating of aqueous cryoprotectant solutions from cryogenic temperatures|url=https://www.ncbi.nlm.nih.gov/pubmed/2249450|journal=Cryobiology|volume=27|issue=5|pages=465–478|issn=0011-2240|pmid=2249450}}</ref>
 
|-
 
|-
| 1990-10 || cryobiology || science || vitrification || Fahy, et al. || Fahy, et al., publish first paper documenting the behavior of large volumes of vitrification solution with respect to fracture temperature, thermal gradient, cooling rate, ice nucleation and crystal growth as a preliminary step to avoid fracturing in vitrified organs and tissues and to prevent devitrification during re-warming.<ref name="Fahy1990"/>
+
| 1990-10 || cryobiology || science || vitrification || [[wikipedia:Greg Fahy|Fahy]], et al. || Fahy, et al., publish the first paper documenting the behavior of large volumes of vitrification solution with respect to fracture temperature, thermal gradient, cooling rate, ice nucleation and crystal growth as a preliminary step to avoid fracturing in vitrified organs and tissues and to prevent devitrification during re-warming.<ref name="Fahy1990"/>
 
|-
 
|-
| 1992 || cryonics || futurism || paper || || The application of nanotechnology to reverse human cryopreservation is discussed in a paper for the first time.<ref>{{Cite journal|last=Merkle|first=R. C.|date=1992-09-01|title=The technical feasibility of cryonics|url=http://www.sciencedirect.com/science/article/pii/030698779290133W|journal=Medical Hypotheses|volume=39|issue=1|pages=6–16|doi=10.1016/0306-9877(92)90133-W|issn=0306-9877}}</ref>
+
| 1992 || cryonics || futurism || || R. C. Merkle || The application of nanotechnology to reverse human cryopreservation is discussed in a paper for the first time.<ref>{{Cite journal|last=Merkle|first=R. C.|date=1992-09-01|title=The technical feasibility of cryonics|url=http://www.sciencedirect.com/science/article/pii/030698779290133W|journal=Medical Hypotheses|volume=39|issue=1|pages=6–16|doi=10.1016/0306-9877(92)90133-W|issn=0306-9877}}</ref>
 
|-
 
|-
| 1982 || cryonics || organisation || || {{W|Alcor Life Extension Foundation}} || Alcor starts providing its own cryopreservation as well as patient-storage services.
+
| 1982 || cryonics || organization || milestone || {{W|Alcor Life Extension Foundation}} || Alcor starts providing its own cryopreservation as well as patient-storage services.
 
|-
 
|-
| 1992-02 || cryonics || technological adoption || [[wikipedia:extracorporeal membrane oxygenation|extracorporeal membrane oxygenation]] || || First application of [[wikipedia:extracorporeal membrane oxygenation|extracorporeal membrane oxygenation]] ECMO in the patient’s home followed by ~8 hours of continuous ECMO support prior to perfusion.<ref>{{Cite web|url=https://www.alcor.org/Library/html/casereport9202.html|title=The Transport of Patient A-1312S|last=Henson|first=HK|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
+
| 1992-02 || cryonics || technological adoption || [[wikipedia:extracorporeal membrane oxygenation|extracorporeal membrane oxygenation]] || HK Henson || The first application of [[wikipedia:extracorporeal membrane oxygenation|extracorporeal membrane oxygenation]] ECMO in the patient’s home followed by ~8 hours of continuous ECMO support prior to perfusion.<ref>{{Cite web|url=https://www.alcor.org/Library/html/casereport9202.html|title=The Transport of Patient A-1312S|last=Henson|first=HK|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
 
|-
 
|-
| 1993 || cryonics || organisation || founding || {{W|21st Century Medicine}} || {{W|21st Century Medicine}}, a cryogenics and cryonics research organisation, is founded.<ref>{{Cite web|url=http://www.21cm.com/|title=21st Century Medicine --Expanding the Boundaries of Preservation Science|website=www.21cm.com|access-date=2019-01-22}}</ref>
+
| 1993 || cryonics || organization || founding || {{W|21st Century Medicine}} || {{W|21st Century Medicine}}, a cryogenics and cryonics research organization, is founded.<ref>{{Cite web|url=http://www.21cm.com/|title=21st Century Medicine --Expanding the Boundaries of Preservation Science|website=www.21cm.com|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1993 || cryonics || organisation || founding || CryoCare || The CryoCare Foundation is founded. It would provide human cryopreservation with assistance from two separate businesses: BioPreservation, which would provide remote standby, stabilization, and transport, and CryoSpan, which would provide the long-term storage of patients in liquid-nitrogen. About 50 former Alcor members join in the founding of the organisation.<ref name="BenBestCryonicsHistoryImmortalist"/><ref name="CryoCare>{{Cite web|url=http://www.cryocare.org/index.cgi|title=CryoCare Foundation - Cryonics Services|website=www.cryocare.org|access-date=2019-01-22}}</ref>
+
| 1993 || cryonics || organization || founding || CryoCare || The CryoCare Foundation is founded. It would provide human cryopreservation with assistance from two separate businesses: BioPreservation, which would provide remote standby, stabilization, and transport, and CryoSpan, which would provide the long-term storage of patients in liquid-nitrogen. About 50 former Alcor members join in the founding of the organization.<ref name="BenBestCryonicsHistoryImmortalist"/><ref name="CryoCare>{{Cite web|url=http://www.cryocare.org/index.cgi|title=CryoCare Foundation - Cryonics Services|website=www.cryocare.org|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 1993-03 || cryonics || R&D || intermediate storage temperature || CryoNet || Through the CryoNet email list, collaborative effort is put into designing a room to preserve up to 100 people at −130 ºC.<ref name="IntermediateTemperatureStorage"/>
+
| 1993-03 || cryonics || technological development || intermediate storage temperature || CryoNet || Through the CryoNet email list, collaborative effort is put into designing a room to preserve up to 100 people at −130 ºC.<ref name="IntermediateTemperatureStorage"/>
 
|-
 
|-
| 1994 || cryonics || R&D || intermediate storage temperature || {{W|Alcor Life Extension Foundation}} || Alcor observes fractures in the brain of a patient following removal from cryopreservation. Alcor thinks of intermediate temperature storage systems, and the development of a new acoustic fracturing monitoring device, the "crackphone."<ref name="IntermediateTemperatureStorage"/><ref>{{Cite journal|last=Hixon|first=H.|date=1995|title=Exploring Cracking Phenomena|url=https://alcor.org/cryonics/cryonics1995-1.pdf|journal=Cryonics|volume=|pages=27-32|via=}}</ref>
+
| 1994 || cryonics || technological development || intermediate storage temperature || {{W|Alcor Life Extension Foundation}} || Alcor observes fractures in the brain of a patient following removal from cryopreservation. Alcor thinks of intermediate temperature storage systems, and the development of a new acoustic fracturing monitoring device, the "crackphone."<ref name="IntermediateTemperatureStorage"/><ref>{{Cite journal|last=Hixon|first=H.|date=1995|title=Exploring Cracking Phenomena|url=https://alcor.org/cryonics/cryonics1995-1.pdf|journal=Cryonics|volume=|pages=27-32|via=}}</ref>
 
|-
 
|-
| 1994 || cryonics || R&D || intermediate storage temperature || Timeship || Architect Stephen Valentine begins studying Cold Room intermediate temperature storage design concepts as part of a large cryonics facility design that would eventually be called Timeship.<ref name="IntermediateTemperatureStorage"/>
+
| 1994 || cryonics || technological development || intermediate storage temperature || Timeship || Architect Stephen Valentine begins studying Cold Room intermediate temperature storage design concepts as part of a large cryonics facility design that would eventually be called Timeship.<ref name="IntermediateTemperatureStorage"/>
 
|-
 
|-
 
| 1994-02 || cryonics || risk management || natural catastrophes, legal environment || {{W|Alcor Life Extension Foundation}} || Alcor moves to Scottsdale, Arizona, with all its patients.<ref name="BenBestCryonicsHistory"/><ref>{{Cite web|url=https://alcor.org/Library/html/researchhistory.html|title=A Brief History of Alcor Research|website=alcor.org|access-date=2019-01-22}}</ref>
 
| 1994-02 || cryonics || risk management || natural catastrophes, legal environment || {{W|Alcor Life Extension Foundation}} || Alcor moves to Scottsdale, Arizona, with all its patients.<ref name="BenBestCryonicsHistory"/><ref>{{Cite web|url=https://alcor.org/Library/html/researchhistory.html|title=A Brief History of Alcor Research|website=alcor.org|access-date=2019-01-22}}</ref>
Line 375: Line 401:
 
| 1995 || cryonics || technological adoption || cryoprotection || Alcor, Biopreservation || Both Alcor and Biopreservation begin using high morality glycerol (7.5 to 8. M) as their cryoprotective strategy.<ref>{{Cite journal|last=Jones|first=Tanya L.|date=July 1995|title=Alcor Member Anatole Epstein Suspended|url=https://www.alcor.org/cryonics/cryonics1995-3.pdf|journal=Cryonics Magazine|volume=16|issue=3|pages=8-11|via=}}</ref>
 
| 1995 || cryonics || technological adoption || cryoprotection || Alcor, Biopreservation || Both Alcor and Biopreservation begin using high morality glycerol (7.5 to 8. M) as their cryoprotective strategy.<ref>{{Cite journal|last=Jones|first=Tanya L.|date=July 1995|title=Alcor Member Anatole Epstein Suspended|url=https://www.alcor.org/cryonics/cryonics1995-3.pdf|journal=Cryonics Magazine|volume=16|issue=3|pages=8-11|via=}}</ref>
 
|-
 
|-
| 1995 || cryonics || technological adoption || pre-medication || Darwin || Darwin et al., document the first use of a premedication protocol to mitigate ischemia-reperfusion injury in a cryonics patient.<ref name="CryoCareFirst">{{Cite web|url=http://www.alcor.org/Library/html/casereportC2150.htm|title=Cryopreservation of James Gallagher, CryoCare patient #C-2150|last=Darwin|first=M.|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
+
| 1995 || cryonics || technological adoption || pre-medication || {{W|Mike Darwin}} || Darwin et al., document the first use of a premedication protocol to mitigate ischemia-reperfusion injury in a cryonics patient.<ref name="CryoCareFirst">{{Cite web|url=http://www.alcor.org/Library/html/casereportC2150.htm|title=Cryopreservation of James Gallagher, CryoCare patient #C-2150|last=Darwin|first=M.|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
 
|-
 
|-
| 1995-05-31 || cryobiology || science || cryoprotection || Darwin || Darwin, et al., demonstrate much improved ultrastructural preservation in the dog brain and preservation of vascular integrity after perfusion with 7.5 M glycerol and freezing to -100 °C.<ref>{{Cite journal|last=Darwin|first=M.|last2=Russell|first2=S.|last3=Wakfer|first3=P.|last4=Wood|first4=L.|last5=Wood|first5=C.|date=1995-05-31|title=Effect of Human Cryopreservation Protocol on the Ultrastucture of the Canine Brain|url=|journal=BioPreservation, Inc|volume=|pages=|via=}}</ref><ref>{{Cite journal|last=Platt|first=C.|date=July 1995|title=New Brain Study Shows Reduced Tissue Damage|url=http://www.cryocare.org/index.cgi?subdir=&url=ccrpt4.html#BRAIN|journal=CryoCare Report|volume=|pages=|via=}}</ref>
+
| 1995-05-31 || cryobiology || science || cryoprotection || {{W|Mike Darwin}} || Darwin, et al., demonstrate much improved ultrastructural preservation in the dog brain and preservation of vascular integrity after perfusion with 7.5 M glycerol and freezing to -100 °C.<ref>{{Cite journal|last=Darwin|first=M.|last2=Russell|first2=S.|last3=Wakfer|first3=P.|last4=Wood|first4=L.|last5=Wood|first5=C.|date=1995-05-31|title=Effect of Human Cryopreservation Protocol on the Ultrastucture of the Canine Brain|url=|journal=BioPreservation, Inc|volume=|pages=|via=}}</ref><ref>{{Cite journal|last=Platt|first=C.|date=July 1995|title=New Brain Study Shows Reduced Tissue Damage|url=http://www.cryocare.org/index.cgi?subdir=&url=ccrpt4.html#BRAIN|journal=CryoCare Report|volume=|pages=|via=}}</ref>
 
|-
 
|-
| 1997 || cryonics || technological adoption || intermediate storage temperature || {{W|Alcor Life Extension Foundation}} || Alcor brings the crackphone (an acoustic fracturing monitoring device) into clinical use.<ref name="IntermediateTemperatureStorage"/> The Alcor crackphone has never been tested or validated in any animal or human model, nor in bulk [[wikipedia:cryoprotectant|cryoprotective agents] solutions cooled to deep subzero temperatures.
+
| 1997 || cryonics || technological adoption || intermediate storage temperature || {{W|Alcor Life Extension Foundation}} || Alcor brings the crackphone (an acoustic fracturing monitoring device) into clinical use.<ref name="IntermediateTemperatureStorage"/> The Alcor crackphone has never been tested or validated in any animal or human model, nor in bulk [[wikipedia:cryoprotectant|cryoprotective agents]] solutions cooled to deep subzero temperatures.
 
|-
 
|-
| 1997 || cryonics || risk management || economic stability || {{W|Alcor Life Extension Foundation}} || After a substantial effort led by then-president Steve Bridge, Alcor forms the Patient Care Trust as an entirely separate entity to manage and protect the funding for cryopatients.
+
| 1997 || cryonics || risk management || economic stability || {{W|Alcor Life Extension Foundation}} || After a substantial effort led by then-president Steve Bridge, Alcor forms the Patient Care Trust as an entirely separate entity to manage and protect the funding for cryonics patients.
 
|-
 
|-
| 1998 || cryonics || technological development || cooling rate || Darwin, Harris, Russell || Darwin, Harris, and Russell invent liquid assisted pulmonary cooling allowing for rapid, non-invasive cooling of dogs at rate of 0.5 °C per minute.<ref>{{cite patent | country = | number = EP1117455A1 | status = | title = Mixed-mode liquid ventilation gas and heat exchange | pubdate = | gdate = | fdate = | pridate = 1998-10-01 | inventor = | invent1 = Michael Gregory Darwin | invent2 = Steven Bradley Harris | invent3 = Sandra Renee Russell | assign1 = Critical Care Research Inc | assign2 = | class = | url = }}</ref><ref>{{Cite journal|last=Harris|first=S. B.|last2=Darwin|first2=M. G.|last3=Russell|first3=S. R.|last4=O'Farrell|first4=J. M.|last5=Fletcher|first5=M.|last6=Wowk|first6=B.|date=August 2001|title=Rapid (0.5 degrees C/min) minimally invasive induction of hypothermia using cold perfluorochemical lung lavage in dogs|url=https://www.ncbi.nlm.nih.gov/pubmed/11719148|journal=Resuscitation|volume=50|issue=2|pages=189–204|issn=0300-9572|pmid=11719148}}</ref>
+
| 1998 || cryonics || technological development || cooling rate || [[wikipedia:Mike Darwin|Darwin]], Harris, Russell || Darwin, Harris, and Russell invent liquid assisted pulmonary cooling allowing for rapid, non-invasive cooling of dogs at a rate of 0.5 °C per minute.<ref>{{cite patent | country = | number = EP1117455A1 | status = | title = Mixed-mode liquid ventilation gas and heat exchange | pubdate = | gdate = | fdate = | pridate = 1998-10-01 | inventor = | invent1 = Michael Gregory Darwin | invent2 = Steven Bradley Harris | invent3 = Sandra Renee Russell | assign1 = Critical Care Research Inc | assign2 = | class = | url = }}</ref><ref>{{Cite journal|last=Harris|first=S. B.|last2=Darwin|first2=M. G.|last3=Russell|first3=S. R.|last4=O'Farrell|first4=J. M.|last5=Fletcher|first5=M.|last6=Wowk|first6=B.|date=August 2001|title=Rapid (0.5 degrees C/min) minimally invasive induction of hypothermia using cold perfluorochemical lung lavage in dogs|url=https://www.ncbi.nlm.nih.gov/pubmed/11719148|journal=Resuscitation|volume=50|issue=2|pages=189–204|issn=0300-9572|pmid=11719148}}</ref>
 
|-
 
|-
| 1999 || cryonics || organisation || closing || CryoCare || BioPreservation doesn't renew its contract with CryoCare, and stops offering cryonics services altogether.<ref name="BenBestCryonicsHistory"/> CryoCare doesn't find a new provider.<ref name="BenBestCryonicsHistory"/> They would transfer their 10 patients from the {{W|American Cryonics Society}} to the Cryonics Institute on 2004-04-06, and their 2 other patients to Alcor on 2001-01-24.<ref name="AlcorCase"/><ref name="BenBestCryonicsHistoryImmortalist"/><ref name="CryoCare/>
+
| 1999 || cryonics || organization || status || CryoCare || BioPreservation doesn't renew its contract with CryoCare, and stops offering cryonics services altogether.<ref name="BenBestCryonicsHistory"/> CryoCare doesn't find a new provider.<ref name="BenBestCryonicsHistory"/> They would transfer their 10 patients from the {{W|American Cryonics Society}} to the Cryonics Institute on 2004-04-06, and their 2 other patients to Alcor on 2001-01-24.<ref name="AlcorCase"/><ref name="BenBestCryonicsHistoryImmortalist"/><ref name="CryoCare/>
 
|-
 
|-
 
| 2000-03 || cryobiology || science || vitrification || Song, et al. || The application of {{W|vitrification}} to a relatively large tissue of medical interest, vascular grafts, is successful for the first time.<ref>{{Cite journal|last=Taylor|first=Michael J.|last2=Brockbank|first2=Kelvin G. M.|last3=Lightfoot|first3=Fred|last4=Khirabadi|first4=Bijan S.|last5=Song|first5=Ying C.|date=March 2000|title=Vitreous cryopreservation maintains the function of vascular grafts|url=https://www.nature.com/articles/nbt0300_296|journal=Nature Biotechnology|language=en|volume=18|issue=3|pages=296–299|doi=10.1038/73737|issn=1546-1696}}</ref>
 
| 2000-03 || cryobiology || science || vitrification || Song, et al. || The application of {{W|vitrification}} to a relatively large tissue of medical interest, vascular grafts, is successful for the first time.<ref>{{Cite journal|last=Taylor|first=Michael J.|last2=Brockbank|first2=Kelvin G. M.|last3=Lightfoot|first3=Fred|last4=Khirabadi|first4=Bijan S.|last5=Song|first5=Ying C.|date=March 2000|title=Vitreous cryopreservation maintains the function of vascular grafts|url=https://www.nature.com/articles/nbt0300_296|journal=Nature Biotechnology|language=en|volume=18|issue=3|pages=296–299|doi=10.1038/73737|issn=1546-1696}}</ref>
Line 391: Line 417:
 
| 2000 || cryonics || technological adoption || intermediate storage temperature || {{W|Alcor Life Extension Foundation}} || Alcor acquires a −130 ºC Harris CryoStar laboratory freezer from GS Laboratory Equipment and begins testing its utility for possible storage of neuropatients.<ref name="IntermediateTemperatureStorage"/><ref>{{Cite journal|last=|first=|date=2000|title=BioTransport Purchases CryoStar Freezer|url=https://alcor.org/cryonics/cryonics2000-3.pdf|journal=Cryonics|volume=|pages=11|via=}}</ref>
 
| 2000 || cryonics || technological adoption || intermediate storage temperature || {{W|Alcor Life Extension Foundation}} || Alcor acquires a −130 ºC Harris CryoStar laboratory freezer from GS Laboratory Equipment and begins testing its utility for possible storage of neuropatients.<ref name="IntermediateTemperatureStorage"/><ref>{{Cite journal|last=|first=|date=2000|title=BioTransport Purchases CryoStar Freezer|url=https://alcor.org/cryonics/cryonics2000-3.pdf|journal=Cryonics|volume=|pages=11|via=}}</ref>
 
|-
 
|-
| 2000 || cryonics || organisation || founding || Critical Care Research || Critical Care Research, a research organisation on critical care medicine, is founded.<ref>{{Cite web|url=https://www.researchgate.net/profile/Steven_Harris12|title=Steven B. Harris {{!}} Canine respiratory and hypothermia physiology lab|website=ResearchGate|language=en|access-date=2019-01-22}}</ref>
+
| 2000 || cryonics || organization || founding || Critical Care Research || Critical Care Research, a research organization on critical care medicine, is founded.<ref>{{Cite web|url=https://www.researchgate.net/profile/Steven_Harris12|title=Steven B. Harris {{!}} Canine respiratory and hypothermia physiology lab|website=ResearchGate|language=en|access-date=2019-01-22}}</ref>
 
|-
 
|-
 
| 2000-07-15 || cryobiology || technological development || vitrification || Fahy, Kheirabadi || Fahy and Kheirabadi achieve permanent life support after perfusion of rabbit kidneys with 7.5 M a vitrification solution demonstrating for the first time that concentrations of cryoprotectant compatible with vitrification are tolerable without the loss of renal viability.<ref>{{Cite journal|last=Kheirabadi|first=B. S.|last2=Fahy|first2=G. M.|date=2000-07-15|title=Permanent life support by kidneys perfused with a vitrifiable (7.5 molar) cryoprotectant solution|url=https://www.ncbi.nlm.nih.gov/pubmed/10919575|journal=Transplantation|volume=70|issue=1|pages=51–57|issn=0041-1337|pmid=10919575}}</ref>
 
| 2000-07-15 || cryobiology || technological development || vitrification || Fahy, Kheirabadi || Fahy and Kheirabadi achieve permanent life support after perfusion of rabbit kidneys with 7.5 M a vitrification solution demonstrating for the first time that concentrations of cryoprotectant compatible with vitrification are tolerable without the loss of renal viability.<ref>{{Cite journal|last=Kheirabadi|first=B. S.|last2=Fahy|first2=G. M.|date=2000-07-15|title=Permanent life support by kidneys perfused with a vitrifiable (7.5 molar) cryoprotectant solution|url=https://www.ncbi.nlm.nih.gov/pubmed/10919575|journal=Transplantation|volume=70|issue=1|pages=51–57|issn=0041-1337|pmid=10919575}}</ref>
 
|-
 
|-
| 2001 || cryonics || technological adoption || vitrification || {{W|Alcor Life Extension Foundation}} || Alcor switches from glycerol (which was reducing ice formation, but not vitrifying the brain) to a proprietary mixture of cryoprotectants designed to eliminate ice formation completely, ideally achieving {{W|vitrification}} of the entire brain.<ref>{{Cite web|url=https://alcor.org/sciencefaq.htm|title=Scientists’ Cryonics FAQ|website=alcor.org|access-date=2019-01-22}}</ref>
+
| 2001 || cryonics || technological adoption || vitrification || {{W|Alcor Life Extension Foundation}} || Alcor switches from glycerol (which was reducing ice formation, but not vitrifying the brain) to a proprietary mixture of cryoprotectants called B2C developed by {{W|21st Century Medicine}} designed to eliminate ice formation completely, ideally achieving {{W|vitrification}} of the entire brain.<ref>{{Cite web|url=https://alcor.org/sciencefaq.htm|title=Scientists’ Cryonics FAQ|website=alcor.org|access-date=2019-01-22}}</ref><ref name="BenBestCryonicsHistory"/><ref>{{Cite web|url=https://www.alcor.org/Library/html/newtechnology.html|title=New Cryopreservation technology.|last=|first=|date=October 2005|website=Alcor News|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
 
|-
 
|-
| 2001 || cryonics || technological adoption || vitrification || {{W|Alcor Life Extension Foundation}} || Alcor begins {{W|vitrification}} perfusion of cryonics patients with a cryoprotectant mixture called B2C, which is developed by 21st Century Medicine.<ref name="BenBestCryonicsHistory"/><ref>{{Cite web|url=https://www.alcor.org/Library/html/newtechnology.html|title=New Cryopreservation technology.|last=|first=|date=October 2005|website=Alcor News|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
+
| 2002 || cryonics || science || || || For the first time, a paper shows a rigorous demonstration of memory retention after cooling to +10°C (59°F): "Learning and memory is preserved after induced asanguineous hyperkalemic hypothermic arrest in a swine model of traumatic exsanguination".<ref>{{Cite web|url=https://www.surgjournal.com/action/captchaChallenge?redirectUri=%2Farticle%2FS0039-6060%2802%2900085-5%2Ffulltext|title=Surgery|website=www.surgjournal.com|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 2002 || cryonics || science || paper || || For the first time, a paper shows rigorous demonstration of memory retention after cooling to +10°C (59°F): "Learning and memory is preserved after induced asanguineous hyperkalemic hypothermic arrest in a swine model of traumatic exsanguination".<ref>{{Cite web|url=https://www.surgjournal.com/action/captchaChallenge?redirectUri=%2Farticle%2FS0039-6060%2802%2900085-5%2Ffulltext|title=Surgery|website=www.surgjournal.com|access-date=2019-01-22}}</ref>
+
| 2002 || cryonics || technological development || intermediate storage temperature || Timeship Project || Physicist {{W|Brian Wowk}} and Brookhaven National Laboratory cryogenic engineer Mike Iarocci start collaborating with architect Stephen Valentine to design intermediate temperature storage systems suitable for cryonics in connection with the Timeship Project.<ref name="IntermediateTemperatureStorage"/>
 
|-
 
|-
| 2002 || cryonics || R&D || intermediate storage temperature || Timeship Project || Physicist {{W|Brian Wowk}} and Brookhaven National Laboratory cryogenic engineer Mike Iarocci start collaborating with architect Stephen Valentine to design intermediate temperature storage systems suitable for cryonics in connection with the Timeship Project.<ref name="IntermediateTemperatureStorage"/>
+
| 2002 || cryonics || organization || founding || {{W|Suspended Animation, Inc}} || {{W|Suspended Animation, Inc}}, a for-profit organization that provides cryonics standby, stabilization, and transport services, is founded.<ref name="Alcor2018-2">{{Cite web|url=https://businesssearch.sos.ca.gov/CBS/SearchResults?SearchType=NUMBER&SearchCriteria=C2276225|title=Business Search - Business Entities - Business Programs {{!}} California Secretary of State|website=businesssearch.sos.ca.gov|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 2002 || cryonics || organisation || founding || {{W|Suspended Animation, Inc}} || {{W|Suspended Animation, Inc}}, a for profit organisation that provides cryonics standby, stabilization, and transport services, is founded.<ref name="Alcor2018-2"/>{{Cite web|url=https://businesssearch.sos.ca.gov/CBS/SearchResults?SearchType=NUMBER&SearchCriteria=C2276225|title=Business Search - Business Entities - Business Programs {{!}} California Secretary of State|website=businesssearch.sos.ca.gov|access-date=2019-01-22}}</ref>
+
| 2002 || cryonics || legal || classification || {{W|Alcor Life Extension Foundation}} || Alcor cryopreserves baseball legend {{W|Ted Williams}}.
|-
 
| 2002 || cryonics || political || || {{W|Alcor Life Extension Foundation}} || Alcor cryopreserves baseball legend {{W|Ted Williams}}.
 
  
Following this case, journalists at ''{{W|Sports Illustrated}}'' would write a sensationalistic exposé of Alcor based on information that would be supplied to them by Alcor employee Larry Johnson, who had surreptitiously recorded several conversations.
+
Following more media turmoil<ref group=note>Following this case, journalists at ''{{W|Sports Illustrated}}'' would write a sensationalistic exposé of Alcor based on information that would be supplied to them by Alcor employee Larry Johnson, who had surreptitiously recorded several conversations.</ref>, Arizona state representative Bob Stump would attempt to put Alcor under the control of the Funeral Board. The Arizona Funeral Board Director would tell the ''{{W|New York Times}}'' "These companies need to be regulated or deregulated out of business". After a hard fight by Alcor, the legislation would finally be withdrawn in 2004. Alcor would hire a full-time lobbyist to watch after their interests in the Arizona legislature.<ref name="BenBestCryonicsHistory"/>
 
 
Following more media turmoil, Arizona state representative Bob Stump would attempt to put Alcor under the control of the Funeral Board. The Arizona Funeral Board Director would tell the ''{{W|New York Times}}'' "These companies need to be regulated or deregulated out of business". After a hard fight by Alcor, the legislation would finally be withdrawn in 2004. Alcor would hire a full-time lobbyist to watch after their interests in the Arizona legislature.<ref name="BenBestCryonicsHistory"/>
 
 
|-
 
|-
| 2002 || cryonics || social || || {{W|Frozen Dead Guy Days}} festival || After media turmoil from Trygve Bauge having brought his cryopreserved grandfather to the town of {{W|Nederland, Colorado}}, some people take this opportunity to create an annual {{W|Frozen Dead Guy Days}} festival which would feature coffin races, snow sculptures, and many other activities.
+
| 2002 || cryonics || social || event || {{W|Frozen Dead Guy Days}} festival || After media turmoil from Trygve Bauge having brought his cryopreserved grandfather to the town of {{W|Nederland, Colorado}}, some people take this opportunity to create an annual {{W|Frozen Dead Guy Days}} festival which would feature coffin races, snow sculptures, and many other activities.
  
 
Many cryonicists insist that dry ice is not cold enough for long-term cryopreservation and that the Nederland festival is negative publicity for cryonics.<ref name="BenBestCryonicsHistory"/>
 
Many cryonicists insist that dry ice is not cold enough for long-term cryopreservation and that the Nederland festival is negative publicity for cryonics.<ref name="BenBestCryonicsHistory"/>
 
|-
 
|-
| 2002 summer || cryonics || technological adoption || intermediate storage temperature || {{W|Alcor Life Extension Foundation}} || An Alcor neuropatient receives an excellent uniform perfusion, allowing them to reach the lowest temperature without fracturing ever recorded to date, −128 °C. Cryobiologist consultants would evaluate that this may be the best cryopreservation to date. The patient is transferred to the CryoStar freezer for continued slow cooling and annealing for fracture avoidance. However, the patient would be moved to liquid nitrogen in July 2003 as the maneuver wouldn't be successful. In December, another patient, A-1034, would be also placed into the CryoStar to accommodate the family's preference for this type of storage, and later transferred in a new validated neuroped in April 2006.<ref name="IntermediateTemperatureStorage"/>
+
| 2002 summer || cryonics || technological adoption || intermediate storage temperature || {{W|Alcor Life Extension Foundation}} || An Alcor neuropatient receives an excellent uniform perfusion, allowing them to reach the lowest temperature without fracturing ever recorded to date, −128 °C. Cryobiologist consultants would evaluate that this may be the best cryopreservation to date. The patient is transferred to the CryoStar freezer for continued slow cooling and annealing for fracture avoidance. However, the patient would be moved to liquid nitrogen in July 2003 as the maneuver wouldn't be successful. In December, another patient, A-1034, would be also placed into the CryoStar to accommodate the family's preference for this type of storage, and later transferred in a newly validated neuropod in April 2006.<ref name="IntermediateTemperatureStorage"/>
 +
|-
 +
| 2002-12-13 || cryonics || social || newsletter || {{W|Alcor Life Extension Foundation}} || The first issue of Alcor News, an online newsletter, is distributed.<ref>{{Cite web|url=https://alcor.org/Library/html/alcornewsarchive.html|title=Alcor News Archive|website=alcor.org|access-date=2019-01-22}}</ref>
  
|-
 
| 2002-12-13 || cryonics || writing || newsletter || {{W|Alcor Life Extension Foundation}} || The first issue of Alcor News, an online newsletter, is distributed.<ref>{{Cite web|url=https://alcor.org/Library/html/alcornewsarchive.html|title=Alcor News Archive|website=alcor.org|access-date=2019-01-22}}</ref>
 
 
|-
 
|-
 
| 2003 || cryonics || || procedure || {{W|Alcor Life Extension Foundation}} || There is continued work to create a new patient care bay, operating room, and laboratory area. A truck is purchased for conversion as an ambulance that would be large enough to permit surgical procedures. Alcor makes radical changes to its medications to conform with results of resuscitation research.
 
| 2003 || cryonics || || procedure || {{W|Alcor Life Extension Foundation}} || There is continued work to create a new patient care bay, operating room, and laboratory area. A truck is purchased for conversion as an ambulance that would be large enough to permit surgical procedures. Alcor makes radical changes to its medications to conform with results of resuscitation research.
Line 426: Line 448:
 
| 2003-06 || cryonics || technological adoption || intermediate storage temperature || {{W|Alcor Life Extension Foundation}} || {{W|Brian Wowk}}, Mike Iarocci, and Stephen Valentine present new designs for intermediate temperature storage systems to the Alcor board of directors. Alcor acquires an experimental single-patient "neuropod" intermediate temperature storage system developed by {{W|Brian Wowk}} at 21CM.<ref name="IntermediateTemperatureStorage"/>
 
| 2003-06 || cryonics || technological adoption || intermediate storage temperature || {{W|Alcor Life Extension Foundation}} || {{W|Brian Wowk}}, Mike Iarocci, and Stephen Valentine present new designs for intermediate temperature storage systems to the Alcor board of directors. Alcor acquires an experimental single-patient "neuropod" intermediate temperature storage system developed by {{W|Brian Wowk}} at 21CM.<ref name="IntermediateTemperatureStorage"/>
 
|-
 
|-
| 2003-08 || cryobiology || R&D || intermediate storage temperature || {{W|Carnegie Mellon University}} || {{W|Carnegie Mellon University}} receives a $1.3 million grant from the U.S. government to study fracturing during {{W|vitrification}} of tissue for medical applications, which would considerably advance the field.<ref name="IntermediateTemperatureStorage"/>
+
| 2003-08 || cryobiology || tTechnological development || intermediate storage temperature || {{W|Carnegie Mellon University}} || {{W|Carnegie Mellon University}} receives a million grant from the U.S. government to study fracturing during {{W|vitrification}} of tissue for medical applications, which would considerably advance the field.<ref name="IntermediateTemperatureStorage"/>
 
|-
 
|-
| 2003-10 || cryonics || R&D || intermediate storage temperature || {{W|21st Century Medicine}} || {{W|21st Century Medicine}}, Inc., constructs a prototype dewar for storage at intermediate temperature in which most of the volume of the dewar is converted into a uniform-temperature storage space kept cold by liquid nitrogen.<ref name="IntermediateTemperatureStorage"/>
+
| 2003-10 || cryonics || technological development || intermediate storage temperature || {{W|21st Century Medicine}} || {{W|21st Century Medicine}}, Inc., constructs a prototype dewar for storage at intermediate temperature in which most of the volume of the dewar is converted into a uniform-temperature storage space kept cold by liquid nitrogen.<ref name="IntermediateTemperatureStorage"/>
 
|-
 
|-
| 2004 || cryobiology || science || vitrification || Fahy, et al. || Fahy, et al., make a major advance in understanding the nature of vitrification cryoprotectant toxicity, and significant advances in moderating it. Fahy, et al., develop several highly stable vitrification solutions using synthetic ice blockers which also have extremely low toxicity. It is possible to perfuse kidneys with 9+ molar vitrification solution (~60%) without loss of viability.<ref>{{Cite journal|last=Fahy|first=GM|last2=Wowk|first2=B|last3=Wu|first3=J|last4=Paynter|first4=S|date=2004|title=Improved vitrification solutions based on the predictability of vitrification solution toxicity|url=|journal=Cryobiology|volume=48|issue=1|pages=22-35|via=}}</ref>
+
| 2004 || cryobiology || science || vitrification || [[wikipedia:Greg Fahy|Fahy]], et al. || Fahy, et al., make a major advance in understanding the nature of vitrification cryoprotectant toxicity, and significant advances in moderating it. Fahy, et al., develop several highly stable vitrification solutions using synthetic ice blockers which also have extremely low toxicity. It is possible to perfuse kidneys with 9+ molar vitrification solution (~60%) without loss of viability.<ref>{{Cite journal|last=Fahy|first=GM|last2=Wowk|first2=B|last3=Wu|first3=J|last4=Paynter|first4=S|date=2004|title=Improved vitrification solutions based on the predictability of vitrification solution toxicity|url=|journal=Cryobiology|volume=48|issue=1|pages=22-35|via=}}</ref>
 
|-
 
|-
| 2004 || cryonics || legal || || Cryonics Institute || As a result of media coverage of {{W|Ted Williams}}'s cryopreservation, even though the Cryonics Institute was not involved in that case, the State of Michigan places the organization under a "{{W|Cease and Desist}}" order for six months, ultimately classifying and regulating the Cryonics Institute as a cemetery in 2004. In the spirit of de-regulation, the new Republican Michigan government would remove the cemetery designation for CI in 2012.<ref name="BenBestCryonicsHistory"/>
+
| 2004 || cryonics || legal || classification || {{W|Cryonics Institute}} || As a result of media coverage of {{W|Ted Williams}}'s cryopreservation, even though the Cryonics Institute was not involved in that case, the State of Michigan places the organization under a "{{W|Cease and Desist}}" order for six months, ultimately classifying and regulating the Cryonics Institute as a cemetery in 2004. In the spirit of de-regulation, the new Republican Michigan government would remove the cemetery designation for CI in 2012.<ref name="BenBestCryonicsHistory"/>
 
|-
 
|-
| 2004-08 || cryonics || technological adoption || vitrification || Cryonics Institute || The Cryonics Institute uses a cryoprotectant, CI-VM-1, for the first time. The dog of a CI member is the patient of the experimental perfusion. The mixture was developed by CI staff cryobiologist Yuri Pichugin.<ref name="CITimeline"/>
+
| 2004-08 || cryonics || technological adoption || vitrification || {{W|Cryonics Institute}} || The Cryonics Institute uses a cryoprotectant, CI-VM-1, for the first time. The dog of a CI member is the patient of the experimental perfusion. The mixture was developed by CI staff cryobiologist Yuri Pichugin.<ref name="CITimeline"/>
 
|-
 
|-
 
| 2004-10-23 || cryonics || technological adoption || remote stabilization || {{W|Suspended Animation, Inc}} || {{W|Suspended Animation, Inc}} performs a field cryoprotection with glycerol for the {{W|American Cryonics Society}} before transporting the patient on dry ice to the Cryonics Institute for long-term care.<ref name="fieldcryoprotection">{{Cite web|url=https://alcor.org/Library/html/fieldcryoprotection.html|title=Field Cryoprotection|website=alcor.org|access-date=2019-01-22}}</ref>
 
| 2004-10-23 || cryonics || technological adoption || remote stabilization || {{W|Suspended Animation, Inc}} || {{W|Suspended Animation, Inc}} performs a field cryoprotection with glycerol for the {{W|American Cryonics Society}} before transporting the patient on dry ice to the Cryonics Institute for long-term care.<ref name="fieldcryoprotection">{{Cite web|url=https://alcor.org/Library/html/fieldcryoprotection.html|title=Field Cryoprotection|website=alcor.org|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 2005 || cryonics || science || paper || || Cryonics is discussed in a major medical journal for the first time. It addresses the definition of death in the intensive care unit context.<ref>{{Cite journal|last=Whetstine|first=Leslie|last2=Streat|first2=Stephen|last3=Darwin|first3=Mike|last4=Crippen|first4=David|date=2005-10-31|title=Pro/con ethics debate: When is dead really dead?|url=https://doi.org/10.1186/cc3894|journal=Critical Care|volume=9|issue=6|pages=538|doi=10.1186/cc3894|issn=1364-8535}}</ref>
+
| 2005 || cryonics || science || theory || Whetstine, et al. || Cryonics is discussed in a major medical journal for the first time. It addresses the definition of death in the intensive care unit context.<ref>{{Cite journal|last=Whetstine|first=Leslie|last2=Streat|first2=Stephen|last3=Darwin|first3=Mike|last4=Crippen|first4=David|date=2005-10-31|title=Pro/con ethics debate: When is dead really dead?|url=https://doi.org/10.1186/cc3894|journal=Critical Care|volume=9|issue=6|pages=538|doi=10.1186/cc3894|issn=1364-8535}}</ref>
 
|-
 
|-
| 2005 || cryonics || organisation || founding || OregonCryo || Oregon Cryonics is established as a Non Profit Mutual Benefit corporation.<ref>{{Cite web|url=http://www.oregoncryo.com/aboutOC.html|title=Oregon Cryonics - About OC|website=www.oregoncryo.com|access-date=2019-01-22}}</ref>
+
| 2005 || cryonics || organization || founding || Oregon Cryonics || Oregon Cryonics is established as a Non-Profit Mutual Benefit Corporation.<ref>{{Cite web|url=http://www.oregoncryo.com/aboutOC.html|title=Oregon Cryonics - About OC|website=www.oregoncryo.com|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 2005-06 || || || || KrioRus || KrioRus is founded by 8 Russian cryonicists, and 4 of them serve as Directors{{snd}}{{W|Danila Medvedev}}, Valerija Pride, Igor Artyuhov, and Alexey Potapov.
+
| 2005-06 || cryonics || organization || founding || KrioRus || KrioRus is founded by 8 Russian cryonicists, and 4 of them serve as Directors{{snd}}{{W|Danila Medvedev}}, Valerija Pride, Igor Artyuhov, and Alexey Potapov.
 
|-
 
|-
| 2005 (mid) || cryonics || organisation || founding || Neural Archives Foundation || The Neural Archives Foundation is conceived. The organisation offers brain preservation services. In 2008 it would be incorporated.<ref name="neuralarchivesfoundation">{{Cite web|url=http://neuralarchivesfoundation.org/|title=NAF|website=neuralarchivesfoundation.org|access-date=2019-01-22}}</ref>
+
| 2005 (mid) || cryonics || organization || founding || Neural Archives Foundation || The Neural Archives Foundation is conceived. The organization offers brain preservation services, but only do straight freezes (ie. without perfusion). In 2008 it would be incorporated.<ref name="neuralarchivesfoundation">{{Cite web|url=http://neuralarchivesfoundation.org/|title=NAF|website=neuralarchivesfoundation.org|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 2005-08 || cryonics || technological adoptoin || vitrification || Cryonics Institute || CI's 69th patient is CI's first patient to be vitrified. It receives a {{W|vitrification}} solution named CI-VM-1.<ref name="CITimeline"/>
+
| 2005-08 || cryonics || technological adoption || vitrification || {{W|Cryonics Institute}} || CI's 69th patient is CI's first patient to be vitrified. It receives a {{W|vitrification}} solution named CI-VM-1.<ref name="CITimeline"/>
 
|-
 
|-
 
| 2005-10 || cryonics || technological adoption || vitrification || {{W|Alcor Life Extension Foundation}} || Alcor starts using a {{W|vitrification}} solution called M22, a cryoprotectant licensed from {{W|21st Century Medicine}}.<ref>{{Cite web|url=https://alcor.org/Library/html/newtechnology.html|title=New Cryopreservation Technology|website=alcor.org|access-date=2019-01-22}}</ref><ref>{{Cite journal|last=|first=|date=|title=M22 Implementation|url=https://alcor.org/Library/html/alcornews044.html|journal=Alcor News Bulletin|volume=|issue=44|pages=|via=}}</ref>
 
| 2005-10 || cryonics || technological adoption || vitrification || {{W|Alcor Life Extension Foundation}} || Alcor starts using a {{W|vitrification}} solution called M22, a cryoprotectant licensed from {{W|21st Century Medicine}}.<ref>{{Cite web|url=https://alcor.org/Library/html/newtechnology.html|title=New Cryopreservation Technology|website=alcor.org|access-date=2019-01-22}}</ref><ref>{{Cite journal|last=|first=|date=|title=M22 Implementation|url=https://alcor.org/Library/html/alcornews044.html|journal=Alcor News Bulletin|volume=|issue=44|pages=|via=}}</ref>
Line 454: Line 476:
 
| 2006-01 || cryonics || technological adoption || intermediate storage temperature || {{W|Alcor Life Extension Foundation}} || An Alcor neuropatient cryopreserved with M22 {{W|vitrification}} solution sets a new record for lowest temperature reached without fracturing of −134 °C.<ref name="IntermediateTemperatureStorage"/>
 
| 2006-01 || cryonics || technological adoption || intermediate storage temperature || {{W|Alcor Life Extension Foundation}} || An Alcor neuropatient cryopreserved with M22 {{W|vitrification}} solution sets a new record for lowest temperature reached without fracturing of −134 °C.<ref name="IntermediateTemperatureStorage"/>
 
|-
 
|-
| 2008 || cryonics || writing || || || A review of scientific justifications of cryonics is published.<ref>{{Cite journal|last=Best|first=Benjamin P.|date=2008-04-28|title=Scientific Justification of Cryonics Practice|url=http://dx.doi.org/10.1089/rej.2008.0661|journal=Rejuvenation Research|volume=11|issue=2|pages=493–503|doi=10.1089/rej.2008.0661|issn=1549-1684|pmc=4733321|pmid=18321197}}</ref>
+
| 2008 || cryonics || social || paper || {{W|Ben Best}} || A review of scientific justifications of cryonics is published.<ref>{{Cite journal|last=Best|first=Benjamin P.|date=2008-04-28|title=Scientific Justification of Cryonics Practice|url=http://dx.doi.org/10.1089/rej.2008.0661|journal=Rejuvenation Research|volume=11|issue=2|pages=493–503|doi=10.1089/rej.2008.0661|issn=1549-1684|pmc=4733321|pmid=18321197}}</ref>
 
|-
 
|-
| 2008 || cryonics || organisation || founding || Advanced Neural Biosciences || Advanced Neural Biosciences, Inc., is founded by Aschwin de Wolf. The organisation mainly aims to improve brain preservations. The laboratory would receive funding from the {{W|Immortalist Society}}, the Life Extension Foundation, the Cryonics Institute, the {{W|Alcor Life Extension Foundation}}, as well as various individuals.<ref>{{Cite web|url=http://www.advancedneuralbio.com/|title=Advanced Neural Biosciences|language=en-US|access-date=2019-01-22}}</ref><ref>{{Cite web|url=http://immortalistsociety.org/anb_research.htm|title=Human Cryopreservation Research at Advanced Neural Biosciences|last=de Wol|first=Aschwin|last2=Phaedra|first2=Chana|date=|website=Immortalist Society|archive-url=|archive-date=|dead-url=|access-date=2019-01-22}}</ref>
+
| 2008 || cryonics || organization || founding || Advanced Neural Biosciences || Advanced Neural Biosciences, Inc., is founded by Aschwin de Wolf. The organization mainly aims to improve brain preservations. The laboratory would receive funding from the {{W|Immortalist Society}}, the Life Extension Foundation, the Cryonics Institute, the {{W|Alcor Life Extension Foundation}}, as well as various individuals.<ref>{{Cite web|url=http://www.advancedneuralbio.com/|title=Advanced Neural Biosciences|language=en-US|access-date=2019-01-22}}</ref><ref>{{Cite web|url=http://immortalistsociety.org/anb_research.htm|title=Human Cryopreservation Research at Advanced Neural Biosciences|last=de Wol|first=Aschwin|last2=Phaedra|first2=Chana|date=|website=Immortalist Society|archive-url=|archive-date=|dead-url=|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 2008 || cryonics || organisation || first || Neural Archives Foundation || Neural Archives Foundation preserves its first human patient.<ref name="neuralarchivesfoundation"/>
+
| 2008 || cryonics || organization || milestone || Neural Archives Foundation || Neural Archives Foundation preserves its first human patient.<ref name="neuralarchivesfoundation"/>
 
|-
 
|-
| 2008-12-12 || cryonics || popularisation || || LessWrong || Robin Hanson, talking about Eliezer Yudkowsky and himself, writes [http://www.overcomingbias.com/2008/12/we-agree-get-froze.html We Agree: Get Froze]. Eliezer Yudkowsky would go on writing [https://wiki.lesswrong.com/wiki/Cryonics#Blog_posts various articles about cryonics], which would spawn a lot of interest in the topic by people in the LessWrong community{{snd}}in 2013, 13% of "experienced" respondents to a LessWrong survey (that were part of the community for over two years and had over 1000 karma) reported being signed up for cryonics.<ref>{{Cite web|last=Alexander|first=Scott|title=Rationalists Are Less Credulous But Better At Taking Ideas Seriously|url=https://www.lesswrong.com/posts/Gh2qQHrCg3teQen3c/rationalists-are-less-credulous-but-better-at-taking-ideas|website=www.lesswrong.com|access-date=2019-02-04}}</ref>
+
| 2008-12-12 || cryonics || social || blog || LessWrong || Robin Hanson, talking about Eliezer Yudkowsky and himself, writes [http://www.overcomingbias.com/2008/12/we-agree-get-froze.html We Agree: Get Froze]. Eliezer Yudkowsky would go on writing [https://wiki.lesswrong.com/wiki/Cryonics#Blog_posts various articles about cryonics], which would spawn a lot of interest in the topic by people in the LessWrong community{{snd}}in 2013, 13% of "experienced" respondents to a LessWrong survey (that were part of the community for over two years and had over 1000 karma) reported being signed up for cryonics.<ref>{{Cite web|last=Alexander|first=Scott|title=Rationalists Are Less Credulous But Better At Taking Ideas Seriously|url=https://www.lesswrong.com/posts/Gh2qQHrCg3teQen3c/rationalists-are-less-credulous-but-better-at-taking-ideas|website=www.lesswrong.com|access-date=2019-02-04}}</ref>
 
|-
 
|-
| 2009 || cryonics || science || || || A vital mammalian organ is successfully vitrified, transplanted, and reused for the first time.<ref>{{Cite journal|last=Fahy|first=Gregory M.|last2=Wowk|first2=Brian|last3=Pagotan|first3=Roberto|last4=Chang|first4=Alice|last5=Phan|first5=John|last6=Thomson|first6=Bruce|last7=Phan|first7=Laura|date=July 2009|title=Physical and biological aspects of renal vitrification|url=http://dx.doi.org/10.4161/org.5.3.9974|journal=Organogenesis|volume=5|issue=3|pages=167–175|doi=10.4161/org.5.3.9974|issn=1547-6278}}</ref>
+
| 2009 || cryonics || science || vitrification || [[wikipedia:Greg Fahy|Fahy]], et al. || A vital mammalian organ is successfully vitrified, transplanted, and reused for the first time.<ref>{{Cite journal|last=Fahy|first=Gregory M.|last2=Wowk|first2=Brian|last3=Pagotan|first3=Roberto|last4=Chang|first4=Alice|last5=Phan|first5=John|last6=Thomson|first6=Bruce|last7=Phan|first7=Laura|date=July 2009|title=Physical and biological aspects of renal vitrification|url=http://dx.doi.org/10.4161/org.5.3.9974|journal=Organogenesis|volume=5|issue=3|pages=167–175|doi=10.4161/org.5.3.9974|issn=1547-6278}}</ref>
 
|-
 
|-
| 2009-05 || brain preservation || organisation || || {{W|Brain Preservation Foundation}} || The {{W|Brain Preservation Foundation}} is founded by Kenneth Hayworth and John Smart with the goal of furthering research in whole brain preservation.<ref name="SmallMammalBrainPrize">{{Cite web|url=http://www.brainpreservation.org/small-mammal-announcement/|title=Small Mammal BPF Prize Winning Announcement – The Brain Preservation Foundation|language=en-US|access-date=2019-01-22}}</ref>
+
| 2009-05 || brain preservation || organization || founding || {{W|Brain Preservation Foundation}} || The {{W|Brain Preservation Foundation}} is founded by Kenneth Hayworth and John Smart with the goal of furthering research in whole brain preservation.<ref name="SmallMammalBrainPrize">{{Cite web|url=http://www.brainpreservation.org/small-mammal-announcement/|title=Small Mammal BPF Prize Winning Announcement – The Brain Preservation Foundation|language=en-US|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 2010 || cryonics || organisation || standby || Cryonics Institute || The Cryonics Institute starts offering, through {{W|Suspended Animation, Inc}}, standby and transport options.<ref>{{Cite web|url=https://www.cryonics.org/resources/suspended-animation-inc-standby-stabilization-and-transport-for-ci-members|title=Resources {{!}} Cryonics Institute|website=www.cryonics.org|access-date=2019-01-22}}</ref>
+
| 2010 || cryonics || organization || standby || {{W|Cryonics Institute}} || The Cryonics Institute starts offering, through {{W|Suspended Animation, Inc}}, standby and transport options.<ref>{{Cite web|url=https://www.cryonics.org/resources/suspended-animation-inc-standby-stabilization-and-transport-for-ci-members|title=Resources {{!}} Cryonics Institute|website=www.cryonics.org|access-date=2019-01-22}}</ref>
 +
|-
 +
| 2010 || cryonics || social || event || Annual Young Cryonicists Gathering || The first edition of the Annual Young Cryonicists Gathering, Teens & Twenties. This event is founded by the {{W|Life Extension Foundation}} in perpetuity.<ref>{{Cite web|url=https://www.cryonics.org/news/2018-teens-and-twenties|title=News {{!}} Cryonics Institute|website=www.cryonics.org|access-date=2019-02-15}}</ref>
 
|-
 
|-
 
| 2010-05 || cryobiology || technological development || cryoprotection || Wowk, et al. || Creation of first synthetic ice blockers and their application to organ and tissue preservation to radically increase the stability of vitrification solutions.<ref>{{Cite journal|last=Wowk|first=B.|last2=Leitl|first2=E.|last3=Rasch|first3=C. M.|last4=Mesbah-Karimi|first4=N.|last5=Harris|first5=S. B.|last6=Fahy|first6=G. M.|date=May 2000|title=Vitrification enhancement by synthetic ice blocking agents|url=https://www.ncbi.nlm.nih.gov/pubmed/10860622|journal=Cryobiology|volume=40|issue=3|pages=228–236|doi=10.1006/cryo.2000.2243|issn=0011-2240|pmid=10860622}}</ref>
 
| 2010-05 || cryobiology || technological development || cryoprotection || Wowk, et al. || Creation of first synthetic ice blockers and their application to organ and tissue preservation to radically increase the stability of vitrification solutions.<ref>{{Cite journal|last=Wowk|first=B.|last2=Leitl|first2=E.|last3=Rasch|first3=C. M.|last4=Mesbah-Karimi|first4=N.|last5=Harris|first5=S. B.|last6=Fahy|first6=G. M.|date=May 2000|title=Vitrification enhancement by synthetic ice blocking agents|url=https://www.ncbi.nlm.nih.gov/pubmed/10860622|journal=Cryobiology|volume=40|issue=3|pages=228–236|doi=10.1006/cryo.2000.2243|issn=0011-2240|pmid=10860622}}</ref>
 
|-
 
|-
| 2010-05 || brain preservation || organisation || || {{W|Brain Preservation Foundation}} || Saar Wilf donates $100,000 to the {{W|Brain Preservation Foundation}}, which then launches its large and small mammal brain preservation prizes, which would be given to the first groups that could reliably preserve the synaptic structure of the brain.<ref name="SmallMammalBrainPrize"/>
+
| 2010-05 || brain preservation || organization || milestone || {{W|Brain Preservation Foundation}} || Saar Wilf donates ,0 to the {{W|Brain Preservation Foundation}}, which then launches its large and small mammal brain preservation prizes, which would be given to the first groups that could reliably preserve the synaptic structure of the brain.<ref name="SmallMammalBrainPrize"/>
 
|-
 
|-
| 2010-07 || cryobiology || technological development || toxicity || Fahy, et al. || Fahy, et al., make significant advances in neutralizing cryoprotectant toxicity.<ref>{{Cite journal|last=Fahy|first=Gregory M.|date=July 2010|title=Cryoprotectant toxicity neutralization|url=https://www.ncbi.nlm.nih.gov/pubmed/19501081|journal=Cryobiology|volume=60|issue=3 Suppl|pages=S45–53|doi=10.1016/j.cryobiol.2009.05.005|issn=1090-2392|pmid=19501081}}</ref>
+
| 2010-07 || cryobiology || technological development || toxicity || [[wikipedia:Greg Fahy|Fahy]], et al. || Fahy, et al., make significant advances in neutralizing cryoprotectant toxicity.<ref>{{Cite journal|last=Fahy|first=Gregory M.|date=July 2010|title=Cryoprotectant toxicity neutralization|url=https://www.ncbi.nlm.nih.gov/pubmed/19501081|journal=Cryobiology|volume=60|issue=3 Suppl|pages=S45–53|doi=10.1016/j.cryobiol.2009.05.005|issn=1090-2392|pmid=19501081}}</ref>
 
|-
 
|-
| 2011 || cryonics || technological development || intermediate storage temperature || Wowk || Brian Wowk develops a passive, non-mechanical, “fail safe” system for intermediate temperature storage in order to reduce or eliminate fracturing in vitrified tissues, organs and patients.<ref name="IntermediateTemperatureStorage"/>
+
| 2011 || cryonics || technological development || intermediate storage temperature || Wowk || Brian Wowk develops a passive, non-mechanical, “fail-safe” system for intermediate temperature storage in order to reduce or eliminate fracturing in vitrified tissues, organs, and patients.<ref name="IntermediateTemperatureStorage"/>
 
|-
 
|-
 
| 2011 || cryonics || quality assessment || scan || Alcor || Alcor initiates CT scanning of neuropatients after discovering that CT examination reveals regional differences in cryoprotectant concentration in the brain and other soft tissues of patients.<ref>{{Cite web|url=https://alcor.org/Library/pdfs/casereportA1088DennisRoss.pdf|title=Alcor A-1088 Case Report|last=Sullivan|first=Mathew|date=August 2013|website=Alcor|archive-url=|archive-date=|dead-url=|access-date=}}</ref><ref>{{Cite web|url=https://alcor.org/Library/pdfs/casereportA1546.pdf|title=Alcor A-1546 Case Report|last=Drake|first=Aaron|date=January 2012|website=Alcor|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
 
| 2011 || cryonics || quality assessment || scan || Alcor || Alcor initiates CT scanning of neuropatients after discovering that CT examination reveals regional differences in cryoprotectant concentration in the brain and other soft tissues of patients.<ref>{{Cite web|url=https://alcor.org/Library/pdfs/casereportA1088DennisRoss.pdf|title=Alcor A-1088 Case Report|last=Sullivan|first=Mathew|date=August 2013|website=Alcor|archive-url=|archive-date=|dead-url=|access-date=}}</ref><ref>{{Cite web|url=https://alcor.org/Library/pdfs/casereportA1546.pdf|title=Alcor A-1546 Case Report|last=Drake|first=Aaron|date=January 2012|website=Alcor|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
 
|-
 
|-
| 2011 || cryonics || || || Cryonics Institute || {{W|Robert Ettinger}} is cryopreserved at the age of 92.<ref name="BenBestCryonicsHistory"/><ref>{{Cite web|url=https://www.washingtonpost.com/local/obituaries/from-phyics-teacher-to-founder-of-the-cryonics-movement/2011/07/24/gIQAupuIXI_story.html|title=Robert Ettinger, founder of the cryonics movement, dies at 92|last=Brown|first=Emma|date=2011-06-24|website=|archive-url=|archive-date=|dead-url=|access-date=2019-01-22}}</ref>
+
| 2011 || cryonics || organization || milestone || {{W|Cryonics Institute}} || {{W|Robert Ettinger}} is cryopreserved at the age of 92.<ref name="BenBestCryonicsHistory"/><ref>{{Cite web|url=https://www.washingtonpost.com/local/obituaries/from-phyics-teacher-to-founder-of-the-cryonics-movement/2011/07/24/gIQAupuIXI_story.html|title=Robert Ettinger, founder of the cryonics movement, dies at 92|last=Brown|first=Emma|date=2011-06-24|website=|archive-url=|archive-date=|dead-url=|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 2011-01 || cryonics || technological adoption || remote stabilization || Cryonics Institute || The Cryonics Institute ships its {{W|vitrification}} solution (CI-VM-1) to the United Kingdom so that European cryonics patients could be vitrified before shipping in dry ice to the United States.<ref name="BenBestCryonicsHistory"/>
+
| 2011-01 || cryonics || technological adoption || remote stabilization || {{W|Cryonics Institute}} || The Cryonics Institute ships its {{W|vitrification}} solution (CI-VM-1) to the United Kingdom so that European cryonics patients could be vitrified before shipping in dry ice to the United States.<ref name="BenBestCryonicsHistory"/>
 
|-
 
|-
| 2012 || brain preservation || organisation || || {{W|Brain Preservation Foundation}} || Shawn Mikula at the Winfred Denk lab in Germany uses uses plastic embedding to preserve mouse brains, and submits his results for the Small Mammal Brain Preservation Prize. But the preservation quality is not complete.<ref name="SmallMammalBrainPrize"/>
+
| 2012 || brain preservation || organization || milestone || {{W|Brain Preservation Foundation}} || Shawn Mikula at the Winfred Denk lab in Germany uses plastic embedding to preserve mouse brains, and submits his results for the Small Mammal Brain Preservation Prize. But the preservation quality is not complete.<ref name="SmallMammalBrainPrize"/>
 
|-
 
|-
| 2012 || brain preservation || organisation || || {{W|Brain Preservation Foundation}} || {{W|Greg Fahy}} at {{W|21st Century Medicine}} (21CM) uses cryobiological techniques to preserve mouse brains, and submits his results for the Small Mammal Brain Preservation Prize. The Brain Preservation Foundation deems the submitted micrographs as inadequate to win the prize because the extensive dehydration produced by M22 perfusions makes an examination of brain ultrastructure and of the connectome at the ultrastructural level impossible using existing FIB-SEM techniques.<ref name="SmallMammalBrainPrize"/><ref>{{Cite web|url=http://www.brainpreservation.org/21cm-cryopreservation-eval-page/|title=21CM Cryopreservation Eval Page – The Brain Preservation Foundation|language=en-US|access-date=2019-02-03}}</ref>
+
| 2012 || brain preservation || organization || milestone || {{W|Brain Preservation Foundation}} || {{W|Greg Fahy}} at {{W|21st Century Medicine}} (21CM) uses cryobiological techniques to preserve mouse brains, and submits his results for the Small Mammal Brain Preservation Prize. The Brain Preservation Foundation deems the submitted micrographs as inadequate to win the prize because the extensive dehydration produced by M22 perfusions makes an examination of brain ultrastructure and of the connectome at the ultrastructural level impossible using existing FIB-SEM techniques.<ref name="SmallMammalBrainPrize"/><ref>{{Cite web|url=http://www.brainpreservation.org/21cm-cryopreservation-eval-page/|title=21CM Cryopreservation Eval Page – The Brain Preservation Foundation|language=en-US|access-date=2019-02-03}}</ref>
 
|-
 
|-
| 2012 || cryonics || technological research || remote stabilization || {{W|Alcor Life Extension Foundation}} || Advanced Neural Biosciences collaborates with Alcor to validate Alcor’s proposed field cryoprotection protocol in the rat model. No ice formation is found after up to 48 hours of storing the brains at dry ice temperature prior to further cooling.<ref name="fieldcryoprotection"/>
+
| 2012 || cryonics || technological development || remote stabilization || {{W|Alcor Life Extension Foundation}} || Advanced Neural Biosciences collaborates with Alcor to validate Alcor’s proposed field cryoprotection protocol in the rat model. No ice formation is found after up to 48 hours of storing the brains at dry ice temperature prior to further cooling.<ref name="fieldcryoprotection"/>
 
|-
 
|-
| 2012-03-22 || cryonics || || || {{W|Alcor Life Extension Foundation}} || Fred Chamberlain III, a co-founder of Alcor, becomes the first patient to be demonstrably preserved free of ice formation as would observe from CT scans in 2018.
+
| 2012-03-22 || cryonics || organization || milestone || {{W|Alcor Life Extension Foundation}} || Fred Chamberlain III, a co-founder of Alcor, becomes the first patient to be demonstrably preserved free of ice formation as would observe from CT scans in 2018.
 
|-
 
|-
| 2013 || cryobiology || science || vitrification || Fahy, et al. || Fahy, et al., demonstrate recovery of LTP memory electrophysiology for half millimeter thick hippocampal brain slices that had previously been vitrified and stored for weeks.<ref>{{Cite journal|last=Fahy|first=Gregory M.|last2=Guan|first2=Na|last3=de Graaf|first3=Inge A. M.|last4=Tan|first4=Yuansheng|last5=Griffin|first5=Lenetta|last6=Groothuis|first6=Geny M. M.|date=2012-10-30|title=Cryopreservation of precision-cut tissue slices|url=http://dx.doi.org/10.3109/00498254.2012.728300|journal=Xenobiotica|volume=43|issue=1|pages=113–132|doi=10.3109/00498254.2012.728300|issn=0049-8254}}</ref>
+
| 2013 || cryobiology || science || vitrification || [[wikipedia:Greg Fahy|Fahy]], et al. || Fahy, et al., demonstrate recovery of LTP memory electrophysiology for half millimeter thick hippocampal brain slices that had previously been vitrified and stored for weeks.<ref>{{Cite journal|last=Fahy|first=Gregory M.|last2=Guan|first2=Na|last3=de Graaf|first3=Inge A. M.|last4=Tan|first4=Yuansheng|last5=Griffin|first5=Lenetta|last6=Groothuis|first6=Geny M. M.|date=2012-10-30|title=Cryopreservation of precision-cut tissue slices|url=http://dx.doi.org/10.3109/00498254.2012.728300|journal=Xenobiotica|volume=43|issue=1|pages=113–132|doi=10.3109/00498254.2012.728300|issn=0049-8254}}</ref>
 
|-
 
|-
| 2013-05 || cryonics || technological adoption || remote stabilization || Cryonics Institute || The wife of UK cryonicist Alan Sinclair receives a field cryoprotection before being shipped to the Cryonics Institute.<ref name="BenBestCryonicsHistory"/>
+
| 2013-05 || cryonics || technological adoption || remote stabilization || {{W|Cryonics Institute}} || The wife of UK cryonicist Alan Sinclair receives a field cryoprotection before being shipped to the Cryonics Institute.<ref name="BenBestCryonicsHistory"/>
 
|-
 
|-
| 2014 || cryonics || writing || || || 68 scientists from relevant disciplines sign an open letter to legitimize cryonics and support the right to be cryopreserved.<ref>{{Cite web|url=https://www.biostasis.com/scientists-open-letter-on-cryonics/|title=Scientists’ Open Letter on Cryonics – Biostasis|language=en-US|access-date=2019-01-22}}</ref>
+
| 2014 || cryonics || social || open letter || Biostasis || 68 scientists from relevant disciplines sign an open letter to legitimize cryonics and support the right to be cryopreserved.<ref>{{Cite web|url=https://www.biostasis.com/scientists-open-letter-on-cryonics/|title=Scientists’ Open Letter on Cryonics – Biostasis|language=en-US|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 2014 || brain preservation || science || || {{W|21st Century Medicine}} || Robert McIntyre from {{W|21st Century Medicine}} wins the Small Mammal Prize from the {{W|Brain Preservation Foundation}} with a technique called vitrifixation, an Aldehyde Stabilized Cryopreservation (ASC). He combines research done by {{W|Greg Fahy}} and Shawn Mikula.<ref name="SmallMammalBrainPrize"/>
+
| 2014 || brain preservation || science || vitrifixation || {{W|21st Century Medicine}} || Robert McIntyre from {{W|21st Century Medicine}} wins the Small Mammal Prize from the {{W|Brain Preservation Foundation}} with a technique called vitrifixation, an Aldehyde Stabilized Cryopreservation (ASC). He combines research done by {{W|Greg Fahy}} and Shawn Mikula.<ref name="SmallMammalBrainPrize"/>
 
|-
 
|-
| 2014-05-06 || cryonics || organisation || || OregonCryo || OregonCryo preserves its first patient, a dog named Cupcake.<ref>{{Cite web|url=http://www.oregoncryo.com/caseReportsPets.html|title=Oregon Cryonics - Pet Case Reports|website=www.oregoncryo.com|access-date=2019-01-22}}</ref>
+
| 2014 || emergency preservation || science || hypothermia || University of Maryland, University of Pittsburgh || The Emergency Preservation and Resuscitation for Cardiac Arrest from Trauma study began. It is a study of the safety of hypothermic circulatory arrest on patients who recently suffered an injury. Patients who suffer cardiac arrest after injury and whose pulse cannot be restarted will have their aorta cannulated and cooled with ice-cold saline.<ref name="sciencedirect_hypothermia_resuscitation">{{Cite web|url=https://www.sciencedirect.com/science/article/pii/S1743919115012790?via%3Dihub|title=Emergency preservation and resuscitation for cardiac arrest from trauma|last1=Kutcher|first1=Matthew|last2=Forsythe|first2=Raquel|last3=Tisherman|first3=Samuel|access-date=2022-10-06}}</ref>
 +
|-
 +
| 2014-05-06 || cryonics || organization || milestone || Oregon Cryonics || OregonCryo preserves its first patient, a dog named Cupcake.<ref>{{Cite web|url=http://www.oregoncryo.com/caseReportsPets.html|title=Oregon Cryonics - Pet Case Reports|website=www.oregoncryo.com|access-date=2019-01-22}}</ref>
 
|-
 
|-
 
| 2014-07 || cryonics || technological adoption || remote stabilization || {{W|Alcor Life Extension Foundation}} || Alcor starts implementing a plan to practice field cryoprotection for cases in Canada and Europe.<ref name="BenBestCryonicsHistory"/><ref name="fieldcryoprotection"/>
 
| 2014-07 || cryonics || technological adoption || remote stabilization || {{W|Alcor Life Extension Foundation}} || Alcor starts implementing a plan to practice field cryoprotection for cases in Canada and Europe.<ref name="BenBestCryonicsHistory"/><ref name="fieldcryoprotection"/>
 
|-
 
|-
| 2015 || cryonics || science || || || Memory retention in a cryopreserved and revived animal is demonstrated for the first time.<ref>{{Cite journal|last=Vita-More|first=Natasha|last2=Barranco|first2=Daniel|date=October 2015|title=Persistence of Long-Term Memory in Vitrified and Revived Caenorhabditis elegans|url=http://dx.doi.org/10.1089/rej.2014.1636|journal=Rejuvenation Research|volume=18|issue=5|pages=458–463|doi=10.1089/rej.2014.1636|issn=1549-1684|pmc=4620520|pmid=25867710}}</ref>
+
| 2015 || cryonics || science || || Vita-More, et al. || Memory retention in a cryopreserved and revived caenorhabditis elegans is demonstrated.<ref>{{Cite journal|last=Vita-More|first=Natasha|last2=Barranco|first2=Daniel|date=October 2015|title=Persistence of Long-Term Memory in Vitrified and Revived Caenorhabditis elegans|url=http://dx.doi.org/10.1089/rej.2014.1636|journal=Rejuvenation Research|volume=18|issue=5|pages=458–463|doi=10.1089/rej.2014.1636|issn=1549-1684|pmc=4620520|pmid=25867710}}</ref>
 
|-
 
|-
| 2015-12 || brain preservation || technological development || || {{W|21st Century Medicine}} || Perfect histological and ultrastructural preservation of an entire porcine brain in a nonviable state using aldehyde fixation combined with vitrification.<ref>{{Cite journal|last=McIntyre|first=Robert L.|last2=Fahy|first2=Gregory M.|date=1 December 2015|title=Aldehyde-stabilized cryopreservation|url=http://www.sciencedirect.com/science/article/pii/S001122401500245X|journal=Cryobiology|volume=71|issue=3|pages=448–458|doi=10.1016/j.cryobiol.2015.09.003|issn=0011-2240}}</ref><ref>{{Cite journal|last=McIntyre|first=Robert L.|last2=Fahy|first2=Gregory M.|date=December 2015|title=Aldehyde-stabilized cryopreservation|url=https://www.ncbi.nlm.nih.gov/pubmed/26408851|journal=Cryobiology|volume=71|issue=3|pages=448–458|doi=10.1016/j.cryobiol.2015.09.003|issn=1090-2392|pmid=26408851}}</ref>
+
| 2015-03-13 || brain preservation || technological adoption || fixation || Oregon Cryonics || For the first time, a brain is preserved using fixation technology, by having her brain immersed in a fixative solution. The patient was Deborah Cheek, and she was preserved by OregonCryo.<ref name="OregonCryoCaseReports">{{Cite web|url=http://www.oregoncryo.com/caseReports.html|title=Oregon Cryonics - Cases|website=www.oregoncryo.com|access-date=2019-01-22}}</ref>
 +
 
 +
Immersion fixation is well established to be ineffective in halting autolysis (decomposition).<ref>{{Cite journal|last=Kanawaku|first=Yoshimasa|last2=Someya|first2=Satoka|last3=Kobayashi|first3=Tomoya|last4=Hirakawa|first4=Keiko|last5=Shiotani|first5=Seiji|last6=Fukunaga|first6=Tatsushige|last7=Ohno|first7=Youkichi|last8=Kawakami|first8=Saki|last9=Kanetake|first9=Jun|date=July 2014|title=High-resolution 3D-MRI of postmortem brain specimens fixed by formalin and gadoteridol|url=http://dx.doi.org/10.1016/j.legalmed.2014.03.003|journal=Legal Medicine|volume=16|issue=4|pages=218–221|doi=10.1016/j.legalmed.2014.03.003|issn=1344-6223}}</ref><ref>{{Cite journal|last=Shatil|first=Anwar S.|last2=Uddin|first2=Md Nasir|last3=Matsuda|first3=Kant M.|last4=Figley|first4=Chase R.|date=20 February 2018|title=Quantitative Ex Vivo MRI Changes due to Progressive Formalin Fixation in Whole Human Brain Specimens: Longitudinal Characterization of Diffusion, Relaxometry, and Myelin Water Fraction Measurements at 3T|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826187/|journal=Frontiers in Medicine|volume=5|doi=10.3389/fmed.2018.00031|issn=2296-858X|pmc=5826187|pmid=29515998}}</ref> This is documented in the peer-reviewed literature with the time to fixation of the immersed brain being on the order of 5-15 weeks.<ref>{{Cite journal|last=Yong-Hing|first=Charlotte J.|last2=Obenaus|first2=Andre|last3=Stryker|first3=Rodrick|last4=Tong|first4=Karen|last5=Sarty|first5=Gordon E.|date=August 2005|title=Magnetic resonance imaging and mathematical modeling of progressive formalin fixation of the human brain|url=https://www.ncbi.nlm.nih.gov/pubmed/16032673|journal=Magnetic Resonance in Medicine|volume=54|issue=2|pages=324–332|doi=10.1002/mrm.20578|issn=0740-3194|pmid=16032673}}</ref> However, this procedure is very inexpensive{{snd}}Oregon Cryonics charges 1000 USD{{snd}}so this option is sometimes chosen with the hope that very advance technology might be able to recover some part of the brain.
 +
|-
 +
| 2015-10-03 || cryonics || organization || milestone || {{W|Alcor Life Extension Foundation}} || James Bedford, if properly preserved, becomes the longest-surviving human being ever, after 122 years and 165 days.<ref>{{Cite web|url=https://www.alcor.org/blog/james-bedford-first-cryonaut-is-now-the-longest-surviving-human-being-ever/|title=First cryonaut, is now the longest-surviving human being ever|last=admin|date=2015-10-06|website=Alcor News|language=en-US|access-date=2020-01-22}}</ref>
 +
|-
 +
| 2015-12 || brain preservation || technological development || vitrifixation || {{W|21st Century Medicine}} || Perfect histological and ultrastructural preservation of an entire porcine brain in a nonviable state using aldehyde fixation combined with vitrification.<ref>{{Cite journal|last=McIntyre|first=Robert L.|last2=Fahy|first2=Gregory M.|date=1 December 2015|title=Aldehyde-stabilized cryopreservation|url=http://www.sciencedirect.com/science/article/pii/S001122401500245X|journal=Cryobiology|volume=71|issue=3|pages=448–458|doi=10.1016/j.cryobiol.2015.09.003|issn=0011-2240}}</ref><ref>{{Cite journal|last=McIntyre|first=Robert L.|last2=Fahy|first2=Gregory M.|date=December 2015|title=Aldehyde-stabilized cryopreservation|url=https://www.ncbi.nlm.nih.gov/pubmed/26408851|journal=Cryobiology|volume=71|issue=3|pages=448–458|doi=10.1016/j.cryobiol.2015.09.003|issn=1090-2392|pmid=26408851}}</ref>
  
 
In 2016, Robert McIntyre, {{W|Greg Fahy}}, and {{W|21st Century Medicine}} would win the Large Mammal Prize from the {{W|Brain Preservation Foundation}} with this vitrifixation technique.<ref>{{Cite web|url=https://www.brainpreservation.org/large-mammal-announcement/|title=Large Mammal BPF Prize Winning Announcement – The Brain Preservation Foundation|language=en-US|access-date=2019-01-22}}</ref>
 
In 2016, Robert McIntyre, {{W|Greg Fahy}}, and {{W|21st Century Medicine}} would win the Large Mammal Prize from the {{W|Brain Preservation Foundation}} with this vitrifixation technique.<ref>{{Cite web|url=https://www.brainpreservation.org/large-mammal-announcement/|title=Large Mammal BPF Prize Winning Announcement – The Brain Preservation Foundation|language=en-US|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 2015-03-13 || brain preservation || technological adoption || fixation || OregonCryo || For the first time, a brain is preserved using fixation technology, by having her brain immersed in a fixative solution. The patient was Deborah Cheek, and she was preserved by OregonCryo.<ref name="OregonCryoCaseReports">{{Cite web|url=http://www.oregoncryo.com/caseReports.html|title=Oregon Cryonics - Cases|website=www.oregoncryo.com|access-date=2019-01-22}}</ref>
+
| 2016 || cryonics || organization || founding || Osiris || Osiris Back to Life is founded by Dvir Derhy.<ref>{{Cite web|url=http://osiriscryonics.com/|title=Cryogenics Human & Pet Freezing for Preservation and Revival|website=Osiris {{!}} Back to Life|language=en-US|access-date=2019-01-22}}</ref>
 
+
|-
Immersion fixation is well established to be ineffective in halting autolysis (decomposition).<ref>{{Cite journal|last=Kanawaku|first=Yoshimasa|last2=Someya|first2=Satoka|last3=Kobayashi|first3=Tomoya|last4=Hirakawa|first4=Keiko|last5=Shiotani|first5=Seiji|last6=Fukunaga|first6=Tatsushige|last7=Ohno|first7=Youkichi|last8=Kawakami|first8=Saki|last9=Kanetake|first9=Jun|date=July 2014|title=High-resolution 3D-MRI of postmortem brain specimens fixed by formalin and gadoteridol|url=http://dx.doi.org/10.1016/j.legalmed.2014.03.003|journal=Legal Medicine|volume=16|issue=4|pages=218–221|doi=10.1016/j.legalmed.2014.03.003|issn=1344-6223}}</ref><ref>{{Cite journal|last=Shatil|first=Anwar S.|last2=Uddin|first2=Md Nasir|last3=Matsuda|first3=Kant M.|last4=Figley|first4=Chase R.|date=20 February 2018|title=Quantitative Ex Vivo MRI Changes due to Progressive Formalin Fixation in Whole Human Brain Specimens: Longitudinal Characterization of Diffusion, Relaxometry, and Myelin Water Fraction Measurements at 3T|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826187/|journal=Frontiers in Medicine|volume=5|doi=10.3389/fmed.2018.00031|issn=2296-858X|pmc=5826187|pmid=29515998}}</ref> This is documented in the peer-reviewed literature with the time to fixation of the immersed brain being on the order of 5-15 weeks.<ref>{{Cite journal|last=Yong-Hing|first=Charlotte J.|last2=Obenaus|first2=Andre|last3=Stryker|first3=Rodrick|last4=Tong|first4=Karen|last5=Sarty|first5=Gordon E.|date=August 2005|title=Magnetic resonance imaging and mathematical modeling of progressive formalin fixation of the human brain|url=https://www.ncbi.nlm.nih.gov/pubmed/16032673|journal=Magnetic Resonance in Medicine|volume=54|issue=2|pages=324–332|doi=10.1002/mrm.20578|issn=0740-3194|pmid=16032673}}</ref> However, this procedure is very inexpensive{{snd}}Oregon Cryonics charges 1000 USD{{snd}}so this option is sometimes chosen with the hope that very advance technology might be able to recover some part of the brain.
+
| 2016 || brain preservation || organization || founding || Nectome || Nectome is started by Robert McIntyre after having won the {{W|Brain Preservation Foundation}}'s Large Mammal Prize. Nectome is a research organization developing biological preservation techniques to better preserve the physical traces of memory.<ref name="Nectome">{{Cite web|url=https://nectome.com/|title=Nectome|website=nectome.com|access-date=2019-01-22}}</ref>
 +
|-
 +
| 2016 || brain preservation || technological development || || Nectome || Nectome wins 413,765 USD in research grants from the National Institutes of Health “to enable whole-brain nanoscale preservation and imaging, a vital step towards a deep understanding of the mind and of the brain’s diseases.”<ref>{{Cite web|url=https://projectreporter.nih.gov/project_info_details.cfm?aid=9255571&icde=38525280|title=Project Information - NIH RePORTER - NIH Research Portfolio Online Reporting Tools Expenditures and Results|website=projectreporter.nih.gov|access-date=2019-02-15}}</ref>
 
|-
 
|-
| 2016 || cryonics || organisation || founding || Osiris || Osiris Back to Life is founded by Dvir Derhy.<ref>{{Cite web|url=http://osiriscryonics.com/|title=Cryogenics Human & Pet Freezing for Preservation and Revival|website=Osiris {{!}} Back to Life|language=en-US|access-date=2019-01-22}}</ref>
+
| 2016 || cryonics || organization || milestone || Yinfeng Life Science Research Institute || The Yinfeng Life Science Research Institute in Jinan, Shandong, China starts their operations. They are a branch of Yinfeng Biological which was started in 1999.
 
|-
 
|-
| 2016 || brain preservation || organisation || founding || Nectome || Nectome is started by Robert McIntyre after having won the {{W|Brain Preservation Foundation}}'s Large Mammal Prize. Nectome is a research organization developing biological preservation techniques to better preserve the physical traces of memory.<ref name="Nectome">{{Cite web|url=https://nectome.com/|title=Nectome|website=nectome.com|access-date=2019-01-22}}</ref>
+
| 2016-03-24 || cryonics || social || blog || Wait But Why || Tim Urban publishes "[https://waitbutwhy.com/2016/03/cryonics.html Why Cryonics Makes Sense]" on his blog "[https://waitbutwhy.com Wait But Why]". At the moment the article was published, 331,824 people were subscribed to receive new posts by email.<ref>{{Cite web|url=https://web.archive.org/web/20160325000246/https://waitbutwhy.com/2016/03/cryonics.html|title=Why Cryonics Makes Sense - Wait But Why|date=2016-03-25|website=web.archive.org|access-date=2019-02-04}}</ref> Cryonicists almost unanimously acclaimed this post as the best introduction to cryonics.
 
|-
 
|-
| 2016-03-24 || cryonics || popularisation || || Wait But Why || Tim Urban publishes "[https://waitbutwhy.com/2016/03/cryonics.html Why Cryonics Makes Sense]" on his blog "[https://waitbutwhy.com Wait But Why]". At the moment the artcile as published, 331,824 people were subscribed to receive new posts by email.<ref>{{Cite web|url=https://web.archive.org/web/20160325000246/https://waitbutwhy.com/2016/03/cryonics.html|title=Why Cryonics Makes Sense - Wait But Why|date=2016-03-25|website=web.archive.org|access-date=2019-02-04}}</ref> Cryonicists almost unanimously aclaimed this post as the best introduction to cryonics.
+
| 2016-05-06 || cryonics || organization || milestone || Oregon Cryonics || OregonCryo starts training its medical team with body donors.<ref name="OregonCryoCaseReports"/>
 
|-
 
|-
| 2016-05-06 || cryonics || organisation || training || OregonCryo || OregonCryo starts training its medical team with body donors.<ref name="OregonCryoCaseReports"/>
+
| 2016-06-06 || cryonics || risk management || economic stability || {{W|Alcor Life Extension Foundation}} || The Alcor Care Trust Supporting Organization (ACT) is created. The Patient Care Trust (PCT) continues in existence to receive initial funding from new cryopreservations and to pay for ongoing costs for maintaining patients' cryopreservation. The ACT will make long term investments, continue maintaining the PCT, and possibly eventually fund resuscitation research. Both trusts have a different board of directors that can check on each other.<ref>{{Cite web|url=https://alcor.org/Library/html/alcorcaretrust.htm|title=Alcor Care Trust Supporting Organization|website=alcor.org|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 2016-06-06 || cryonics || risk management || economic stability || {{W|Alcor Life Extension Foundation}} || The Alcor Care Trust Supporting Organization (ACT) is created. The Patient Care Trust (PCT) continues in existence to receive initial funding from new cryopreservations, and to pay for ongoing costs for maintaining patients' cryopreservation. The ACT will make long term investments, continue maintaining the PCT, and possibly eventually fund resuscitation research. Both trusts have different board of directors that can check on each other.<ref>{{Cite web|url=https://alcor.org/Library/html/alcorcaretrust.htm|title=Alcor Care Trust Supporting Organization|website=alcor.org|access-date=2019-01-22}}</ref>
+
| 2016-11-12 || cryonics || social || event || CryoSuisse || CryoSuisse organizes the 1st International Cryonics Conference.
 
|-
 
|-
| 2016-12-24 || brain preservation || technological adoption || fixation || OregonCryo || For the first time, someone is preserved by being perfused with a fixation solution instead of simply being immersed in it.
+
| 2016-12-24 || brain preservation || technological adoption || fixation || Oregon Cryonics || For the first time, someone is preserved by being perfused with a fixation solution instead of simply being immersed in it.
  
 
Fixative perfusion and brain removal for this patient is carried out by the individual's sons in cooperation with a local mortuary and a mobile pathology service. Oregon Cryonics (OC) is storing the brain.<ref name="OregonCryoCaseReports"/>
 
Fixative perfusion and brain removal for this patient is carried out by the individual's sons in cooperation with a local mortuary and a mobile pathology service. Oregon Cryonics (OC) is storing the brain.<ref name="OregonCryoCaseReports"/>
 
|-
 
|-
| 2017-01 to 2017-08 || cryonics || R&D || || OregonCryo || OregonCryo trains and does R&D with 38 {{W|body donations}}.<ref name="OregonCryoCaseReports"/>
+
| 2017-01-12 || cryonics || || || The Church of Perpetual Life || The city of Hollywood, FL officially proclaims January 12th as Dr. James Bedford Day in remembrance of the first person to be cryopreserved with the hope of being revived in the future. Here you can see the [https://drive.google.com/open?id=0By3LNRGk0wixbWZrNW14Q24xOFM3bGI4cl9COFdLTmdkNGJJ official proclamation].
 
|-
 
|-
| 42795 || cryobiology || technological development || re-warming || Bischoff, et al. || Bischoff, et al., develop a novel technique of inductive heat re-warming using magnetic nanoparticles in the vasculature allowing for uniform re-warming of organs the size of rabbit kidneys at rates high enough to prevent devitrification of M-22 vitrification solution at a concentration compatible with kidney viability. The system is potentially applicable to larger organs, such as the human brain.<ref>{{Cite journal|last=Manuchehrabadi|first=Navid|last2=Gao|first2=Zhe|last3=Zhang|first3=Jinjin|last4=Ring|first4=Hattie L.|last5=Shao|first5=Qi|last6=Liu|first6=Feng|last7=McDermott|first7=Michael|last8=Fok|first8=Alex|last9=Rabin|first9=Yoed|date=1 March 2017|title=Improved tissue cryopreservation using inductive heating of magnetic nanoparticles|url=https://www.ncbi.nlm.nih.gov/pubmed/28251904|journal=Science Translational Medicine|volume=9|issue=379|doi=10.1126/scitranslmed.aah4586|issn=1946-6242|pmc=5470364|pmid=28251904}}</ref><ref>{{Cite web|url=https://www.ibtimes.co.uk/organ-cryopreservation-becoming-reality-bringing-whole-bodies-back-still-100-years-away-1609149|title=Organ cryopreservation is becoming a reality – but bringing whole bodies back still 100 years away|date=2017-03-01|website=International Business Times UK|language=en|access-date=2019-02-04}}</ref>
+
| 2017-01 to 2017-08 || cryonics || technological development || || Oregon Cryonics || OregonCryo trains and does research and development with 38 {{W|body donations}}.<ref name="OregonCryoCaseReports"/>
 
|-
 
|-
| 2018 || cryonics || quality assessment || scan || Darwin || M. Darwin publishes “Preliminary Evaluation of Alcor Patient Cryogenic CT Scans” analyzing three of the four available Alcor neuropatient CT scans. Darwin concludes that it is highly likely that Alcor patient A-1002 was possibly the first human cryonics patient to achieve essentially ice free brain cryopreservation.<ref>{{Cite web|url=https://spaces.hightail.com/receive/qqSYgDnnI1|title=Preliminary Evaluation of Alcor Patient Cryogenic CT Scans|last=Darwin|first=Michael|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
+
| 2017-03-01 || cryobiology || technological development || re-warming || Bischoff, et al. || Bischoff, et al., develop a novel technique of inductive heat re-warming using magnetic nanoparticles in the vasculature allowing for uniform re-warming of organs the size of rabbit kidneys at rates high enough to prevent devitrification of M-22 vitrification solution at a concentration compatible with kidney viability. The system is potentially applicable to larger organs, such as the human brain.<ref>{{Cite journal|last=Manuchehrabadi|first=Navid|last2=Gao|first2=Zhe|last3=Zhang|first3=Jinjin|last4=Ring|first4=Hattie L.|last5=Shao|first5=Qi|last6=Liu|first6=Feng|last7=McDermott|first7=Michael|last8=Fok|first8=Alex|last9=Rabin|first9=Yoed|date=1 March 2017|title=Improved tissue cryopreservation using inductive heating of magnetic nanoparticles|url=https://www.ncbi.nlm.nih.gov/pubmed/28251904|journal=Science Translational Medicine|volume=9|issue=379|doi=10.1126/scitranslmed.aah4586|issn=1946-6242|pmc=5470364|pmid=28251904}}</ref><ref>{{Cite web|url=https://www.ibtimes.co.uk/organ-cryopreservation-becoming-reality-bringing-whole-bodies-back-still-100-years-away-1609149|title=Organ cryopreservation is becoming a reality – but bringing whole bodies back still 100 years away|date=2017-03-01|website=International Business Times UK|language=en|access-date=2019-02-04}}</ref>
 
|-
 
|-
| 2018 winter || brain preservation || organisation || || Nectome || Nectome participates in the startup accelerator {{W|Y Combinator}}.<ref name="Nectome"/><ref>{{Cite web|url=https://blog.ycombinator.com/10-companies-from-yc-winter-2018/|title=10 Companies From YC Winter 2018|last=Combinator|first=Y.|website=Y Combinator|language=en-US|access-date=2019-01-22}}</ref>
+
| 2017-04-26 || cryonics || social || writeup || Open Phlanthropy || As part of research into the history of philanthropy, Luke Muehlhauser writes "Some Case Studies in Early Field Growth" that, among other things, includes a section called "Failure modes in cryonics and molecular nanotechnology" that, he says, "saw especially slow, anemic field growth." Muehlhauser muses about possible reasons for the slow growth: "First, early advocates of cryonics and MNT focused on writings and media aimed at a broad popular audience, before they did much technical, scientific work. [...] Second, early advocates of cryonics and MNT spoke and wrote in a way that was critical and dismissive toward the most relevant mainstream scientific fields [...] Third, [...] these “neighboring” established scientific communities (of cryobiologists and chemists) engaged in substantial “boundary work” to keep advocates of cryonics and MNT excluded."<ref>{{cite web|url = https://www.openphilanthropy.org/research/history-of-philanthropy/some-case-studies-early-field-growth#FailureModes|title = Some Case Studies in Early Field Growth: Failure modes in cryonics and molecular nanotechnology|last = Muehlhauser|first = Luke|publisher = Open Philanthropy|language = en|date = 2017-04-26|accessdate = 2020-07-05}}</ref><ref>{{cite web|url = https://www.openphilanthropy.org/blog/new-report-early-field-growth|title = New Report on Early Field Growth|last = Muehlhauser|first = Luke|publisher = Open Philanthropy|language = en|date = 2017-04-26|accessdate = 2020-07-05}}</ref>
 
|-
 
|-
| 2018-04-06 || cryonics || organisation || founding || International Cryomedicine Experts || Alcor signs an agreement with the newly funded International Cryomedicine Experts, a for-profit organisation providing international cryonics standby, stabilization, and transport services.
+
| 2017-05-08 || cryonics || organization || milestone || Yinfeng Life Science Research Institute || The Yinfeng Life Science Research Institute in Jinan, Shandong, China cryopreserves their first patient.<ref>{{Cite web|url=https://www.chinadaily.com.cn/a/201806/26/WS5b319590a3103349141dec01.html|title=Chinese woman's body frozen in advanced procedure - Chinadaily.com.cn|last=李松|website=www.chinadaily.com.cn|access-date=2019-02-04}}</ref><ref>{{Cite web|url=http://www.mirror.co.uk/news/world-news/woman-cryogenically-frozen-after-dying-10985205|title=Woman cryogenically frozen after death in hope of being resurrected in future|last=Feng|first=Scott|date=2017-08-14|website=mirror|access-date=2020-01-12}}</ref> A documentary documents the procedure: [https://vimeo.com/243966672 China Whole Body Cryopreservation].
 
|-
 
|-
| 2018-05-16 || cryonics || risk management || economic stability || {{W|Alcor Life Extension Foundation}} || Alcor announces the creation of a sibling organisation called the Alcor Endowment Trust Supporting Organization. Its goal is to maintain funds that are invested, and which support Alcor's general operation and research through giving a fraction of the interests made.<ref>{{Cite web|url=https://www.alcor.org/blog/the-alcor-endowment-trust-supporting-organization/|title=The Alcor Endowment Trust Supporting Organization|last=admin|date=2018-05-16|website=Alcor News|language=en-US|access-date=2019-01-22}}</ref>
+
| 2018 || cryonics || quality assessment || scan || {{W|Mike Darwin}} || M. Darwin publishes “Preliminary Evaluation of Alcor Patient Cryogenic CT Scans” analyzing three of the four available Alcor neuropatient CT scans. Darwin concludes that it is highly likely that Alcor patient A-1002 was possibly the first human cryonics patient to achieve essentially ice-free brain cryopreservation.<ref>{{Cite web|url=https://spaces.hightail.com/receive/qqSYgDnnI1|title=Preliminary Evaluation of Alcor Patient Cryogenic CT Scans|last=Darwin|first=Michael|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
 
|-
 
|-
| 2018-06-17 || cryonics || organisation || || Yinfeng Life Science Research Institute || The Yinfeng Life Science Research Institute in Jinan, Shandong, China cryopreserves their first patient.<ref>{{Cite web|url=https://www.chinadaily.com.cn/a/201806/26/WS5b319590a3103349141dec01.html|title=Chinese woman's body frozen in advanced procedure - Chinadaily.com.cn|last=李松|website=www.chinadaily.com.cn|access-date=2019-02-04}}</ref> A documentary documents the procedure: [https://vimeo.com/243966672 China Whole Body Cryopreservation].
+
| 2018 winter || brain preservation || organization || milestone || Nectome || Nectome participates in the startup accelerator {{W|Y Combinator}}.<ref name="Nectome"/><ref>{{Cite web|url=https://blog.ycombinator.com/10-companies-from-yc-winter-2018/|title=10 Companies From YC Winter 2018|last=Combinator|first=Y.|website=Y Combinator|language=en-US|access-date=2019-01-22}}</ref>
 
|-
 
|-
| 2018-10-30 || cryonics || legal || || Norman Hardy || For the first time, a cryonics patient uses the Death With Dignity legislation. The patient's name is Norman Hardy.<ref>{{Cite web|url=https://alcor.org/Library/html/casesummary1990.html|title=Alcor Case Summary: A-1990|website=alcor.org|access-date=2019-01-22}}</ref>
+
| 2018-04-06 || cryonics || organization || founding || International Cryomedicine Experts || Alcor signs an agreement with the newly funded International Cryomedicine Experts, a for-profit organization providing international cryonics standby, stabilization, and transport services.
 
|-
 
|-
| 2018-11 || cryonics || social || || {{W|Society for Cryobiology}} || The {{W|Society for Cryobiology}} releases a position statement clarifying their stance in regards to cryonics, saying they respect people's freedom in chosing this option, but that the procedure is speculative, and that the scientific knowledge necessary to sucessfully cryopreserve someone doesn't currently exist.<ref group=note>"The Society recognizes and respects the freedom of individuals to hold and express their own opinions and to act, within lawful limits, according to their beliefs. Preferences regarding disposition of postmortem human bodies or brains are clearly a matter of personal choice and, therefore, inappropriate subjects of Society policy. The Society does, however, take the position that the knowledge necessary for the revival of live or dead whole mammals following cryopreservation does not currently exist and can come only from conscientious and patient research in cryobiology and medicine. In short, the act of preserving a body, head or brain after clinical death and storing it indefinitely on the chance that some future generation may restore it to life is an act of speculation or hope, not science, and as such is outside the purview of the Society for Cryobiology."</ref><ref>{{Cite web|url=https://www.societyforcryobiology.org/assets/documents/Position_Statement_Cryonics_Nov_18.pdf|title=Society for Cryobiology Position Statement - Cryonics|last=|first=|date=November 2018|website=Society for Cryobiology|archive-url=|archive-date=|dead-url=|access-date=2019-01-23}}</ref>
+
| 2018-05-16 || cryonics || risk management || economic stability || {{W|Alcor Life Extension Foundation}} || Alcor announces the creation of a sibling organization called the Alcor Endowment Trust Supporting Organization. Its goal is to maintain funds that are invested, and which support Alcor's general operation and research through giving a fraction of the interests made.<ref>{{Cite web|url=https://www.alcor.org/blog/the-alcor-endowment-trust-supporting-organization/|title=The Alcor Endowment Trust Supporting Organization|last=admin|date=2018-05-16|website=Alcor News|language=en-US|access-date=2019-01-22}}</ref>
 +
|-
 +
| 2018-10-30 || cryonics || legal || right-to-die || Norman Hardy || For the first time, a cryonics patient uses the Death With Dignity legislation. The patient's name is Norman Hardy.<ref>{{Cite web|url=https://alcor.org/Library/html/casesummary1990.html|title=Alcor Case Summary: A-1990|website=alcor.org|access-date=2019-01-22}}</ref>
 +
|-
 +
| 2018-11 || cryonics || social || bylaws || {{W|Society for Cryobiology}} || The {{W|Society for Cryobiology}} releases a position statement clarifying their stance in regards to cryonics, saying they respect people's freedom in choosing this option, but that the procedure is speculative, and that the scientific knowledge necessary to successfully cryopreserve someone doesn't currently exist.<ref group=note>"The Society recognizes and respects the freedom of individuals to hold and express their own opinions and to act, within lawful limits, according to their beliefs. Preferences regarding disposition of postmortem human bodies or brains are clearly a matter of personal choice and, therefore, inappropriate subjects of Society policy. The Society does, however, take the position that the knowledge necessary for the revival of live or dead whole mammals following cryopreservation does not currently exist and can come only from conscientious and patient research in cryobiology and medicine. In short, the act of preserving a body, head or brain after clinical death and storing it indefinitely on the chance that some future generation may restore it to life is an act of speculation or hope, not science, and as such is outside the purview of the Society for Cryobiology."</ref><ref>{{Cite web|url=https://www.societyforcryobiology.org/assets/documents/Position_Statement_Cryonics_Nov_18.pdf|title=Society for Cryobiology Position Statement - Cryonics|last=|first=|date=November 2018|website=Society for Cryobiology|archive-url=|archive-date=|dead-url=|access-date=2019-01-23}}</ref>
 +
|-
 +
| 2019-04 || cryonics || organization || milestone || {{W|Brain Preservation Foundation}} || The {{W|Brain Preservation Foundation}} launches the Aspirational Neuroscience Prize with the commitment to give 4 prizes of 25,000 USD every year for the next 10 years for breakthroughs in the neuroscience of memory, brain preservation, and connectomics.<ref>{{Cite web|url=http://www.brainpreservation.org/aspirational-neuroscience-prize/|title=Aspirational Neuroscience Prize – The Brain Preservation Foundation|language=en-US|access-date=2019-08-06}}</ref>
 
|}
 
|}
  
 
== More information ==
 
== More information ==
Some events that weren't important enough to make it into this timeline are noted in the Google Sheet [https://docs.google.com/spreadsheets/d/1uEvT8oHOQJOOYzYglkFgrEgKbhbkz1A0jdO5OYZPwEk/ Timeline of cryonics - not significant enough].
+
Some events that weren't important enough to make it into this timeline are noted on the Discussion page (as well as on the Google Sheet [https://docs.google.com/spreadsheets/d/1uEvT8oHOQJOOYzYglkFgrEgKbhbkz1A0jdO5OYZPwEk/ Timeline of cryonics - extended timeline]).
  
 
An exhaustive list of publicly known preserved patients (including a yet incomplete evaluation of the quality of their preservation) can be found in the Google Sheet [https://docs.google.com/spreadsheets/d/1vBrlNvPkPQbLKxtSUlTF_ZpUS4lwW2W7lENRj9Gdk3I List of cryonics patients].
 
An exhaustive list of publicly known preserved patients (including a yet incomplete evaluation of the quality of their preservation) can be found in the Google Sheet [https://docs.google.com/spreadsheets/d/1vBrlNvPkPQbLKxtSUlTF_ZpUS4lwW2W7lENRj9Gdk3I List of cryonics patients].
  
A detailed account of membership statistics of cryonics organisations has been compiled in the Google Sheet [https://docs.google.com/spreadsheets/d/1CW5tyCLp-jGT4ta4k1esDaw-I2eKd7rcI7jhcQEk4NE/ Cryonic members statistics] (although not all organisations share all, or any of their membership statistics). A detailed account of patient statistics has been compiled in the Google Sheet [https://docs.google.com/spreadsheets/d/15Ix7iocvo5WdNgtC3MSkYlyysV95_TrJjK87Z371FrY/ Cryonic patients statistics]. The membership and patient statistics should be updated at the beginning of every year, after the publication of the statistics from last year.
+
A detailed account of membership statistics of cryonics organizations has been compiled in the Google Sheet [https://docs.google.com/spreadsheets/d/1CW5tyCLp-jGT4ta4k1esDaw-I2eKd7rcI7jhcQEk4NE/ Cryonic members statistics] (although not all organizations share all or any of their membership statistics). A detailed account of patient statistics has been compiled in the Google Sheet [https://docs.google.com/spreadsheets/d/15Ix7iocvo5WdNgtC3MSkYlyysV95_TrJjK87Z371FrY/ Cryonic patients statistics]. The membership and patient statistics should be updated at the beginning of every year, after the publication of the statistics from last year.
  
All those external lists are editable, and everyone is encouraged to contribute to them. They are all available in the Google Folder [https://drive.google.com/open?id=1zRQIIVmh8Io-Ao5HZV1UtzkWTY61wbFI Cryonics Statistics]. [[User:Mati Roy|Mati Roy]] created and is maintaining all of those Google Sheets. Most of the membership statistics were entered by someone anonymous.
+
== Meta information on the timeline ==
  
A list of papers tracking the development of cryonics is tracked in the GitHub repository [https://github.com/RomanPlusPlus/scientific-progress-towards-cryonics Scientific progress towards cryonics], and is currently maintained by Roman.
+
=== Timeline update strategy ===
 +
As of 2020, [[User:Mati Roy|Mati Roy]] is currently roughly staying up-to-date with new major cryonics events, and should, therefore, update the timeline roughly continuously, at least in the near future. If you're interested in helping in any way, feel free to take the initiative. If you have any questions, want guidance or feedback, want to discuss ways to improve this timeline, or have a suggestion for an addition to this timeline, let [[User:Mati Roy|Mati]] know on the [https://www.reddit.com/r/TimelinesWiki/ TimelinesWiki Subreddit] or [https://www.facebook.com/groups/TimelinesWiki/ TimelinesWiki Facebook Group] (and link me the post) or contact me directly at contact@matiroy.com.
  
The graphs from the [[#Trends|Trends section]] can be updated whenever the relevant external lists are.
+
Also see the section "More information" for other related information that can be updated or otherwise improved. All those external lists are editable, and everyone is encouraged to contribute to them. They are all available in the Google Folder [https://drive.google.com/open?id=1zRQIIVmh8Io-Ao5HZV1UtzkWTY61wbFI Cryonics Statistics]. The graphs from the [[#Trends|Trends section]] can be updated whenever the relevant external lists are.
  
== Meta information on the timeline ==
+
An older version of the timeline is available on Google Sheet: [https://docs.google.com/spreadsheets/d/1uEvT8oHOQJOOYzYglkFgrEgKbhbkz1A0jdO5OYZPwEk/ Timeline of brain preservation].
The initial version of the timeline was written by [[User:Mati Roy|Mati Roy]].
+
 
 +
To update the [https://docs.google.com/spreadsheets/d/1vBrlNvPkPQbLKxtSUlTF_ZpUS4lwW2W7lENRj9Gdk3I/ graph of cryonics patients] and the [https://docs.google.com/spreadsheets/d/15Ix7iocvo5WdNgtC3MSkYlyysV95_TrJjK87Z371FrY/edit#gid=1842966112 graph of cryonics patients per organization], consult:
 +
 
 +
* [https://alcor.org/cases.html Alcor's cases]
 +
* [https://www.cryonics.org/ci-landing/patient-details/ CI's cases]
 +
* [http://www.oregoncryo.com/caseReports.html OregonCryo's cases]
 +
* [http://kriorus.ru/en/cryopreserved%20people KrioRus' cases]
 +
 
 +
To update the [https://docs.google.com/spreadsheets/d/1CW5tyCLp-jGT4ta4k1esDaw-I2eKd7rcI7jhcQEk4NE/edit#gid=2052124163 cryonics membership graph]:
 +
 
 +
* [https://alcor.org/Library/html/stats-members.html Alcor's membership stats]
 +
* [http://forum.oregoncryo.com/viewtopic.php?f=2&t=56 OregonCryo's membership stats]
 +
* [https://www.cryonics.org/images/uploads/magazines/ CI's membership stats] (see latest magazine)
 +
* [https://osiriscryonics.com/contact-us.html Osiris' membership stats]
 +
 
 +
=== To do ===
 +
* [[User:Sebastian|Sebastian]] feedback: [https://web.archive.org/web/20220308150041/https://www.thebrighterside.news/post/hibernation-found-to-naturally-stop-the-aging-process] (EtA: I was told this "talks about hibernation, not brain preservation")
 +
* Add: March 2020 news and updates, creation of the Alcor Longevity Circle of Distinguished Donors
 +
* Make a graph of historical money spent on cryonics by members, philanthropists and other interest groups.
 +
* Read [https://www.sciencedirect.com/science/article/pii/S1743919115012790?via%3Dihub Emergency preservation and resuscitation for cardiac arrest from trauma] to add the major milestones of the used of hypothermia. (EtA: I was told this "has one or two specific years but most dates are decades")
 +
* Read [https://www.createursdemondes.fr/veille-techno/bio-informatique-genetique/vivre-eternellement/cryogenisation-des-corps-ou-cryonie/ CRYOGÉNISATION DES CORPS OU “CRYONIE”] and add missing relevant events
 +
* Add publication from Argentina about their preservation in 2018
 +
* Add {{W|The Door into Summer}} (although probably not notable enough for the main timeline)
 +
* Add info from the [https://www.icryonic.com/sobre-icryonic/investigacion-y-desarrollo/ iCryonics World Lab timeline] (although maybe it should go in the extended timeline, at least for now)
 +
* 2020-07-19: [https://www.youtube.com/watch?v=oc6ffxAiZ28 Should I FREEZE MYSELF when I die? | S2E9 with Katee Sackhoff]
 +
* 2020-07-09: [https://www.cnet.com/features/cryonics-brain-preservation-and-the-weird-science-of-cheating-death-alcor/ Cryonics, brain preservation and the weird science of cheating death] by CNET (EtA: I was told this "is a description of cryonics but does not indicate when milestones happened"
 +
* 2020-09-12: Announcement of Alcor's new website
 +
* [https://www.biostasis.com/protocol/ Medical Biostasis Protocol]
 +
* 2018-06: Documentary "Hope Frozen" is published. It's a documentary about the cryopreservation of a two-year old person. [https://www.imdb.com/title/tt8060472/releaseinfo?ref_=tt_dt_dt source] On 2020-08-18, Netflix released the documentary. [source: https://www.youtube.com/watch?v=vecjCWsrhww]
 +
* add [https://www.tomorrowbiostasis.com Tomorrow Biostasis] ; Organization based in Berlin, Germany. Founded in 2019, accepts members in Germany, Switzerland and Austria (as of 2021). Standby vehicle and team based in Berlin
 +
* ANB's reporting of brain vitrification after chemical fixation, and the ability to conduct cryoprotectant perfusion without edema two weeks after chemical fixation. This research was conducted in 2010 (January) and reported in Long Life magazine in 2011: http://immortalistsociety.org/anb_research.htm (Long Life Jul-Aug 2011 (p. 17-18) ; Long Life Sep-Oct 2011 (p. 7-8))
 +
* Add [https://bmcbiol.biomedcentral.com/articles/10.1186/s12915-021-00976-8 Winter is coming: the future of cryopreservation]
 +
* [https://charities.govt.nz/charities-in-new-zealand/legal-decisions/view-the-decisions/view/the-foundation-for-anti-aging-research-and-the-foundation-for-reversal-of-solid-state-hypothermia-v-charities-registration-board The Foundation for Anti-Aging Research and The Foundation For Reversal of Solid State Hypothermia v Charities Registration Board]
 +
* [https://bigthink.com/surprising-science/zombie-pigs-brainex]
 +
* [https://www.tandfonline.com/doi/full/10.1080/20502877.2022.2055868 The cryonic refugee: appropriate analogy or confusing rhetoric?]
 +
* consider adding the "EUTHANASIA AND CRYOTHANASIA" paper
 +
* Alcor 50th anniversary event (180 attendees; 7 different media organizations)
 +
* (for extended timeline) Osiris changes their name to Cryonics America (https://cryonicsamerica.com/) (verify exact date, ex.: on Web Archive; but it was at the latest in june 2022)
 +
* consider including [Winter is coming: the future of cryopreservation](https://pubmed.ncbi.nlm.nih.gov/33761937/)
 +
* [The Spring Of Cryobiology: One Enabling Technology That Will Help Build The New Industry Of The Future](https://www.forbes.com/sites/alexzhavoronkov/2022/09/22/the-spring-of-cryobiology-one-enabling-technology-that-will-help-build-the-new-industry-of-the-future/?sh=426fae207699)
 +
* Include relevant items from the [https://cryonics.miraheze.org/wiki/Category:Cryonics_by_year Cryonics Wiki]
 +
* "Worldwide Cryonics Attitudes About the Body, Cryopreservation, and Revival: Personal Identity Malleability and a Theory of Cryonic Life Extension" by Melanie Swan
 +
* @TheOrville had a contest where you could win a "lifetime [cryonics membership], and a partial prepayment towards the preservation itself";
 +
"It’s reminiscent of a similar essay contest features in Omni Magazine many years ago." (https://deadline.com/2017/07/comic-con-seth-macfarlane-the-orville-cryogenics-fan-contest-fox-1202131271/ ; https://www.alcor.org/2017/08/link-roundup-812/)
 +
* maybe include some of the news stories listed at the bottom here: http://www.ralphmerkle.com/cryo/
 +
* stats: Tomorrow Biostasis newsletter said "250 members since we opened to signups in  January 2021" on 2022-11-07
 +
* legal: Roe v Mitchell (https://www.alcor.org/cryonics-magazine-2022/ issue #3)
 +
* legal: "In response to bad cryonics publicity in 2004, the Arizona State Legislature almost passed a law that would have regulated cryonics in Arizona under Board of Funeral Directors and Embalmers." (https://www.alcor.org/cryonics-magazine-2022/ issue #3)
 +
* 2022-12-16 [Tomorrow Bio Offering Brain Cryopreservation](https://www.tomorrow.bio/post/tomorrow-bio-offering-brain-cryopreservation)
 +
* [Biostasis Technologies](https://www.linkedin.com/company/biostasis-technologies/?isFollowingPage=true) founded around January 2023
 +
* https://www.newsweek.com/back-life-science-reviving-dead-104449
  
=== Timeline update strategy ===
+
=== Legal ===
As of 2019, [[User:Mati Roy|Mati Roy]] is currently roughly staying up-to-date with new major cryonics events, and should therefore update the timeline roughly continuously, at least in the near future. The timeline on this wiki is manually synced with the Google Sheet [https://docs.google.com/spreadsheets/d/1uEvT8oHOQJOOYzYglkFgrEgKbhbkz1A0jdO5OYZPwEk/ Timeline of cryonics] as the main author, [[User:Mati Roy|Mati Roy]], finds it easier to maintain it there. So feel free to edit either, and it will then get manually synced.
+
* Arizona: HB2583 - End-of-life decisions; terminally ill individuals
 +
* Arizona: SB1646 - End-of-life decisions; terminally ill individuals
  
If you're interested in helping in any way, feel free to take the initiative. If you have any questions, want guidance or feedback, or want to discuss about ways to improve this timeline, feel free to contact [[User:Mati Roy|Mati Roy]] at contact@matiroy.com or post on [https://www.reddit.com/r/TimelinesWiki/comments/aj89vr/timeline_of_cryonics/ TimelinesWiki Reddit cryonics post].
+
==== Records ====
 +
* Fastest cooldown with ice water: [https://www.alcor.org/library/complete-list-of-alcor-cryopreservations/case-report-a-1871/ CryoCare Patient C-2150]
  
Also see the section "More information" for other related information that can be updated or otherwise improved.
+
=== Terminology ===
 +
By default, [[User:Mati Roy|Mati Roy]] suggests using the [http://www.oregoncryo.com/terminology.html terminology proposed by OregonCryo].
  
 
=== Tracking preservation quality ===
 
=== Tracking preservation quality ===
An interesting addition that could be done to this page is to measure the progress cryonics cases. If you're interested in contributing to this project, you can fill the columns related to the quality of the cryopreservation in the Google Sheet [https://docs.google.com/spreadsheets/d/1vBrlNvPkPQbLKxtSUlTF_ZpUS4lwW2W7lENRj9Gdk3I List of cryonics patients] by going through some of the cases published by the cryonics organisations; see: [https://alcor.org/cases.html Alcor (human cases)], the [https://www.cryonics.org/case-reports/ Cryonics Institute (human cases)], [http://www.oregoncryo.com/caseReports.html OregonCryo (human cases)], [http://www.oregoncryo.com/caseReportsPets.html OregonCryo (non-human cases)], [http://kriorus.ru/Krionirovannye-lyudi KrioRus (human cases)], [http://kriorus.ru/Zhivotnye-kriopacienty KrioRus (non-human cases)].
+
An interesting addition that could be done to this page is to measure the progress of the quality of cryonics cases. If you're interested in contributing to this project, you can fill the columns related to the quality of the cryopreservation in the Google Sheet [https://docs.google.com/spreadsheets/d/1vBrlNvPkPQbLKxtSUlTF_ZpUS4lwW2W7lENRj9Gdk3I List of cryonics patients] by going through some of the cases published by the cryonics organizations; see: [https://alcor.org/cases.html Alcor (human cases)], the [https://www.cryonics.org/case-reports/ Cryonics Institute (human cases)], [http://www.oregoncryo.com/caseReports.html OregonCryo (human cases)], [http://www.oregoncryo.com/caseReportsPets.html OregonCryo (non-human cases)], [http://kriorus.ru/Krionirovannye-lyudi KrioRus (human cases)], [http://kriorus.ru/Zhivotnye-kriopacienty KrioRus (non-human cases)].
  
 
While ways to quantify the quality of preservations have been proposed, notably by [http://www.oregoncryo.com/qualityScores.html OregonCryo], there are currently no systematic analyses done about the quality of current preservations by any of the cryonics providers.
 
While ways to quantify the quality of preservations have been proposed, notably by [http://www.oregoncryo.com/qualityScores.html OregonCryo], there are currently no systematic analyses done about the quality of current preservations by any of the cryonics providers.
Line 575: Line 669:
 
As for the improvements done in laboratory conditions, progress is better tracked by noting various discrete technological development as done in the full timeline above.
 
As for the improvements done in laboratory conditions, progress is better tracked by noting various discrete technological development as done in the full timeline above.
  
While having a graph tracking the [https://github.com/RomanPlusPlus/scientific-progress-towards-cryonics "biggest mass of a successfully cryopreserved tissue/organ/organism by year, kg"] is appealing, it doesn't meaningfully track progress done on brain preservations which pose a series of challenges not present in smaller volumes of tissue as [https://drive.google.com/file/d/1eGVzwmr1TDgN9HnDfTZNnzP98-hipHoc/ noted by Mike Darwin].
+
While having a graph tracking the [https://github.com/RomanPlusPlus/scientific-progress-towards-cryonics "biggest mass of a successfully cryopreserved tissue/organ/organism by year, kg"] is appealing, it doesn't meaningfully track progress done on brain preservations which pose a series of challenges not present in smaller volumes of tissue as [https://drive.google.com/file/d/1eGVzwmr1TDgN9HnDfTZNnzP98-hipHoc/ noted by Mike Darwin]. This can still be found on the Discussion page.
 +
 
 +
=== Acknowledgement ===
 +
[[User:Mati Roy|Mati Roy]] created the first version of the timeline of brain preservation published here with [https://contractwork.vipulnaik.com/tasks.php?receptacle=Timeline+of+brain+preservation&matching=exact payment from Vipul]. [[User:Mati Roy|Mati Roy]] also created and is maintaining, with the help of other volunteers, all of the Google Sheets mentioned in the section [[#More information]]. Most of the membership statistics were entered by Marta Sandberg. {{W|Mike Darwin}} contributed a lot of information on notable technological progress on [https://www.reddit.com/r/longevity/comments/ajanjs/timeline_of_cryonics/ Reddit]. {{W|Mike Darwin}} and [[User:Issa|Issa Rice]] provided a lot of useful feedback. Alexey Potapov, Marta Sandberg, Aschwin de Wolf, as well as others contributed ideas for events to add. The graph and table tracking [https://github.com/RomanPlusPlus/scientific-progress-towards-cryonics Scientific progress towards cryonics] was created by Roman.
  
=== Improving types of events ===
+
In January 2020, [[User:Mati Roy|Mati Roy]] updated the timeline, and Jim Yount, CEO of the American Cryonics Society, provided a lot of useful feedback.
The types and subtypes of events in the timelines could be more exhaustive. The science and R&D types could have subtypes for the different field of research.
 
  
 
==Notes and references==
 
==Notes and references==

Latest revision as of 07:41, 8 July 2023

This is a timeline of brain preservation.

Brain preservation is the attempt to preserve a human or non-human animal with the hope that partial or complete resuscitation may be possible in the future.

Cryonics is the most popular method of brain preservation, and preserves individuals using low-temperature. But other methods are being used and developed as well, notably fixation, and a combination of both called aldehyde-stabilized cryopreservation.

Alternative names for brain preservation include biostasis and neural archiving.

Often confused with cryonics, suspended animation (or anabiosis) is a distinct practice where a patient body would remain biologically intact, and could be reanimated without the need to deeply repair the brain, or transfer its information to another substrate.[1] However, improvements in suspended animation would also improve the quality of cryopreservations given a patient could be maintained alive at lower temperature before undergoing the damaging cryonics procedure. So this timeline also includes some important milestones with regards to suspended animation.

Trends

Popularity

Interests

The following graph shows the relative popularity of web searches on the topic of cryonics on Google. For the latest version, check out Google Trends.

Cryonics worldwide popularity per month (Google Trends).png

The following graph shows the number of views the Wikipedia page "Cryonics" had every day since July 2015. Note that the y-axis is logarithmic, with 5 main peaks. For the latest version, check out WMF Labs. There were 433,734 views in 2019, 367,632 views in 2018, 352,831 views in 2017, and 544,065 views in 2016.

Cryonics pageviews wikipedia.png

Patients

The first people to start advocating for cryonics emerged in 1962, and the first preservation happened 4 years later. From 1966 until 1973, of the 17 attempts at freezing, only one person remained cryopreserved[2] (hence the bumps at the beginning of the curve in the graph below). Consequently, the "pay-as-you-go" funding model was abandoned by the cryonics community as relatives had shown to generally eventually lose interest in paying maintenance fees. From then onward, the number of cryopreservations would grow exponentially, but to this day still represent a trivial amount in comparison to the number of burials and cremations. Since cryonics was first publicized, an estimated 2.9 billion people have died,[3] which could represent about 2.7% of humans to have ever lived.[4] As of January 2019, 416 people are known to be cryopreserved.

The following graph shows a history of the number of bodies preserved (complete or neuro-only). Given that the quality of preservations varies a lot, and it can often take many hours or even days before someone gets preserved from the time of their clinical death,[5][6] the graph below represents an upper bound of the number of people that are preserved: some have probably been irreversibly lost, and some might only have been partially preserved. Given that we don't currently know how effective current preservation methods are, the lower bound for the number of people that have been preserved remains 0.

Number of people preserved over time.png

The following graph shows the number of patients over time for many organizations.

Cryopreservation count per organisation over time.png

Members

Memberships statistics can be tricky to track for a couple of reasons:

  • Lack of present data: some organizations don't publicize their membership statistics
  • Lack of historical data: some organizations only started tracking their membership statistics later in their history
  • Lack of cryonics membership data: the Cryonics Institute stopped publicizing the number of their members that are fully-funded since 2015, and now only reports the number of members they have; some are also members only for other of their services, such as DNA preservation
  • Dual memberships: some cryonicists are members of more than one organization, often to support several organizations, or as a fall-back for themselves if one organization was to fail in some ways.

Alcor is the only large cryonics organization that has tracked the number of fully-funded members it has had since its beginnings.[7] All Alcor members are subscribed to standby services. The Cryonics Institute has tracked the number of members it has signed up with standby services since it started offering it in 2006.[8] It also has a lot of members that are signed up but plan to use the services of a funeral director for transport – this number is however unknown to the public. The graph below tracks those two numbers. The recent growth has been pretty linear. However, given that there are more and more cryonics organizations, worldwide cryonics memberships is likely growing exponentially.

Number of members 2019-01.png

Cost

Alcor and the Cryonics Institute are the main cryonics providers that have existed for decades.[note 1] Alcor has been adjusting its prices according to the Consumer Price Index (which has been lower than medical inflation), while the Cryonics Institute has maintained its initial price. The first graph below shows the nominal cost charged by the organization, while the second graph shows the real cost (that is inflation adjusted) of various cryonics services.

While the graphs start in 1976, it is worth noting that before 1982, Alcor was contracting Trans Time for its storage services, and the Institute for Advanced Biological Studies for its stabilization services. Also, besides Ettinger's mother and wife, the first patient of the Cryonics Institute was preserved in 1991.

A direct comparison between the prices of different organizations is difficult because of the different services provided, and different types of payments. For example, Alcor has an annual membership fee and has surcharges for late-minute cases. Some of the reason for Alcor's higher price than the Cryonics Institute includes the cost of stabilization and transport, as well as being more financially conservative by putting more money aside in a patient care trust.

The graphs below show the price of cryonics for whole-body and / or neuro-only as offered by Alcor[9][10], the Cryonics Institute[11], OregonCryo[12], KrioRus[13]. The second graph has prices inflation adjusted in 2018 USD.

The raw data of those graphs are available in the Google Sheet Timeline of brain preservation: cost.

Historical cost of cryonics.png

Historical cost of cryonics, inflation adjusted.png

Big picture

Time period Development summary
1897-1961 Early cryobiology research starts, and reaches one of the first important success by cryopreserving human sperms by 1961.

During that time, the idea of cryonics is conceived by various people; presumably independently from each other. In 1901, Porfiry Ivanovich Bakhmetyev suggests using the phenomenon of anabiosis to prolong human life, to “travel to the future”. In 1931, Neil R. Jones writes a story about someone preserved in orbit due to the cold temperature. In 1948, Robert Ettinger publishes a story on suspended animation, which addresses various cryonics issues. In 1962, Evan Cooper publishes "Immortality: Physically, Scientifically, Now" and coins the slogan "freeze, wait, reanimate". In the same year, Ettinger privately publishes "The Prospect of Immortality" which would be pivotal for the growth of cryonics.

1960-1966 The first cryonics activists start grouping and developing the capabilities to perform cryopreservations. They have difficulty finding a first person interested in receiving the procedure.
1966-1975 Early cryonics organizations struggle to maintain their patients in liquid nitrogen. Out of 22 cryopreservations done during that period, only 3 would remain preserved to this day [2020].
1974-1990 The two cryonics organizations that have provided continuous service for the longest time and have the most members, Alcor and the Cryonics Institute, are created in 1976. They would slowly grow during the following years. The American Cryonics Society would have patients under its responsibility from 1974 up to this day [2020].
1991-2000 The Cryonics Institute preserves their third patient in 1991 – the first two being relatives from the founder, Robert Ettinger. Alcor and the Cryonics Institute start getting more members and patients.
2001-2018 Alcor starts using a vitrification solution in 2001, and the Cryonics Institute follows in 2004. In 2018, Mike Darwin reports, from CT scans he analyzed, that Alcor member Fred Chamberlain III, cryopreserved in 2012, was the first patient to demonstratively have their brain cryopreserved essentially ice-free. In 2015, 21st Century Medicine wins a prize from the Brain Preservation Foundation for having demonstrably preserved the connectome of a pig with a technique combining vitrification and fixation.

Full timeline

The events in the timeline are sometimes classified in the following categories, types and sub-types.

Categories:

Types:

  • General Progress:
    • Futurism, fiction
    • Science
    • Technological development (ie. engineering, research and development)
    • Technological adoption (ie. commercialization)
    • Quality assessment
  • Societal context:
    • Social
    • Legal
    • Risk management
  • Organization Progress

Sub-Types:

  • Science, technological development, technological assessment: nature, theory, cold, cryonics, cryoprotection, vitrification, toxicity, vitrifixation, field cryoprotection, fixation, intermediate storage temperature, fracturing
  • Social:
    • Event: festival, meeting, conference
    • Writing: newsletter, communication, textbook, journal, paper, open letter, email list, fiction, blog, writeup
    • Other: groups, bylaws
  • Legal: cryopreservation, life insurance, right-to-die, classification
  • Organization: founding, milestone, status
  • Risk management: natural catastrophes, economic stability

You can click on the header to sort the events by categories, types or subtypes.

Date Category Type Subtype Organisation or individual Event
1773-04 cryonics futurism Benjamin Franklin In a letter to Jacques Dubourg, Benjamin Franklin says: "I wish it were possible ...to invent a method of embalming drowned persons, in such a manner that they might be recalled to life at any period, however distant; for having a very ardent desire to see and observe the state of America a hundred years hence, I should prefer to an ordinary death, being immersed with a few friends in a cask of Madeira, until that time, then to be recalled to life by the solar warmth of my dear country! But ... in all probability, we live in a century too little advanced, and too near the infancy of science, to see such an art brought in our time to its perfection ...".[14]
1883-04-15 cryogenics technological development cold Jagiellonian University Nitrogen is liquefied by Zygmunt Wróblewski and Karol Olszewski.[15]
1897 cryobiology science Porfiry Ivanovich Bakhmetyev Porfiry Ivanovich Bakhmetyev starts studying the phenomena of anabiosis during overcooling of animals.
1901 cryonics futurism Porfiry Ivanovich Bakhmetyev In his essay “The Recipe for Survival to the 21st Century” (“Natural Science and Geography”, 1901), Porfiry Ivanovich Bakhmetyev suggests using the phenomenon of anabiosis to prolong human life, to “travel to the future”.[16]
1931-07 cryonics social fiction Robert Ettinger Robert Ettinger reads Neil R. Jones' newly published story, "The Jameson Satellite",[17], in which a professor has his corpse sent into earth orbit where it would remain preserved indefinitely at near absolute zero (note: this is not scientifically accurate), until millions of years later, when, with humanity extinct, a race of mechanical beings discovers, revives, and repairs him by transferring his brain in a mechanical body.[18]
1936 reanimatology organization founding Negovsky Negovsky founds the first resuscitation research laboratory in the world. In 1986 his laboratory would be renamed Institute of Reanimatology of the USSR (since 1991 of the Russian) Academy of Medical Sciences. This marks the inception of both reanimatology (resuscitation medicine) and critical care medicine both of which would be crucial to the credibility of cryonics paradigm.[19]
1938 cryobiology science vitrification Goetz, Goetz Alexander Goetz and S. Scott Goetz publish a paper discussing vitrification and crystallization of organic cells at low temperatures.
1940 cryobiology science Basil Luyet, Marie Pierre Gehino Basil Luyet and Marie Pierre Gehino publish "Life and Death at Low Temperatures", the book which marks the beginning of cryobiology as a formal area of study. In this landmark work, they document the survival of a wide variety of cells and some tissues after ultra-rapid cooling to -194.5°C providing that ice formation in the tissue is inhibited by vitrification due to the ultra-rapid cooling.[20]
1940s cryogenics technological development cold Liquid nitrogen becomes commercially available.[21]
1947 cryogenics social Polge, Smith, Parkes Robert Ettinger, while in the hospital for his battle wounds, discovers Jean Rostand research in cryogenics.[22]
1948 cryobiology technological development vitrification Polge, Smith, and Parkes discover the cryoprotective effects of glycerol and publish a paper documenting the successful hatching of chicks from fowl sperm cryopreserved with glycerol.[23]
1948-03 cryonics social fiction Robert Ettinger Robert Ettinger publishes the story The Penultimate Trump in the March 1948 issue of the magazine Startling Stories. This story was written in 1947. This is a suspended animation story where many of the questions and problems also common to cryonics are discussed.[24]
1950-05 cryobiology technological development vitrification Luyet, Gonzales Luyet and Gonzales achieve successful vitrification of chicken embryo hearts using ethylene glycol.[25]
1954-06 suspended animation science nature Smith et al. Smith et al., demonstrate the ability of golden hamsters to recover and survive long term following the freezing of ~60% of the water in their brains and the survival a full recovery of hamsters cooled to -5°C.[26][27] Related YouTube video: I promise this story about microwaves is interesting..
1959-05 cryobiology technological development vitrification Lovelock, Bishop Lovelock and Bishop discover the cryoprotective properties of dimethyl sulfoxide (Me2SO). Me2SO would subsequently become a mainstay of most experimental vitrification solutions used in organ preservation.[28]
1960 cryonics social communication Robert Ettinger Robert Ettinger expected other scientists to advocate for cryonics. Given that this still hasn't happened, Ettinger finally makes the scientific case for cryonics. He sends this to approximately 200 people whom he selected from Who's Who in America, but got little response.[17]
1960s cryonics organization founding Cryo-Care Equipment Corporation Cryo-Care Equipment Corporation[note 2] in Phoenix, Arizona is founded by Ed Hope. These freezings would be advertised as being for cosmetic purposes rather than eventual reanimation, though the cryonics issue would naturally arise.[note 3][2]
1961 cryobiology technological development cryoprotection Lovelock, Bishop By 1961 the work of Lovelock and Bishop is rapidly extended to other animal sperm, including human sperm, and glycerol is also shown to be an effective cryoprotectant for both red cells and many nucleated mammalian cells.[29]
1962 reanimatology science Vladimir A. Negovsky Vladimir A. Negovsky publishes his landmark book, "Resuscitation and Artificial Hypothermia".[30][19]
1962 cryonics social book Evan Cooper Evan Cooper publishes "Immortality: Physically, Scientifically, Now" under the pseudonym Nathan Duhring.[31] He coins the immortal "freeze, wait, reanimate" slogan.[32][33]
1962 cryonics futurism Robert Ettinger Ettinger privately publishes a preliminary version of The Prospect of Immortality, in which he makes the case for cryonics.[17]
1962 cryonics social meeting About 20 people attend the first informal cryonics meeting.[31]
1962 cryonics social group Evan Cooper After the first cryonics meeting, Cooper and a few other individuals form the Immortality Communication Exchange (ICE), an informal, "special-interest group" for the "freeze and wait" idea that would later be known as cryonics.[31]
1964 cryonics organization founding Life Extension Society During the conference, the Life Extension Society, the first cryonics organization, is founded by Evan Cooper. It would be situated in Washington, D.C.[33]
1963-12-29 cryonics social conference The first cryonics conference happens.[31][34]
1964 cryonics futurism Robert Ettinger Robert Ettinger's The Prospect of Immortality finally attracts the attention of a major publisher, Doubleday, which sends a copy to Isaac Asimov; Asimov says that the science behind cryonics is sound, so the book is published. The book becomes a selection of the Book of the Month Club and is published in nine languages. Ettinger becomes a media celebrity, discussed in many periodicals, television shows, and radio programs.[17]
1964-01 cryonics social newsletter Life Extension Society The first issue of the Life Extension Society Newsletter is published.[31][34]
1965 cryonics social Karl Werner Karl Werner coins the word "cryonics".[35]
1965 cryonics organization founding Cryonics Society of New York The Cryonics Society of New York (CSNY) is founded by Saul Kent, Curtis Henderson and Karl Werner. CSNY is a non-profit organization contracting with the for-profit organization Cryospan for cryonics freezing and storage.[35][36]
1965-03 cryobiology technological development cryoprotection James Farrant James Farrant shows that viable ice-free cryopreservation of a highly organized tissue is possible and that eliminating ice formation, even at -79 °C, eliminates virtually all of the extensive mechanical (histological) and ultrastructural disruption observed with conventional cryoprotection and freezing of complex tissues.[37]
1965-05-20 cryonics Life Extension Society Wilma Jean McLaughlin of Springfield, Ohio dies from heart and circulatory problems. Ev Cooper would fill a report the following day "The woman who almost became the first person frozen for a possible reanimation in the future died yesterday." The attempt to freeze her is abandoned. While reports on this event would vary, many would mention the lack of preparation, cooperation from various people, and explicit consent as obstacles to the freezing.[38]
1965-06 cryonics organization milestone Life Extension Society The Life Extension Society offers to freeze the first person for free: "The Life Extension Society now has primitive facilities for emergency short term freezing and storing our friend the large homeotherm (man). LES offers to freeze free of charge the first person desirous and in need of cryogenic suspension." No one would take them on their offer.[38]
1966 cryonics organization founding Immortalist Soceity The Cryonics Society of Michigan (later renamed the Cryonics Association, and then, in 1985, the Immortalist Society) is founded with Ettinger elected as its president.[39]
1966 cryonics organization founding Cryonics Society of California The Cryonics Society of California (CSC) is founded by Robert Nelson. CSC is a non-profit organization contracting with the for-profit organization Cryonic Interment for cryonics freezing and storage. Cryonics Interment would later be renamed General Fluidics by Robert Nelson and Marshal Neel.[2][39]
1966 cryobiology science fracturing Kroener and Luyet Kroener and Luyet observe fracturing in vitrified glycerol solutions.[40][41]
1966-04-22 cryonics milestone Cryo-Care Equipment Corporation An elderly woman (probably from Los Angeles – never identified) who has been embalmed for two months and maintained slightly above-freezing temperature is straight-frozen.[38] There is some thought of the cryonics premise of eventual reanimation, but within a year she would be thawed and buried by relatives.[42][43]
1966-10-15 cryonics science Adachi, et al. Recovery of brain electrical activity after freezing to −20 °C is demonstrated.[44]
1967-01-12 cryonics technological adoption cryonics Cryonics Society of California James Bedford is the first human to be cryopreserved.

The freezing is carried out by affiliates of the newly-formed Cryonics Society of California: Robert Prehoda, author and cryobiological researcher; Dante Brunol, physician and biophysicist; and Robert Nelson, President of the Society. Also assisting is Bedford's physician, Renault Able.

6 days later, relatives would move Bedford to the Cryo-Care facility in Phoenix. Later, his son would store him, and finally, on September 22, 1987, Bedford would be moved to Alcor.[38][5][45]

1968 cryonics organization status Cryo-Care Equipment Corporation Ed Hope closes Cryo-Care Equipment Corporation after seeing it wouldn't turn a profit. The remaining patients are turned over to other organizations or to relatives.[2]
1968 cryobiology technological development cryoprotection Dog kidneys are cryopreserved using Farrant's technique resulting in no ice formation and with excellent structural preservation, and the ability to tolerate reperfusion with blood in the animal without immediate failure.[46]
1968-02 reanimatology science Ames, et al. Ames, et al., discover the cerebral no-re-flow phenomenon which prevents adequate reperfusion of the brain after ~10 minutes of global cerebral ischemia and identifies this as the likely cause of failure to achieve brain resuscitation after 6-10 minutes of normothermic ischemia rather than the acute death of brain cells as the supposed cause.[47]
1969 cryonics social magazine Immortalist Soceity The Cryonics Society of Michigan publishes the first issue of the Long Life magazine, which is still published to this day [2020].[48]
1969 cryonics organization founding American Cryonics Society The Bay Area Cryonics Society is founded by two physicians, the prominent allergist and editor of Annals of Allergy, Dr. M. Coleman Harris, and Dr. Grace Talbot, alongside with 5 other founders, including Jerry White and Edgar Swank, both of which are now cryopreserved under the ACS program.[49] The organization would be renamed to the American Cryonics Society in 1985.[35][50][51]
1969 cryonics social Evan Cooper Cooper ends his involvement in cryonics. He feels overloaded and burned-out, and thinks cryonics is not going to be a viable option for himself for practical (political, social, economic) reasons and that he is not going to spend the time he had left trying to obtain the impossible. He is also concerned with the commercial and political aspects within cryonics.[32]
1969-04-11 cryonics futurism Jerome White Jerome White, one of the founders of the Bay Area Cryonics Society, proposes the use of specially engineered viruses to effect repair of cells that are damaged by freezing and compromised by aging.[52]
1970 cryonics science Hossmann, Sato Hossmann and Sato demonstrate that, contrary to decades of biomedical dogma, it is possible to restore robust electrical activity and demonstrate evoked potentials in cat brains that had been subjected to 1 hour of normothermic ischemia. This marks the beginning of the debunking of 3-6 minute limit on brain viability under conditions of normothermic ischemia. It also shows that brain cells do not undergo autolysis after ~10 minutes of normothermic ischemia, a view that was commonly held by both many physicians and neurologists prior to this time.[53]
1970 cryonics organization founding Cryonics Society of America The Cryonics Society of America (CSA) is incorporated.

The purpose of the CSA is to establish “standards and practices” of operations for all of the cryonics societies, to mandate validation of human freezing by requiring the submission of photographic proof along with a death certificate, and a description of the procedure used and the location where the patient was being stored (essentially establishing a registry of cryonics patients). It is also created to allow for the creation of a Scientific Advisory Board which would, in fact, formed in March of 1968. CSA itself never got off the ground due to noncompliance with the "standards and practices" by the Cryonics Society of California.[54]

1970-05-15 cryonics organization status Cryonics Society of California Nelson moves the 4 patients from the Cryonics Society of California into an underground vault he recently had designed and built under the aegis of Cryonics Interment. The vault is located in Oakwood Cemetery in Chatsworth, Los Angeles.[2]
1970-05-22 cryobiology science theory Peter Mazur Peter Mazur publishes his “two-factor theory” elucidating the basic mechanisms of freezing damage to living cells: solution effects injury and/or intracellular freezing. This insight facilitates a more rational design of freezing and thawing protocols allowing the development of freezing techniques for animal embryos.[55]
1971 resuscitation science Hossmann Hossmann demonstrates the possible recovery of the cat brain after complete ischemia for 1 hour. The field of cerebral resuscitation is born.[56]
1971 cryonics futurism Martin Cryonics by neuropreservation is proposed.[57]
1971-08 cryonics social journal Manrise Technical Review Fred and Linda Chamberlain begin publishing a bi-monthly technical journal, Manrise Technical Review and in 1972 they publish the first comprehensive technical manual of human cryopreservation procedures. This marks the beginning of a biomedically informed and rigorously scientific approach to cryonics. In this manual, the Chamberlains suggest application of the Farrant technique to cryonics patients.[58]
1971 (end of) - 1979-04 cryonics organization status Cryonics Society of California 9 patients are thawed by the Cryonics Society of California. This would become known as the Chatsworth Scandal because the patients were stored in an underground vault at a cemetery in Chatsworth.[2]
1972 cryonics technological adoption Trans Time A collaborative working group led by Trans Time President Art Quaife and consisting of Gregory Fahy, Peter Gouras, M.D., Fred, and Linda Chamberlain and Mike Darwin begin working on a standardized protocol for the cryoprotection of cryonics patients. Quaife publishes the first results of this effort, a modification of Collins’ organ preservation solution for use as the carrier solution for Me2SO during cryoprotective perfusion. This marks the first attempt at creating a standardized, science-based human cryopreservation protocol.[59]
1972 cryonics organization founding Trans Time Trans Time, Inc., (TT) a cryonics service provider, is founded by Art Quaife, along with John Day and other cryonicists. It is a for-profit organization. It's initially a perfusion service-provider for the Bay Area Cryonics Society. They buy the perfusion equipment from Manrise Corporation.[35] They would be the first to undertake the effort of clarifying legal issues around cryonics, and to actively market cryonics.[35] The name "Trans Time" is inspired by Trans World Airlines, a prominent airline.[60][61]
1972 cryonics social book Robert Ettinger Robert Ettinger publishes Man Into Superman. The book expands on the implications and possibilities of cryonics from his previous book, "The Prospect of Immortality".[62]
1972 cryonics Mike Darwin Mike Darwin is the first full-time cryonics researcher. He would work at Alcor for a year.[63]
1972-01-12 suspended animation technological adoption Klebanoff Klebanoff reports survival of the first human after blood washout and induction of profound hypothermia with full recovery of health and normal mentation, Air Force Seargent Tor Olsen who, as of 2018, would still be alive and well.[64]
1972-02-23 cryonics organization founding Alcor Life Extension Foundation The Alcor Life Extension Foundation, a cryonics service provider, is founded by Fred and Linda Chamberlain in the State of California. The organization is named after a star in the Big Dipper used in ancient times as a test of visual acuity. It would serve as a response team for the Cryonics Society of California. Alcor is initially incorporated as the Alcor Society for Solid State Hypothermia, but would change its name to the "Alcor Life Extension Foundation" in 1977.[35][65]
1973-08 cryobiology technological development cryoprotection, re-warming Hamilton, Lehr Hamilton and Lehr demonstrate successful preservation of canine small intestine allografts using Me2SO as the cryoprotectant, and cooling and warming using vascular perfusion with helium gas suggesting that even controlled cooling and emptying of the vasculature's fluid/ice are beneficial in organ freezing. The organ is successfully transplanted.[66][67]
1973-03 cryonics science Cryonics Society of New York Fahy and Darwin publish the first technical case report documenting the procedures, problems, and responses of a human patient (Clara Dostal) to cryoprotective perfusion and freezing. The report is severely critical of the way cryonics patients are being treated and suggests many reform and improvements.[68]
1974 cryonics organization status Trans Time Due to the closure of the storage facility in New York, the Bay Area Cryonics Society and the Alcor Life Extension Foundation change their plan to preserve their patients to the Trans Time facility instead of the New York one, and would do so until the 1980s.[35] In February 1974, 2 patients are accepted by the Bay Area Cryonics Society as anatomical donations and kept by Trans Time.
1974 cryonics science Suda, et al. Partial recovery of brain electrical activity after 7 years of frozen storage is demonstrated.[69]
1974 cryonics organization status Cryonics Society of New York Curtis Henderson, who has been maintaining three cryonics patients for the Cryonics Society of New York, is told by the New York Department of Public Health that he must close down his cryonics facility. The three cryonics patients are returned to their families, and would later be thawed.[35]
1974[note 4] cryonics organization milestone American Cryonics Society John Day, Jerry White, Art Quaife and Jim Yount freeze and place into liquid nitrogen a dog from a member of the Bay Area Cryonics Society. This is the first companion animal to be cryopreserved.[70]
1975-07 suspended animation technological development Gerald Klebanoff Gerald Klebanoff demonstrates the recovery of dogs from total blood washout and profound hypothermia with no neurological deficit using a defined asanguineous solution. Klebanoff documents the critical importance of adequate amounts of colloid in the perfusate to prevent death from pulmonary edema.[71]
1976 cryonics technological development Alcor Life Extension Foundation Manrise Corporation provides initial funding to Alcor for cryonics research.
1976-04-28 cryonics organization founding Cryonics Institute Cryonics Institute is founded by the directors of the Cryonics Association[72], and starts offering cryonics services: preparation, cooling, and long term storage.[73]
1976-07-16 cryonics technological adoption Alcor Life Extension Foundation Alcor carries out the first human cryopreservation where cardiopulmonary support is initiated immediately post pronouncement and is continued until the patient is cooled to 15°C (~400 minutes) and where a scientifically designed custom perfusion machine with heat exchanger was used to carry out cryoprotective perfusion (as opposed to an embalming pump) with control over flow, pressure and temperature and incorporating a bubble trap was used. This is also the first neurocryopreservation (head only) patient. The patient was the father of Fred Chamberlain, the co-founder of the organization.[74][63]
1977 cryonics organization founding Institute for Advanced Biological Studies The Institute for Advanced Biological Studies (IABS) is incorporated by Steve Bridge. IABS is a nonprofit research startup.[75]
1977 cryonics organization founding Soma, Inc. Soma, Inc. is incorporated. Soma is intended as a for-profit organization to provide cryopreservation and human storage services. Its president is Mike Darwin.
1977 cryonics organization milestone Cryonics Institute The Cryonics Institute preserves its first patient, Rhea Ettinger. She would be preserved in dry ice for 10 years, and then switch to liquid nitrogen.
1977(?) - 1986 cryonics social festival Life Extension Festival The Life Extension Festival is run by Fred and Linda Chamberlain.[76]
1977-07 cryonics futurism Mike Darwin Darwin is the first to conceive of the idea of an autonomous, bioengineered cell repair and replacement device to reverse cryo-injury and aging, which he called the “anabolocyte”.[77]
1978 cryonics organization founding Cryovita Laboratories Cryovita Laboratories is founded by Jerry Leaf[78], who had been teaching surgery at the University of California, Los Angeles. Cryovita is a for-profit organization which would provide cryopreservation services for Alcor and Trans Time in the 1980s.[35]
1978-07 cryonics technological adoption Cryovita Laboratories Jerry Leaf of Cryovita Laboratories introduces the principles and equipment of extracorporeal medicine into cryonics with the cryopreservation of Samuel Berkowitz. This included the use of the heart-lung machine, closed-circuit perfusion, 40µ arterial filtration, and sterile technique and Universal Precautions to protect the staff caring for the patient:[79]
1979 cryonics milestone Institute for Advanced Biological Studies The Institute for Advanced Biological Studies (IABS) puts Mitzi into cryopreservation, the first companion animal to receive the procedure. Alcor would later store the animal starting in 1982.
1980 cryonics technological development Leaf, et al. Leaf et al., carry out the first closed circuit perfusions with stepped increases in cryoprotectant concentration under well-controlled conditions with physiological and biochemical monitoring of the patients in real-time. This is also the first case where remote standby and stabilization using continuous heart-lung resuscitator support is carried out.[80]
1980 cryonics organization founding Life Extension Foundation The Life Extension Foundation (LEF) is founded. It would later help fund various cryonics organizations, notably Alcor, 21st Century Medicine, Critical Care Research, and Suspended Animation, Inc.[35]
1980 cryonics organization founding Institute for Cryobiological Extension The Institute for Cryobiological Extension is founded, and would soon publish its first volume of ICE Proceedings.
1981 cryonics futurism K. Eric Drexler The first paper suggesting that nanotechnology could reverse freezing injury is published.[81]
1981 cryonics organization status Cryovita Laboratories Soma, Inc. merges with Cryovita Laboratories.
1981-03 cryonics social journal Darwin, Bridge Michael Darwin and Stephen Bridge begin publication of the monthly magazine Cryonics which, for the next 10 years, would be the principal vehicle for publication of technical and scientific papers in cryonics.[82]
1982 cryobiology science toxicity Fahy, et al. Fahy, et al., publish papers which extensively documents the role of cryoprotectant toxicity as a barrier to tissue and organ cryopreservation suggest possible molecular mechanisms.[83][84]
1982 cryonics organization milestone Alcor Life Extension Foundation Alcor begins storing its own patients. It was previously storing its patients with Trans Time, Inc.
1982 cryonics organization status Alcor Life Extension Foundation The Institute for Advanced Biological Studies merges with Alcor.
1982-09-15 cryonics social bylaws Society for Cryobiology The Society for Cryobiology adopts new bylaws denying membership to organizations or individuals supporting cryonics.[85][86]
1983-01 cryonics technological development Darwin, et al. Darwin, et al. carry out an extensive study to evaluate the efficacy of a human cryopreservation protocol on whole mammals (rabbits). This research discloses extensive ultrastructural disruption of the brain even when freezing in the presence of 3 M glycerol is employed. This work also documents the extremely adverse effects of prolonged cold ischemia on cryoprotective perfusion.[87][88][89][90][91][92][93][94]
1983 cryonics organization status Institute for Cryobiological Extension Leaf changes hats to President of the Institute for Cryobiological Extension (ICE) with the intention to devise a new project with the goal of having animal heads frozen, thawed, and reattached to a new body in such a way that would allow for neurocognitive evaluation. The project would later be deemed impractical. [95]
1984 cryonics science Darwin, et al. Darwin et al. publish the first paper documenting the effects of cryopreservation protocols on human patients. This paper documents the presence of extensive macro-tissue fracturing in all three patients examined and shows relatively good histological preservation in the patient treated with 3 M glycerol.[96]
1984 suspended animation technological development Leaf, Darwin, Hixon Leaf, Darwin and Hixon complete 3-years of research demonstrating successful 4-hour asanguineous perfusion of dogs at 5°C with full recovery of health, mentation, and long term memory. The paper documenting this work is rejected by the Society for Cryobiology because the work was conducted by cryonicists. The perfusate developed during this research, MHP-2 continues to be used for total body washout through the present.[97]
1984 cryobiology science cryoprotection Fahy, et al. The first paper showing that large organs can be cryopreserved without structural damage from ice is published.[98]
1984 cryonics science fracturing Alcor Life Extension Foundation Alcor observes fractures in human cryopreservation patients. [40][99]
1985 cryonics technological adoption remote stabilization Federowicz, et al. For the first time, a cryonics patient is given remote standby with in-field total body washout. Cardiopulmonary support (CPS) is initiated within 2 minutes following monitored cardiac arrest. This is also the first case where anesthesia is used to inhibit consciousness during cardiopulmonary arrest (CPA) and external cooling.[100][101][102]
1985 cryobiology technological development vitrification Fahy, Rall Fahy and Rall successfully apply vitrification to embryo preservation introducing the technique to mainstream medicine and highlighting its potential utility in solid organ cryopreservation.[103]
1980s (mid) cryonics legal life insurance Jackson National Jackson National is the first life insurance company to definitively state that it acknowledges that cryonics arrangements constitute a legitimate insurable interest.[104]
1980s (mid) cryobiology technological adoption vitrification Greg Fahy and William F. Rall Researchers Greg Fahy and William F. Rall help introduce vitrification to reproductive cryopreservation.
1986 cryonics social textbook Mike Darwin M. Darwin publishes the first textbook on acute stabilization of human cryopreservation patients.[105]
1986 cryobiology science vitrification Greg Fahy Greg Fahy proposes vitrification as a mean of achieving viable parenchymatous organ preservation.[106]
1986 cryonics futurism K. Eric Drexler K. Eric Drexler publishes Engines of Creation[107] -- the first book on molecular nanotechnology --. The book has a chapter on cryonics. It creates a surge in growth in cryonics interest and membership.
1986 suspended animation science Haneda, et al. The first paper showing that large mammals can be recovered after three hours of total circulatory arrest (“clinical death”) at +3°C (37°F) is published. This supports the reversibility of the hypothermic phase of cryonics.[108]
1986 cryonics organization milestone Alcor Life Extension Foundation Alcor cryopreserves a member's companion animal for the first time.
1986 cryonics futurism K. Eric Drexler Aldehyde-stabilized cryopreservation is proposed under the name of "fixation and vitrification".[109]
1987 cryonics organization founding Cryonics Society of Canada Douglas Quinn launches the Cryonics Society of Canada and Canadian Cryonics News.[110]
1987 cryonics technological adoption cold Cryonics Institute The Cryonics Institute starts using liquid nitrogen instead of dry ice.[35]
1987-06 cryonics technological development extracorporeal membrane oxygenation Leaf, Darwin, Hixon Leaf, Darwin, and Hixon develop a mobile extracorporeal membrane oxygenation (ECMO) cart which is capable of providing acute, in-field extracorporeal life support and cooling providing the first truly adequate method of maintaining viability and achieving rapid induction of hypothermia in cryonics patients.[111][112]
1987-06-08 cryonics technological adoption extracorporeal membrane oxygenation Mike Darwin The first use of extracorporeal membrane oxygenation (ECMO) support on a cryonics patient.[113]
1987-12 cryonics legal cryopreservation Alcor Life Extension Foundation Saul Kent brings his terminally ill mother (Dora Kent) into the Alcor facility where she deanimates. Her head would be cryopreserved.

The rest of the body would be given to a coroner. The coroner's office wouldn't understand that circulation would be artificially restarted after legal death, and that barbiturate would be given to slow down the brain metabolism. Seeing the distributed barbiturate throughout the body, they would change the cause of death from natural causes to homicide.

In January 1988, Alcor would be raided by coroner's deputies, a SWAT team, and UCLA police. The Alcor staff would be taken to the police station in handcuffs and the Alcor facility would be ransacked, with computers and records being seized. The coroner's office would want to seize Dora Kent's head for autopsy, but the head would be removed from the Alcor facility and taken to a location that would never be disclosed. Alcor would later sue for false arrest and for illegal seizures, and would win both cases.[35][114]

1988 cryonics social email list Cryonet The Cryonet email list starts.[115]
1988 cryonics legal cryopreservation Dick Clair Alcor member Dick Clair – who is dying of AIDS – sues for, and ultimately wins for everyone, the right to be cryopreserved in the State of California.[35][116]
1989 cryonics technological development cooling rate Mike Darwin M. Darwin creates the portable ice bath (PIB) to substantially increase the efficacy of external cooling with Fred Chamberlain subsequently developing a surface convective cooling device to further improve heat exchange doubling the rate of cooling during external cooling for induction of hypothermia.[117]
1989 cryonics technological adoption Mike Darwin M. Darwin introduces high impulse cardiopulmonary resuscitation (CPR) improving cardiac output during cardiopulmonary support (CPS).[118]
1989-02 cryonics social textbook Wowk, Darwin Wowk and Darwin author the first comprehensive textbook on cryonics, "Cryonics: Reaching for Tomorrow", designed for use in recruiting new members to Alcor. It would be published in 1991.[119]
1990 cryonics technological development pre-medication Mike Darwin M. Darwin publishes the first pre-medication protocol to minimize ischemia-reperfusion injury in cryonics patients.[120]
1990 cryonics quality assessment Mike Darwin M. Darwin introduces end-tidal CO2 monitoring to cryonics and sets out a comprehensive set of guidelines for determining the efficacy of in-field cardiopulmonary support.[121]
1990 cryonics legal right-to-die Thomas K. Donaldson Thomas K. Donaldson, after being diagnosed with terminal brain cancer, petitions the California courts, seeking a declaration that he has a constitutional right to achieve cryonic suspension before his natural death. Donaldson and his doctors build their argument in light of the recent right-to-die legislation where patients could have life-sustaining medical treatment withdrawn. The trial court would dismiss the complaint for failure to state a cause of action, and Donaldson would then appeal. The court holds that he does not have a constitutional right to assisted death because the cryonic process would necessarily involve physician-assisted death, or the aiding, advising, or encouraging of another to commit suicide.[122]
1990 cryobiology science intermediate storage temperature Greg Fahy Fahy publishes a detailed study of fracturing in large volumes of vitrification solution.[40][123]
1990 cryonics organization status Trygve Bauge Trygve Bauge, a member of the American Cryonics Society, brings his deceased grandfather from Norvegia to the United States.

He would store his body at Trans Time from 1990 to 1993.

Bauge would then transport his grandfather to Nederland, Colorado in dry ice with the intention of starting his own cryonics company.

After media turmoil, the town would outlaw cryonics, but would "grandfather the grandfather" who would remain there on dry ice.[35]

1990-06 cryonics technological adoption remote stabilization Alcor Life Extension Foundation Alcor patient A-1239 receives a field cryoprotection with glycerol in Australia before being transported on dry ice to Alcor.[124]
1990-06 cryonics VSED Alcor Arlene Fried does voluntary stopping of eating and drinking (VSED) for approximately 12 days[125], until clinical death would occur, in order to hasten her cryopreservation, hence reducing damages caused by her cancer which had metastasized to the brain.[126][note 5]
1990-06-09 cryonics quality assessment Alcor First evaluation of viability in a cryonics patient using Na+/K+ ratio in the renal cortex demonstrating good tissue viability following application of the Alcor Transport Protocol, including rapid post-arrest in-field washout and rapid air transport of the patient to the cryoprotective perfusion facility.[127]
1990-10 cryobiology technological development re-warming Ruggera, Fahy Ruggera and Fahy demonstrate uniform radio frequency re-warming of a vitrified solution in volumes comparable to those of the rabbit kidney without thermal runaway and at rates of re-warming sufficient to inhibit devitrification in their model system.[128]
1990-10 cryobiology science vitrification Fahy, et al. Fahy, et al., publish the first paper documenting the behavior of large volumes of vitrification solution with respect to fracture temperature, thermal gradient, cooling rate, ice nucleation and crystal growth as a preliminary step to avoid fracturing in vitrified organs and tissues and to prevent devitrification during re-warming.[123]
1992 cryonics futurism R. C. Merkle The application of nanotechnology to reverse human cryopreservation is discussed in a paper for the first time.[129]
1982 cryonics organization milestone Alcor Life Extension Foundation Alcor starts providing its own cryopreservation as well as patient-storage services.
1992-02 cryonics technological adoption extracorporeal membrane oxygenation HK Henson The first application of extracorporeal membrane oxygenation ECMO in the patient’s home followed by ~8 hours of continuous ECMO support prior to perfusion.[130]
1993 cryonics organization founding 21st Century Medicine 21st Century Medicine, a cryogenics and cryonics research organization, is founded.[131]
1993 cryonics organization founding CryoCare The CryoCare Foundation is founded. It would provide human cryopreservation with assistance from two separate businesses: BioPreservation, which would provide remote standby, stabilization, and transport, and CryoSpan, which would provide the long-term storage of patients in liquid-nitrogen. About 50 former Alcor members join in the founding of the organization.[63][132]
1993-03 cryonics technological development intermediate storage temperature CryoNet Through the CryoNet email list, collaborative effort is put into designing a room to preserve up to 100 people at −130 ºC.[40]
1994 cryonics technological development intermediate storage temperature Alcor Life Extension Foundation Alcor observes fractures in the brain of a patient following removal from cryopreservation. Alcor thinks of intermediate temperature storage systems, and the development of a new acoustic fracturing monitoring device, the "crackphone."[40][133]
1994 cryonics technological development intermediate storage temperature Timeship Architect Stephen Valentine begins studying Cold Room intermediate temperature storage design concepts as part of a large cryonics facility design that would eventually be called Timeship.[40]
1994-02 cryonics risk management natural catastrophes, legal environment Alcor Life Extension Foundation Alcor moves to Scottsdale, Arizona, with all its patients.[35][134]
1995 cryonics technological adoption cryoprotection Alcor, Biopreservation Both Alcor and Biopreservation begin using high morality glycerol (7.5 to 8. M) as their cryoprotective strategy.[135]
1995 cryonics technological adoption pre-medication Mike Darwin Darwin et al., document the first use of a premedication protocol to mitigate ischemia-reperfusion injury in a cryonics patient.[136]
1995-05-31 cryobiology science cryoprotection Mike Darwin Darwin, et al., demonstrate much improved ultrastructural preservation in the dog brain and preservation of vascular integrity after perfusion with 7.5 M glycerol and freezing to -100 °C.[137][138]
1997 cryonics technological adoption intermediate storage temperature Alcor Life Extension Foundation Alcor brings the crackphone (an acoustic fracturing monitoring device) into clinical use.[40] The Alcor crackphone has never been tested or validated in any animal or human model, nor in bulk cryoprotective agents solutions cooled to deep subzero temperatures.
1997 cryonics risk management economic stability Alcor Life Extension Foundation After a substantial effort led by then-president Steve Bridge, Alcor forms the Patient Care Trust as an entirely separate entity to manage and protect the funding for cryonics patients.
1998 cryonics technological development cooling rate Darwin, Harris, Russell Darwin, Harris, and Russell invent liquid assisted pulmonary cooling allowing for rapid, non-invasive cooling of dogs at a rate of 0.5 °C per minute.[139][140]
1999 cryonics organization status CryoCare BioPreservation doesn't renew its contract with CryoCare, and stops offering cryonics services altogether.[35] CryoCare doesn't find a new provider.[35] They would transfer their 10 patients from the American Cryonics Society to the Cryonics Institute on 2004-04-06, and their 2 other patients to Alcor on 2001-01-24.[5][63][132]
2000-03 cryobiology science vitrification Song, et al. The application of vitrification to a relatively large tissue of medical interest, vascular grafts, is successful for the first time.[141]
2000 cryonics technological adoption intermediate storage temperature Alcor Life Extension Foundation Alcor acquires a −130 ºC Harris CryoStar laboratory freezer from GS Laboratory Equipment and begins testing its utility for possible storage of neuropatients.[40][142]
2000 cryonics organization founding Critical Care Research Critical Care Research, a research organization on critical care medicine, is founded.[143]
2000-07-15 cryobiology technological development vitrification Fahy, Kheirabadi Fahy and Kheirabadi achieve permanent life support after perfusion of rabbit kidneys with 7.5 M a vitrification solution demonstrating for the first time that concentrations of cryoprotectant compatible with vitrification are tolerable without the loss of renal viability.[144]
2001 cryonics technological adoption vitrification Alcor Life Extension Foundation Alcor switches from glycerol (which was reducing ice formation, but not vitrifying the brain) to a proprietary mixture of cryoprotectants called B2C developed by 21st Century Medicine designed to eliminate ice formation completely, ideally achieving vitrification of the entire brain.[145][35][146]
2002 cryonics science For the first time, a paper shows a rigorous demonstration of memory retention after cooling to +10°C (59°F): "Learning and memory is preserved after induced asanguineous hyperkalemic hypothermic arrest in a swine model of traumatic exsanguination".[147]
2002 cryonics technological development intermediate storage temperature Timeship Project Physicist Brian Wowk and Brookhaven National Laboratory cryogenic engineer Mike Iarocci start collaborating with architect Stephen Valentine to design intermediate temperature storage systems suitable for cryonics in connection with the Timeship Project.[40]
2002 cryonics organization founding Suspended Animation, Inc Suspended Animation, Inc, a for-profit organization that provides cryonics standby, stabilization, and transport services, is founded.[148]
2002 cryonics legal classification Alcor Life Extension Foundation Alcor cryopreserves baseball legend Ted Williams.

Following more media turmoil[note 6], Arizona state representative Bob Stump would attempt to put Alcor under the control of the Funeral Board. The Arizona Funeral Board Director would tell the New York Times "These companies need to be regulated or deregulated out of business". After a hard fight by Alcor, the legislation would finally be withdrawn in 2004. Alcor would hire a full-time lobbyist to watch after their interests in the Arizona legislature.[35]

2002 cryonics social event Frozen Dead Guy Days festival After media turmoil from Trygve Bauge having brought his cryopreserved grandfather to the town of Nederland, Colorado, some people take this opportunity to create an annual Frozen Dead Guy Days festival which would feature coffin races, snow sculptures, and many other activities.

Many cryonicists insist that dry ice is not cold enough for long-term cryopreservation and that the Nederland festival is negative publicity for cryonics.[35]

2002 summer cryonics technological adoption intermediate storage temperature Alcor Life Extension Foundation An Alcor neuropatient receives an excellent uniform perfusion, allowing them to reach the lowest temperature without fracturing ever recorded to date, −128 °C. Cryobiologist consultants would evaluate that this may be the best cryopreservation to date. The patient is transferred to the CryoStar freezer for continued slow cooling and annealing for fracture avoidance. However, the patient would be moved to liquid nitrogen in July 2003 as the maneuver wouldn't be successful. In December, another patient, A-1034, would be also placed into the CryoStar to accommodate the family's preference for this type of storage, and later transferred in a newly validated neuropod in April 2006.[40]
2002-12-13 cryonics social newsletter Alcor Life Extension Foundation The first issue of Alcor News, an online newsletter, is distributed.[149]
2003 cryonics procedure Alcor Life Extension Foundation There is continued work to create a new patient care bay, operating room, and laboratory area. A truck is purchased for conversion as an ambulance that would be large enough to permit surgical procedures. Alcor makes radical changes to its medications to conform with results of resuscitation research.

The research upon which this change in the stabilization medication protocol is based was conducted by Darwin, et al., at 21st Century Medicine from 1995 to 1998. This research was successful in recovering dogs from 16 minutes of normothermic ischemia with 75% of the animals showing no defects in mentation and memory. This research was never published, but a video presentation was made.[150]

2003-06 cryonics technological adoption intermediate storage temperature Alcor Life Extension Foundation Brian Wowk, Mike Iarocci, and Stephen Valentine present new designs for intermediate temperature storage systems to the Alcor board of directors. Alcor acquires an experimental single-patient "neuropod" intermediate temperature storage system developed by Brian Wowk at 21CM.[40]
2003-08 cryobiology tTechnological development intermediate storage temperature Carnegie Mellon University Carnegie Mellon University receives a million grant from the U.S. government to study fracturing during vitrification of tissue for medical applications, which would considerably advance the field.[40]
2003-10 cryonics technological development intermediate storage temperature 21st Century Medicine 21st Century Medicine, Inc., constructs a prototype dewar for storage at intermediate temperature in which most of the volume of the dewar is converted into a uniform-temperature storage space kept cold by liquid nitrogen.[40]
2004 cryobiology science vitrification Fahy, et al. Fahy, et al., make a major advance in understanding the nature of vitrification cryoprotectant toxicity, and significant advances in moderating it. Fahy, et al., develop several highly stable vitrification solutions using synthetic ice blockers which also have extremely low toxicity. It is possible to perfuse kidneys with 9+ molar vitrification solution (~60%) without loss of viability.[151]
2004 cryonics legal classification Cryonics Institute As a result of media coverage of Ted Williams's cryopreservation, even though the Cryonics Institute was not involved in that case, the State of Michigan places the organization under a "Cease and Desist" order for six months, ultimately classifying and regulating the Cryonics Institute as a cemetery in 2004. In the spirit of de-regulation, the new Republican Michigan government would remove the cemetery designation for CI in 2012.[35]
2004-08 cryonics technological adoption vitrification Cryonics Institute The Cryonics Institute uses a cryoprotectant, CI-VM-1, for the first time. The dog of a CI member is the patient of the experimental perfusion. The mixture was developed by CI staff cryobiologist Yuri Pichugin.[22]
2004-10-23 cryonics technological adoption remote stabilization Suspended Animation, Inc Suspended Animation, Inc performs a field cryoprotection with glycerol for the American Cryonics Society before transporting the patient on dry ice to the Cryonics Institute for long-term care.[124]
2005 cryonics science theory Whetstine, et al. Cryonics is discussed in a major medical journal for the first time. It addresses the definition of death in the intensive care unit context.[152]
2005 cryonics organization founding Oregon Cryonics Oregon Cryonics is established as a Non-Profit Mutual Benefit Corporation.[153]
2005-06 cryonics organization founding KrioRus KrioRus is founded by 8 Russian cryonicists, and 4 of them serve as Directors – Danila Medvedev, Valerija Pride, Igor Artyuhov, and Alexey Potapov.
2005 (mid) cryonics organization founding Neural Archives Foundation The Neural Archives Foundation is conceived. The organization offers brain preservation services, but only do straight freezes (ie. without perfusion). In 2008 it would be incorporated.[154]
2005-08 cryonics technological adoption vitrification Cryonics Institute CI's 69th patient is CI's first patient to be vitrified. It receives a vitrification solution named CI-VM-1.[22]
2005-10 cryonics technological adoption vitrification Alcor Life Extension Foundation Alcor starts using a vitrification solution called M22, a cryoprotectant licensed from 21st Century Medicine.[155][156]
2006-04-01 cryobiology science vitrification Pichugin, et al. Pichugin, et al., demonstrate the conservation of both viability and excellent histological and ultrastructural preservation in the rabbit brain hippocampal brain slice subjected to vitrification as well as proving the vast superiority of vitrification over freezing in preserving viability and tissue architecture in rabbit brain slices.[157]
2006-01 cryonics technological adoption intermediate storage temperature Alcor Life Extension Foundation An Alcor neuropatient cryopreserved with M22 vitrification solution sets a new record for lowest temperature reached without fracturing of −134 °C.[40]
2008 cryonics social paper Ben Best A review of scientific justifications of cryonics is published.[158]
2008 cryonics organization founding Advanced Neural Biosciences Advanced Neural Biosciences, Inc., is founded by Aschwin de Wolf. The organization mainly aims to improve brain preservations. The laboratory would receive funding from the Immortalist Society, the Life Extension Foundation, the Cryonics Institute, the Alcor Life Extension Foundation, as well as various individuals.[159][160]
2008 cryonics organization milestone Neural Archives Foundation Neural Archives Foundation preserves its first human patient.[154]
2008-12-12 cryonics social blog LessWrong Robin Hanson, talking about Eliezer Yudkowsky and himself, writes We Agree: Get Froze. Eliezer Yudkowsky would go on writing various articles about cryonics, which would spawn a lot of interest in the topic by people in the LessWrong community – in 2013, 13% of "experienced" respondents to a LessWrong survey (that were part of the community for over two years and had over 1000 karma) reported being signed up for cryonics.[161]
2009 cryonics science vitrification Fahy, et al. A vital mammalian organ is successfully vitrified, transplanted, and reused for the first time.[162]
2009-05 brain preservation organization founding Brain Preservation Foundation The Brain Preservation Foundation is founded by Kenneth Hayworth and John Smart with the goal of furthering research in whole brain preservation.[163]
2010 cryonics organization standby Cryonics Institute The Cryonics Institute starts offering, through Suspended Animation, Inc, standby and transport options.[164]
2010 cryonics social event Annual Young Cryonicists Gathering The first edition of the Annual Young Cryonicists Gathering, Teens & Twenties. This event is founded by the Life Extension Foundation in perpetuity.[165]
2010-05 cryobiology technological development cryoprotection Wowk, et al. Creation of first synthetic ice blockers and their application to organ and tissue preservation to radically increase the stability of vitrification solutions.[166]
2010-05 brain preservation organization milestone Brain Preservation Foundation Saar Wilf donates ,0 to the Brain Preservation Foundation, which then launches its large and small mammal brain preservation prizes, which would be given to the first groups that could reliably preserve the synaptic structure of the brain.[163]
2010-07 cryobiology technological development toxicity Fahy, et al. Fahy, et al., make significant advances in neutralizing cryoprotectant toxicity.[167]
2011 cryonics technological development intermediate storage temperature Wowk Brian Wowk develops a passive, non-mechanical, “fail-safe” system for intermediate temperature storage in order to reduce or eliminate fracturing in vitrified tissues, organs, and patients.[40]
2011 cryonics quality assessment scan Alcor Alcor initiates CT scanning of neuropatients after discovering that CT examination reveals regional differences in cryoprotectant concentration in the brain and other soft tissues of patients.[168][169]
2011 cryonics organization milestone Cryonics Institute Robert Ettinger is cryopreserved at the age of 92.[35][170]
2011-01 cryonics technological adoption remote stabilization Cryonics Institute The Cryonics Institute ships its vitrification solution (CI-VM-1) to the United Kingdom so that European cryonics patients could be vitrified before shipping in dry ice to the United States.[35]
2012 brain preservation organization milestone Brain Preservation Foundation Shawn Mikula at the Winfred Denk lab in Germany uses plastic embedding to preserve mouse brains, and submits his results for the Small Mammal Brain Preservation Prize. But the preservation quality is not complete.[163]
2012 brain preservation organization milestone Brain Preservation Foundation Greg Fahy at 21st Century Medicine (21CM) uses cryobiological techniques to preserve mouse brains, and submits his results for the Small Mammal Brain Preservation Prize. The Brain Preservation Foundation deems the submitted micrographs as inadequate to win the prize because the extensive dehydration produced by M22 perfusions makes an examination of brain ultrastructure and of the connectome at the ultrastructural level impossible using existing FIB-SEM techniques.[163][171]
2012 cryonics technological development remote stabilization Alcor Life Extension Foundation Advanced Neural Biosciences collaborates with Alcor to validate Alcor’s proposed field cryoprotection protocol in the rat model. No ice formation is found after up to 48 hours of storing the brains at dry ice temperature prior to further cooling.[124]
2012-03-22 cryonics organization milestone Alcor Life Extension Foundation Fred Chamberlain III, a co-founder of Alcor, becomes the first patient to be demonstrably preserved free of ice formation as would observe from CT scans in 2018.
2013 cryobiology science vitrification Fahy, et al. Fahy, et al., demonstrate recovery of LTP memory electrophysiology for half millimeter thick hippocampal brain slices that had previously been vitrified and stored for weeks.[172]
2013-05 cryonics technological adoption remote stabilization Cryonics Institute The wife of UK cryonicist Alan Sinclair receives a field cryoprotection before being shipped to the Cryonics Institute.[35]
2014 cryonics social open letter Biostasis 68 scientists from relevant disciplines sign an open letter to legitimize cryonics and support the right to be cryopreserved.[173]
2014 brain preservation science vitrifixation 21st Century Medicine Robert McIntyre from 21st Century Medicine wins the Small Mammal Prize from the Brain Preservation Foundation with a technique called vitrifixation, an Aldehyde Stabilized Cryopreservation (ASC). He combines research done by Greg Fahy and Shawn Mikula.[163]
2014 emergency preservation science hypothermia University of Maryland, University of Pittsburgh The Emergency Preservation and Resuscitation for Cardiac Arrest from Trauma study began. It is a study of the safety of hypothermic circulatory arrest on patients who recently suffered an injury. Patients who suffer cardiac arrest after injury and whose pulse cannot be restarted will have their aorta cannulated and cooled with ice-cold saline.[174]
2014-05-06 cryonics organization milestone Oregon Cryonics OregonCryo preserves its first patient, a dog named Cupcake.[175]
2014-07 cryonics technological adoption remote stabilization Alcor Life Extension Foundation Alcor starts implementing a plan to practice field cryoprotection for cases in Canada and Europe.[35][124]
2015 cryonics science Vita-More, et al. Memory retention in a cryopreserved and revived caenorhabditis elegans is demonstrated.[176]
2015-03-13 brain preservation technological adoption fixation Oregon Cryonics For the first time, a brain is preserved using fixation technology, by having her brain immersed in a fixative solution. The patient was Deborah Cheek, and she was preserved by OregonCryo.[177]

Immersion fixation is well established to be ineffective in halting autolysis (decomposition).[178][179] This is documented in the peer-reviewed literature with the time to fixation of the immersed brain being on the order of 5-15 weeks.[180] However, this procedure is very inexpensive – Oregon Cryonics charges 1000 USD – so this option is sometimes chosen with the hope that very advance technology might be able to recover some part of the brain.

2015-10-03 cryonics organization milestone Alcor Life Extension Foundation James Bedford, if properly preserved, becomes the longest-surviving human being ever, after 122 years and 165 days.[181]
2015-12 brain preservation technological development vitrifixation 21st Century Medicine Perfect histological and ultrastructural preservation of an entire porcine brain in a nonviable state using aldehyde fixation combined with vitrification.[182][183]

In 2016, Robert McIntyre, Greg Fahy, and 21st Century Medicine would win the Large Mammal Prize from the Brain Preservation Foundation with this vitrifixation technique.[184]

2016 cryonics organization founding Osiris Osiris Back to Life is founded by Dvir Derhy.[185]
2016 brain preservation organization founding Nectome Nectome is started by Robert McIntyre after having won the Brain Preservation Foundation's Large Mammal Prize. Nectome is a research organization developing biological preservation techniques to better preserve the physical traces of memory.[186]
2016 brain preservation technological development Nectome Nectome wins 413,765 USD in research grants from the National Institutes of Health “to enable whole-brain nanoscale preservation and imaging, a vital step towards a deep understanding of the mind and of the brain’s diseases.”[187]
2016 cryonics organization milestone Yinfeng Life Science Research Institute The Yinfeng Life Science Research Institute in Jinan, Shandong, China starts their operations. They are a branch of Yinfeng Biological which was started in 1999.
2016-03-24 cryonics social blog Wait But Why Tim Urban publishes "Why Cryonics Makes Sense" on his blog "Wait But Why". At the moment the article was published, 331,824 people were subscribed to receive new posts by email.[188] Cryonicists almost unanimously acclaimed this post as the best introduction to cryonics.
2016-05-06 cryonics organization milestone Oregon Cryonics OregonCryo starts training its medical team with body donors.[177]
2016-06-06 cryonics risk management economic stability Alcor Life Extension Foundation The Alcor Care Trust Supporting Organization (ACT) is created. The Patient Care Trust (PCT) continues in existence to receive initial funding from new cryopreservations and to pay for ongoing costs for maintaining patients' cryopreservation. The ACT will make long term investments, continue maintaining the PCT, and possibly eventually fund resuscitation research. Both trusts have a different board of directors that can check on each other.[189]
2016-11-12 cryonics social event CryoSuisse CryoSuisse organizes the 1st International Cryonics Conference.
2016-12-24 brain preservation technological adoption fixation Oregon Cryonics For the first time, someone is preserved by being perfused with a fixation solution instead of simply being immersed in it.

Fixative perfusion and brain removal for this patient is carried out by the individual's sons in cooperation with a local mortuary and a mobile pathology service. Oregon Cryonics (OC) is storing the brain.[177]

2017-01-12 cryonics The Church of Perpetual Life The city of Hollywood, FL officially proclaims January 12th as Dr. James Bedford Day in remembrance of the first person to be cryopreserved with the hope of being revived in the future. Here you can see the official proclamation.
2017-01 to 2017-08 cryonics technological development Oregon Cryonics OregonCryo trains and does research and development with 38 body donations.[177]
2017-03-01 cryobiology technological development re-warming Bischoff, et al. Bischoff, et al., develop a novel technique of inductive heat re-warming using magnetic nanoparticles in the vasculature allowing for uniform re-warming of organs the size of rabbit kidneys at rates high enough to prevent devitrification of M-22 vitrification solution at a concentration compatible with kidney viability. The system is potentially applicable to larger organs, such as the human brain.[190][191]
2017-04-26 cryonics social writeup Open Phlanthropy As part of research into the history of philanthropy, Luke Muehlhauser writes "Some Case Studies in Early Field Growth" that, among other things, includes a section called "Failure modes in cryonics and molecular nanotechnology" that, he says, "saw especially slow, anemic field growth." Muehlhauser muses about possible reasons for the slow growth: "First, early advocates of cryonics and MNT focused on writings and media aimed at a broad popular audience, before they did much technical, scientific work. [...] Second, early advocates of cryonics and MNT spoke and wrote in a way that was critical and dismissive toward the most relevant mainstream scientific fields [...] Third, [...] these “neighboring” established scientific communities (of cryobiologists and chemists) engaged in substantial “boundary work” to keep advocates of cryonics and MNT excluded."[192][193]
2017-05-08 cryonics organization milestone Yinfeng Life Science Research Institute The Yinfeng Life Science Research Institute in Jinan, Shandong, China cryopreserves their first patient.[194][195] A documentary documents the procedure: China Whole Body Cryopreservation.
2018 cryonics quality assessment scan Mike Darwin M. Darwin publishes “Preliminary Evaluation of Alcor Patient Cryogenic CT Scans” analyzing three of the four available Alcor neuropatient CT scans. Darwin concludes that it is highly likely that Alcor patient A-1002 was possibly the first human cryonics patient to achieve essentially ice-free brain cryopreservation.[196]
2018 winter brain preservation organization milestone Nectome Nectome participates in the startup accelerator Y Combinator.[186][197]
2018-04-06 cryonics organization founding International Cryomedicine Experts Alcor signs an agreement with the newly funded International Cryomedicine Experts, a for-profit organization providing international cryonics standby, stabilization, and transport services.
2018-05-16 cryonics risk management economic stability Alcor Life Extension Foundation Alcor announces the creation of a sibling organization called the Alcor Endowment Trust Supporting Organization. Its goal is to maintain funds that are invested, and which support Alcor's general operation and research through giving a fraction of the interests made.[198]
2018-10-30 cryonics legal right-to-die Norman Hardy For the first time, a cryonics patient uses the Death With Dignity legislation. The patient's name is Norman Hardy.[199]
2018-11 cryonics social bylaws Society for Cryobiology The Society for Cryobiology releases a position statement clarifying their stance in regards to cryonics, saying they respect people's freedom in choosing this option, but that the procedure is speculative, and that the scientific knowledge necessary to successfully cryopreserve someone doesn't currently exist.[note 7][200]
2019-04 cryonics organization milestone Brain Preservation Foundation The Brain Preservation Foundation launches the Aspirational Neuroscience Prize with the commitment to give 4 prizes of 25,000 USD every year for the next 10 years for breakthroughs in the neuroscience of memory, brain preservation, and connectomics.[201]

More information

Some events that weren't important enough to make it into this timeline are noted on the Discussion page (as well as on the Google Sheet Timeline of cryonics - extended timeline).

An exhaustive list of publicly known preserved patients (including a yet incomplete evaluation of the quality of their preservation) can be found in the Google Sheet List of cryonics patients.

A detailed account of membership statistics of cryonics organizations has been compiled in the Google Sheet Cryonic members statistics (although not all organizations share all or any of their membership statistics). A detailed account of patient statistics has been compiled in the Google Sheet Cryonic patients statistics. The membership and patient statistics should be updated at the beginning of every year, after the publication of the statistics from last year.

Meta information on the timeline

Timeline update strategy

As of 2020, Mati Roy is currently roughly staying up-to-date with new major cryonics events, and should, therefore, update the timeline roughly continuously, at least in the near future. If you're interested in helping in any way, feel free to take the initiative. If you have any questions, want guidance or feedback, want to discuss ways to improve this timeline, or have a suggestion for an addition to this timeline, let Mati know on the TimelinesWiki Subreddit or TimelinesWiki Facebook Group (and link me the post) or contact me directly at contact@matiroy.com.

Also see the section "More information" for other related information that can be updated or otherwise improved. All those external lists are editable, and everyone is encouraged to contribute to them. They are all available in the Google Folder Cryonics Statistics. The graphs from the Trends section can be updated whenever the relevant external lists are.

An older version of the timeline is available on Google Sheet: Timeline of brain preservation.

To update the graph of cryonics patients and the graph of cryonics patients per organization, consult:

To update the cryonics membership graph:

To do

"It’s reminiscent of a similar essay contest features in Omni Magazine many years ago." (https://deadline.com/2017/07/comic-con-seth-macfarlane-the-orville-cryogenics-fan-contest-fox-1202131271/ ; https://www.alcor.org/2017/08/link-roundup-812/)

Legal

  • Arizona: HB2583 - End-of-life decisions; terminally ill individuals
  • Arizona: SB1646 - End-of-life decisions; terminally ill individuals

Records

Terminology

By default, Mati Roy suggests using the terminology proposed by OregonCryo.

Tracking preservation quality

An interesting addition that could be done to this page is to measure the progress of the quality of cryonics cases. If you're interested in contributing to this project, you can fill the columns related to the quality of the cryopreservation in the Google Sheet List of cryonics patients by going through some of the cases published by the cryonics organizations; see: Alcor (human cases), the Cryonics Institute (human cases), OregonCryo (human cases), OregonCryo (non-human cases), KrioRus (human cases), KrioRus (non-human cases).

While ways to quantify the quality of preservations have been proposed, notably by OregonCryo, there are currently no systematic analyses done about the quality of current preservations by any of the cryonics providers.

As for the improvements done in laboratory conditions, progress is better tracked by noting various discrete technological development as done in the full timeline above.

While having a graph tracking the "biggest mass of a successfully cryopreserved tissue/organ/organism by year, kg" is appealing, it doesn't meaningfully track progress done on brain preservations which pose a series of challenges not present in smaller volumes of tissue as noted by Mike Darwin. This can still be found on the Discussion page.

Acknowledgement

Mati Roy created the first version of the timeline of brain preservation published here with payment from Vipul. Mati Roy also created and is maintaining, with the help of other volunteers, all of the Google Sheets mentioned in the section #More information. Most of the membership statistics were entered by Marta Sandberg. Mike Darwin contributed a lot of information on notable technological progress on Reddit. Mike Darwin and Issa Rice provided a lot of useful feedback. Alexey Potapov, Marta Sandberg, Aschwin de Wolf, as well as others contributed ideas for events to add. The graph and table tracking Scientific progress towards cryonics was created by Roman.

In January 2020, Mati Roy updated the timeline, and Jim Yount, CEO of the American Cryonics Society, provided a lot of useful feedback.

Notes and references

Notes

  1. Trans Time has also existed for a long time, but they haven't always been offering cryonics services, and only have 3 patients in storage. The American Cryonics Society has also existed for a long time, but they contract with other cryonics providers.
  2. not the same as the California organization with similar name
  3. Cryo-Care would not use cryoprotectants or perfusion with its patients but would only do straight freezes to liquid nitrogen temperature.
  4. Jim Yount thinks it was in September from memory
  5. This is the earliest example of VSED used for identity preservation purposes that could be found online.
  6. Following this case, journalists at Sports Illustrated would write a sensationalistic exposé of Alcor based on information that would be supplied to them by Alcor employee Larry Johnson, who had surreptitiously recorded several conversations.
  7. "The Society recognizes and respects the freedom of individuals to hold and express their own opinions and to act, within lawful limits, according to their beliefs. Preferences regarding disposition of postmortem human bodies or brains are clearly a matter of personal choice and, therefore, inappropriate subjects of Society policy. The Society does, however, take the position that the knowledge necessary for the revival of live or dead whole mammals following cryopreservation does not currently exist and can come only from conscientious and patient research in cryobiology and medicine. In short, the act of preserving a body, head or brain after clinical death and storing it indefinitely on the chance that some future generation may restore it to life is an act of speculation or hope, not science, and as such is outside the purview of the Society for Cryobiology."

References

  1. "Oregon Cryonics - Suspended Animation". www.oregoncryo.com. Retrieved 2019-01-24. 
  2. 2.0 2.1 2.2 2.3 2.4 2.5 "Suspension Failures - Lessons from the Early Days". www.alcor.org. Retrieved 2019-01-21. 
  3. Ortiz-Ospina, Esteban; Roser, Max (2019-01-23). "World Population Growth". Our World in Data. 
  4. "How Many People Have Ever Lived on Earth? – Population Reference Bureau". Retrieved 2019-01-23. 
  5. 5.0 5.1 5.2 "Alcor Cases". alcor.org. Retrieved 2019-01-22. 
  6. "Case Reports | Cryonics Institute". www.cryonics.org. Retrieved 2019-01-23. 
  7. "Alcor: Membership Statistics". alcor.org. Retrieved 2019-01-23. 
  8. "Member Statistics | Cryonics Institute". www.cryonics.org. Retrieved 2019-02-15. 
  9. "Crypreservation Funding and Inflation". alcor.org. Retrieved 2019-01-31. 
  10. "Alcor: Membership Info - How to Join". alcor.org. Retrieved 2019-01-31. 
  11. "Funding for Cryostasis | Cryonics Institute". www.cryonics.org. Retrieved 2019-01-31. 
  12. "Oregon Cryonics - Services". oregoncryo.com. Retrieved 2019-01-31. 
  13. "Human cryopreservation | KrioRus". kriorus.ru. Retrieved 2019-01-31. 
  14. "Page:Works of the Late Doctor Benjamin Franklin (1793).djvu/233 - Wikisource, the free online library". en.wikisource.org. Retrieved 2019-01-21. 
  15. Tilden, William Augustus (2009). A Short History of the Progress of Scientific Chemistry in Our Own Times. BiblioBazaar, LLC. p. 249. ISBN 1-103-35842-1. 
  16. "ЏредвидениЯ ЏорфириЯ Ѓахметьева - "антаст". www.fandom.ru. Retrieved 2019-02-04. 
  17. 17.0 17.1 17.2 17.3 Regis, Ed (1991). Great Mambo Chicken and the Transhuman Condition: Science Slightly Over The Edge. Westview Press. pp. 87–88. ISBN 0-201-56751-2. 
  18. "Robert Ettinger". Cryonics Institute. Archived from the original on September 5, 2012. Retrieved May 24, 2009. 
  19. 19.0 19.1 Safar, P. (June 2001). "Vladimir A. Negovsky the father of 'reanimatology'". Resuscitation. 49 (3): 223–229. ISSN 0300-9572. PMID 11723996. doi:10.1016/s0300-9572(01)00356-2. 
  20. J., Luyet, B. (1940). Life and death at low temperatures. Biodynamica. OCLC 716713726. 
  21. Cooper, S M; Dawber, R P R (April 2001). "The history of cryosurgery". Journal of the Royal Society of Medicine. 94 (4): 196–201. ISSN 0141-0768. PMC 1281398Freely accessible. PMID 11317629. 
  22. 22.0 22.1 22.2 "History/Timeline | Cryonics Institute". www.cryonics.org. Retrieved 2019-01-21. 
  23. POLGE, C. (June 1951). "Functional Survival of Fowl Spermatozoa after Freezing at −79° C.". Nature. 167 (4258): 949–950. ISSN 0028-0836. doi:10.1038/167949b0. 
  24. "Title: The Penultimate Trump". www.isfdb.org. Retrieved 2019-01-21. 
  25. Gonzales, F.; Luyet, B. (May 1950). "Resumption of heart-beat in chick embryo frozen in liquid nitrogen". Biodynamica. 7 (126-128): 1–5. ISSN 0006-3010. PMID 15426631. 
  26. Parkes, A. S.; Lovelock, J. E.; Smith, A. U. (June 1954). "Resuscitation of Hamsters after Supercooling or Partial Crystallization at Body Temperatures Below 0° C.". Nature. 173 (4415): 1136–1137. ISSN 1476-4687. doi:10.1038/1731136a0. 
  27. "Studies on golden hamsters during cooling to and rewarming from body temperatures below 0° C. III. Biophysical aspects and general discussion". Proceedings of the Royal Society of London. Series B - Biological Sciences. 145 (920): 427–442. 1956-07-24. ISSN 2053-9193. doi:10.1098/rspb.1956.0054. 
  28. LOVELOCK, J. E.; BISHOP, M. W. H. (May 1959). "Prevention of Freezing Damage to Living Cells by Dimethyl Sulphoxide". Nature. 183 (4672): 1394–1395. ISSN 0028-0836. doi:10.1038/1831394a0. 
  29. Ursula, Smith, Audrey. Biological effects of freezing and supercooling. OCLC 1027485685. 
  30. Negovsky, Vladimir (1962). Resuscitation and Artificial Hypothermia (USSR). New York: Consultants Bureau. 
  31. 31.0 31.1 31.2 31.3 31.4 Perry, Michael (August 1992). "Unity and Disunity in Cryonics". Cryonics. 13 (145): 5. 
  32. 32.0 32.1 "Ev Cooper". www.cryonet.org. Retrieved 2019-01-21. 
  33. 33.0 33.1 "Ev Cooper's cryonics classic published online – Biostasis". Retrieved 2019-01-21. 
  34. 34.0 34.1 Perry, Mike (2011-01-19). "The First Cryonics Newsletter". Evidence Based Cryonics. Archived from the original on 2016-11-26. 
  35. 35.00 35.01 35.02 35.03 35.04 35.05 35.06 35.07 35.08 35.09 35.10 35.11 35.12 35.13 35.14 35.15 35.16 35.17 35.18 35.19 35.20 35.21 35.22 35.23 35.24 "A HISTORY OF CRYONICS". www.benbest.com. Retrieved 2019-01-22. 
  36. Hattenstone, Simon (2009-11-07). "The Dad's Army of British cryonics". The Guardian. ISSN 0261-3077. Retrieved 2019-01-22. 
  37. FARRANT, J. (March 1965). "Mechanism of Cell Damage During Freezing and Thawing and its Prevention". Nature. 205 (4978): 1284–1287. ISSN 0028-0836. doi:10.1038/2051284a0. 
  38. 38.0 38.1 38.2 38.3 "The First Cryonic Suspension". alcor.org. Retrieved 2019-01-22. 
  39. 39.0 39.1 "Search Summary State of Michigan Corporations Division". cofs.lara.state.mi.us. Retrieved 2019-01-22. 
  40. 40.00 40.01 40.02 40.03 40.04 40.05 40.06 40.07 40.08 40.09 40.10 40.11 40.12 40.13 40.14 "Systems for Intermediate Temperature Storage for Fracture Reduction and Avoidance". alcor.org. Retrieved 2019-01-22. 
  41. Kroener, C.; Luyet, B. (1966). "Formation of cracks during the vitrification of glycerol solutions and disappearance of the cracks during rewarming". Biodynamica. 10: 47–52. 
  42. F. Nelson, Robert; Stanley, Sandra (1968). We Froze the First Man. New York: Dell. pp. 17–20. 
  43. Kraver, Ted (March 1989). "Notes on the First Human Freezing". Cryonics: 11–21. 
  44. Adachi, C.; Kito, K.; Suda, I. (1966-10-15). "Viability of Long Term Frozen Cat Brain In Vitro". Nature. 212 (5059): 268–270. ISSN 1476-4687. doi:10.1038/212268a0. 
  45. "Still Frozen After All These Years". The New York Times. 1997-01-12. ISSN 0362-4331. Retrieved 2019-02-15. 
  46. Kemp, E.; Clark, P. B.; Anderson, C. K.; Laursen, T.; Parsons, F. M. (1968). "Low temperature preservation of mammalian kidneys". Scandinavian Journal of Urology and Nephrology. 2 (3): 183–190. ISSN 0036-5599. PMID 4893380. 
  47. Ames, A.; Wright, R. L.; Kowada, M.; Thurston, J. M.; Majno, G. (Feb 1968). "Cerebral ischemia. II. The no-reflow phenomenon.". The American Journal of Pathology. 52 (2): 437–453. ISSN 0002-9440. PMC 2013326Freely accessible. PMID 5635861. 
  48. "Resources | Cryonics Institute". www.cryonics.org. Retrieved 2020-01-28. 
  49. Private conversation between Mati Roy and Jim Yount
  50. "Business Search - Business Entities - Business Programs | California Secretary of State". businesssearch.sos.ca.gov. Retrieved 2019-01-22. 
  51. "American Cryonics Society - Human Cryopreservation Services for the 21st Century". www.americancryonics.org. Retrieved 2019-01-22. 
  52. White, J. B. (1969-04-11). "Viral Induced Repair of Damaged Neurons with Preservation of Long-Term Information Content," (PDF). Second Annual Cryonics Conference. Ann Arbor, Michigan. 
  53. Hossmann, K. -A.; Sato, K. (1970). "The effect of ischemia on sensorimotor cortex of cat". Zeitschrift für Neurologie. 198 (1): 33–45. ISSN 0340-5354. doi:10.1007/bf00316134. 
  54. "Informational Message". appext20.dos.ny.gov. Retrieved 2019-01-22. 
  55. Mazur, P. (1970-05-22). "Cryobiology: the freezing of biological systems". Science (New York, N.Y.). 168 (3934): 939–949. ISSN 0036-8075. PMID 5462399. 
  56. Hossmann, K.-A.; Lechtape-Grüter, H. (1971). "Blood Flow and Recovery of the Cat Brain after Complete Ischemia for 1 Hour". European Neurology. 6 (1-6): 318–322. ISSN 0014-3022. doi:10.1159/000114515. 
  57. Martin, George M. (1971). "On Immortality: An Interim Solution". Perspectives in Biology and Medicine. 14 (2): 339–340. ISSN 1529-8795. doi:10.1353/pbm.1971.0015. 
  58. Chamberlain, FR; Chamberlain, LL (1972). "Instructions for the Induction of Solid State Hypothermia". Manrise Corporation. La Canada, CA. 
  59. Quaife, A. (1972). "Recommended modification to Collins' solution for use as the base perfusate for inducing SSH". Manrise Technical Review. 2: 3–9. 
  60. "History of cryonics - H+Pedia". hpluspedia.org. Retrieved 2019-01-22. 
  61. "Business Search - Business Entities - Business Programs | California Secretary of State". businesssearch.sos.ca.gov. Retrieved 2019-01-22. 
  62. "Resources | Cryonics Institute". www.cryonics.org. Retrieved 2020-01-28. 
  63. 63.0 63.1 63.2 63.3 Best, Ben (2008-11-08). "A History of Cryonics" (PDF). Cryonics Institute. Archived from the original (PDF) on 2013-06-28. 
  64. Klebanoff, G.; Hollander, D.; Cosimi, A. B.; Stanford, W.; Kemmerer, W. T. (January 1972). "Asanguineous hypothermic total body perfusion (TBW) in the treatment of stage IV hepatic coma". The Journal of Surgical Research. 12 (1): 1–7. ISSN 0022-4804. PMID 5058015. 
  65. "Business Search - Business Entities - Business Programs | California Secretary of State". businesssearch.sos.ca.gov. Retrieved 2019-01-22. 
  66. LaRossa, D.; Hamilton, R.; Ketterer, F.; Lehr, H. B. (August 1973). "Preservation of structure and function in canine small intestinal autografts after freezing". Plastic and Reconstructive Surgery. 52 (2): 174–177. ISSN 0032-1052. PMID 4722678. 
  67. "Journal of Surgical Research". www.journalofsurgicalresearch.com. doi:10.1016/0022-4804(73)90033-4. Retrieved 2019-01-22. 
  68. Federowicz, MD (1973). "Perfusion and freezing of a 60-year-old woman" (PDF). Manrise Technical Review. 3(1): 9–32. Retrieved 2010-08-31. 
  69. Suda, Isamu; Kito, Kyoko; Adachi, Chizuko (1974-04-26). "Bioelectric discharges of isolated cat brain after revival from years of frozen storage". Brain Research. 70 (3): 527–531. ISSN 0006-8993. doi:10.1016/0006-8993(74)90263-7. 
  70. Private conversation between Mati Roy and Jim Yount
  71. Haff, R. C.; Klebanoff, G.; Brown, B. G.; Koreski, W. R. (July 1975). "Asanguineous hypothermic perfusion as a means of total organism preservation". The Journal of Surgical Research. 19 (1): 13–19. ISSN 0022-4804. PMID 1142760. 
  72. Private conversation between Mati Roy and Jim Yount
  73. "Search Summary State of Michigan Corporations Division". cofs.lara.state.mi.us. Retrieved 2019-01-22. 
  74. Chamberlain, FRC; Chamberlain, LLC (July 16–17, 1976). "Alcor patient A-1001 Case Notes". Alcor Foundation. 
  75. "The Newsletter of The Institute For Advanced Biological Studies, Inc.". Cryonics. 1981-03-08. 
  76. "Report on the Lake Tahoe Life Extension Festival". Cryonics (36): 7–13. July 1983. 
  77. Darwin, MG (July 1977). "The anabolocyte: a biological approach to repairing cryoinjury". Life Extension Magazine: A Journal of the Life Extension Sciences. 1. 
  78. "Business Search - Business Entities - Business Programs | California Secretary of State". businesssearch.sos.ca.gov. Retrieved 2019-01-22. 
  79. Leaf, JD (March–April 1979). "Cryonic Suspension of Sam Berkowitz,". Long Life Magazine: 30–35. 
  80. Leaf, JD; Federowicz, Hixon; H. (1985). "Case report: two consecutive suspensions, a comparative study in experimental human suspended animation". Cryonics. 6(11): 13–38. 
  81. Drexler, K. Eric (1981-09-01). "Molecular engineering: An approach to the development of general capabilities for molecular manipulation". Proceedings of the National Academy of Sciences. 78 (9): 5275–5278. ISSN 0027-8424. PMID 16593078. doi:10.1073/pnas.78.9.5275. 
  82. "Cryonics Magazine". www.alcor.org. Retrieved 2019-02-01. 
  83. Fahy, G. M.; Hirsch, A. (1982), "Prospects for organ preservation by vitrification", Organ Preservation, Springer Netherlands, pp. 399–404, ISBN 9789401162692, retrieved 2019-02-01 
  84. Fahy, Gregory M.; Lilley, Terence H.; Linsdell, Helen; Douglas, Mary St.John; Meryman, Harold T. (June 1990). "Cryoprotectant toxicity and cryoprotectant toxicity reduction: In search of molecular mechanisms". Cryobiology. 27 (3): 247–268. ISSN 0011-2240. doi:10.1016/0011-2240(90)90025-y. 
  85. "Paul Crowley's Blog - Society for Cryobiology statements on cryonics". blog.ciphergoth.org. Retrieved 2019-01-22. 
  86. "Cold War: The Conflict Between Cryonicists and Cryobiologists". www.alcor.org. Retrieved 2019-01-22. 
  87. Darwin, M; Leaf, JD. "Cryoprotective perfusion and freezing of the ischemic and nonischemic cat". 
  88. "CRYONICS: Freezing Damage (Darwin) Part 2". www.cryonet.org. Retrieved 2019-02-01. 
  89. "CRYONICS: Freezing Damage (Darwin) Part 3". www.cryonet.org. Retrieved 2019-02-01. 
  90. "CRYONICS: Freezing Damage (Darwin) Part 4". www.cryonet.org. Retrieved 2019-02-01. 
  91. Federowicz, MG; Leaf, JD (January 1983). "Tahoe Research Proposals". Cryonics (30): 14. 
  92. chronopause. "THE EFFECTS OF CRYOPRESERVATION ON THE CAT, Part 1". CHRONOSPHERE. Retrieved 2019-02-01. 
  93. chronopause. "THE EFFECTS OF CRYOPRESERVATION ON THE CAT, Part 2". CHRONOSPHERE. Retrieved 2019-02-01. 
  94. chronopause. "THE EFFECTS OF CRYOPRESERVATION ON THE CAT, Part 3". CHRONOSPHERE. Retrieved 2019-02-01. 
  95. "Report on the Lake Tahoe Life Extension Festival". Cryonics (36): 7–13. July 1983. 
  96. Federowicz, M.; Hixon, H.; Leaf, J. (1984). "Post-mortem examination of three cryonic suspension patients". Cryonics. 5 (9): 16–28. Retrieved 2010-08-31. 
  97. Leaf, JD; Darwin, M.; Hixon, H. "A mannitol-based perfusate for reversible 5-hour asanguineous ultraprofound hypothermia in canines (Report on work performed from 1984-87)". 1986. Retrieved 2010-08-31. 
  98. Fahy, G. M.; MacFarlane, D. R.; Angell, C. A.; Meryman, H. T. (1984-08-01). "Vitrification as an approach to cryopreservation". Cryobiology. 21 (4): 407–426. ISSN 0011-2240. doi:10.1016/0011-2240(84)90079-8. 
  99. Federowicz, M.; Hixon, H.; Leaf, J. (1984). "Postmortem Examination of Three Cryonic Suspension Patients". Cryonics: 16–28. 
  100. Federowicz, MG; Leaf, JD; Hixon, H. (1986). "Case report: neuropreservation of Alcor patient A-1068 (1 of 2)". Cryonics. 7 (2): 17–32. 
  101. Federowicz, MG; Leaf, JD; Hixon, H. (1986). "Case report: neuropreservation of Alcor patient A-1068 (2 of 2)". Cryonics. 7 (3): 15–29. 
  102. Darwin, M. (18 January 1997). "Securing anesthesia in the human cryopreservation patient". CryoNet. 
  103. Rall, W. F.; Fahy, G. M. (14 Feb 1985). "Ice-free cryopreservation of mouse embryos at -196 degrees C by vitrification". Nature. 313 (6003): 573–575. ISSN 0028-0836. PMID 3969158. 
  104. "Yahoo! Groups". groups.yahoo.com. Retrieved 2019-01-22. 
  105. Darwin, MG (1986). "Transport Protocol for Cryonic suspension of Humans". Alcor Life Extension Foundation. Fullerton, CA. 
  106. Fahy, G. M. (1986). "Vitrification: a new approach to organ cryopreservation". Progress in Clinical and Biological Research. 224: 305–335. ISSN 0361-7742. PMID 3540994. 
  107. K. Eric, Drexler (1986). Engines of creation. Garden City, N.Y: Anchor Press/Doubleday. ISBN 0385199724. 
  108. Haneda, Kiyoshi; Thomas, Robert; Sands, Murray P.; Breazeale, Donald G.; Dillard, David H. (1986-12-01). "Whole body protection during three hours of total circulatory arrest: An experimental study". Cryobiology. 23 (6): 483–494. ISSN 0011-2240. doi:10.1016/0011-2240(86)90057-X. 
  109. Drexler, K. Eric (1986). "9". Engines of Creation: The Coming Era of Nanotechnology. 
  110. "Cryonics Society of Canada -- The Story of the Organization and Its People". www.cryocdn.org. Retrieved 2019-01-22. 
  111. Leaf, Jerry D; Hixon, Hugh; Hugh, Mike (1987). "Development of a mobile advanced life support system for human biostasis operations". Cryonics. 8 (3): 23–40. 
  112. Darwin, Michael G.; Leaf, Jerry D.; Hixon, Hugh L. "Cryonic suspension case report: A-1133" (PDF). Alcor Life Extension Foundation. 
  113. Darwin, M. "Cryonic suspension case report: A-1133" (PDF). 
  114. "The Dora Kent Case". alcor.org. Retrieved 2019-02-15. 
  115. "administrivia". www.cryonet.org. Retrieved 2019-01-22. 
  116. "California Appellate Court Decision on Legality of Cryonics". www.alcor.org. Retrieved 2019-01-22. 
  117. Pizer, David (1989). "Alcor outstanding support award nominee". Cryonics. 17 (7): 10. 
  118. Darwin, M. (1989). "A major advance in suspension patient support". Cryonics. 10 (8): 7–14. Retrieved 2010-09-29. 
  119. Wowk, B.; Darwin, M. (1990). "Cryonics: Reaching for Tomorrow," (PDF). Alcor Life Extension Foundation. Riverside, CA. ISBN 1880209004. Retrieved 2010-10-09. 
  120. Darwin, M. (1991). "Reducing ischemic damage in cryonic suspension patients by premedication". Cryonics. 12: 13–15. Retrieved 2010-09-29. 
  121. Darwin, M. (1990). "Cardiopulmonary support: Evaluation and intervention". Cryonics. 11 (4): 26–31. Retrieved 2010-09-29. 
  122. "Donaldson v. Van de Kamp (Abstract)". www.alcor.org. Retrieved 2019-01-22. 
  123. 123.0 123.1 Fahy, Gregory M.; Saur, Joseph; Williams, Robert J. (October 1990). "Physical problems with the vitrification of large biological systems". Cryobiology. 27 (5): 492–510. ISSN 0011-2240. doi:10.1016/0011-2240(90)90038-6. 
  124. 124.0 124.1 124.2 124.3 "Field Cryoprotection". alcor.org. Retrieved 2019-01-22. 
  125. "Have cryonicists considered preemptively getting cryopreserved? - Quora". www.quora.com. Retrieved 2020-01-23. 
  126. "Options for Elective Cryopreservation". alcor.org. Retrieved 2020-01-22. 
  127. Darwin, MG. "Cryopreservation case report: Arlene Francis Fried, A-1049". 
  128. Ruggera, P. S.; Fahy, G. M. (October 1990). "Rapid and uniform electromagnetic heating of aqueous cryoprotectant solutions from cryogenic temperatures". Cryobiology. 27 (5): 465–478. ISSN 0011-2240. PMID 2249450. 
  129. Merkle, R. C. (1992-09-01). "The technical feasibility of cryonics". Medical Hypotheses. 39 (1): 6–16. ISSN 0306-9877. doi:10.1016/0306-9877(92)90133-W. 
  130. Henson, HK. "The Transport of Patient A-1312S". 
  131. "21st Century Medicine --Expanding the Boundaries of Preservation Science". www.21cm.com. Retrieved 2019-01-22. 
  132. 132.0 132.1 "CryoCare Foundation - Cryonics Services". www.cryocare.org. Retrieved 2019-01-22. 
  133. Hixon, H. (1995). "Exploring Cracking Phenomena" (PDF). Cryonics: 27–32. 
  134. "A Brief History of Alcor Research". alcor.org. Retrieved 2019-01-22. 
  135. Jones, Tanya L. (July 1995). "Alcor Member Anatole Epstein Suspended" (PDF). Cryonics Magazine. 16 (3): 8–11. 
  136. Darwin, M. "Cryopreservation of James Gallagher, CryoCare patient #C-2150". 
  137. Darwin, M.; Russell, S.; Wakfer, P.; Wood, L.; Wood, C. (1995-05-31). "Effect of Human Cryopreservation Protocol on the Ultrastucture of the Canine Brain". BioPreservation, Inc. 
  138. Platt, C. (July 1995). "New Brain Study Shows Reduced Tissue Damage". CryoCare Report. 
  139. EP1117455A1, Michael Gregory Darwin; Steven Bradley Harris & Sandra Renee Russell, "Mixed-mode liquid ventilation gas and heat exchange", assigned to Critical Care Research Inc 
  140. Harris, S. B.; Darwin, M. G.; Russell, S. R.; O'Farrell, J. M.; Fletcher, M.; Wowk, B. (August 2001). "Rapid (0.5 degrees C/min) minimally invasive induction of hypothermia using cold perfluorochemical lung lavage in dogs". Resuscitation. 50 (2): 189–204. ISSN 0300-9572. PMID 11719148. 
  141. Taylor, Michael J.; Brockbank, Kelvin G. M.; Lightfoot, Fred; Khirabadi, Bijan S.; Song, Ying C. (March 2000). "Vitreous cryopreservation maintains the function of vascular grafts". Nature Biotechnology. 18 (3): 296–299. ISSN 1546-1696. doi:10.1038/73737. 
  142. "BioTransport Purchases CryoStar Freezer" (PDF). Cryonics: 11. 2000. 
  143. "Steven B. Harris | Canine respiratory and hypothermia physiology lab". ResearchGate. Retrieved 2019-01-22. 
  144. Kheirabadi, B. S.; Fahy, G. M. (2000-07-15). "Permanent life support by kidneys perfused with a vitrifiable (7.5 molar) cryoprotectant solution". Transplantation. 70 (1): 51–57. ISSN 0041-1337. PMID 10919575. 
  145. "Scientists' Cryonics FAQ". alcor.org. Retrieved 2019-01-22. 
  146. "New Cryopreservation technology.". Alcor News. October 2005. 
  147. "Surgery". www.surgjournal.com. Retrieved 2019-01-22. 
  148. "Business Search - Business Entities - Business Programs | California Secretary of State". businesssearch.sos.ca.gov. Retrieved 2019-01-22. 
  149. "Alcor News Archive". alcor.org. Retrieved 2019-01-22. 
  150. "Alcor: About Alcor". alcor.org. Retrieved 2019-01-22. 
  151. Fahy, GM; Wowk, B; Wu, J; Paynter, S (2004). "Improved vitrification solutions based on the predictability of vitrification solution toxicity". Cryobiology. 48 (1): 22–35. 
  152. Whetstine, Leslie; Streat, Stephen; Darwin, Mike; Crippen, David (2005-10-31). "Pro/con ethics debate: When is dead really dead?". Critical Care. 9 (6): 538. ISSN 1364-8535. doi:10.1186/cc3894. 
  153. "Oregon Cryonics - About OC". www.oregoncryo.com. Retrieved 2019-01-22. 
  154. 154.0 154.1 "NAF". neuralarchivesfoundation.org. Retrieved 2019-01-22. 
  155. "New Cryopreservation Technology". alcor.org. Retrieved 2019-01-22. 
  156. "M22 Implementation". Alcor News Bulletin (44). 
  157. Pichugin, Yuri; Fahy, Gregory M.; Morin, Robert (2006-04-01). "Cryopreservation of rat hippocampal slices by vitrification". Cryobiology. 52 (2): 228–240. ISSN 0011-2240. doi:10.1016/j.cryobiol.2005.11.006. 
  158. Best, Benjamin P. (2008-04-28). "Scientific Justification of Cryonics Practice". Rejuvenation Research. 11 (2): 493–503. ISSN 1549-1684. PMC 4733321Freely accessible. PMID 18321197. doi:10.1089/rej.2008.0661. 
  159. "Advanced Neural Biosciences". Retrieved 2019-01-22. 
  160. de Wol, Aschwin; Phaedra, Chana. "Human Cryopreservation Research at Advanced Neural Biosciences". Immortalist Society. Retrieved 2019-01-22. 
  161. Alexander, Scott. "Rationalists Are Less Credulous But Better At Taking Ideas Seriously". www.lesswrong.com. Retrieved 2019-02-04. 
  162. Fahy, Gregory M.; Wowk, Brian; Pagotan, Roberto; Chang, Alice; Phan, John; Thomson, Bruce; Phan, Laura (July 2009). "Physical and biological aspects of renal vitrification". Organogenesis. 5 (3): 167–175. ISSN 1547-6278. doi:10.4161/org.5.3.9974. 
  163. 163.0 163.1 163.2 163.3 163.4 "Small Mammal BPF Prize Winning Announcement – The Brain Preservation Foundation". Retrieved 2019-01-22. 
  164. "Resources | Cryonics Institute". www.cryonics.org. Retrieved 2019-01-22. 
  165. "News | Cryonics Institute". www.cryonics.org. Retrieved 2019-02-15. 
  166. Wowk, B.; Leitl, E.; Rasch, C. M.; Mesbah-Karimi, N.; Harris, S. B.; Fahy, G. M. (May 2000). "Vitrification enhancement by synthetic ice blocking agents". Cryobiology. 40 (3): 228–236. ISSN 0011-2240. PMID 10860622. doi:10.1006/cryo.2000.2243. 
  167. Fahy, Gregory M. (July 2010). "Cryoprotectant toxicity neutralization". Cryobiology. 60 (3 Suppl): S45–53. ISSN 1090-2392. PMID 19501081. doi:10.1016/j.cryobiol.2009.05.005. 
  168. Sullivan, Mathew (August 2013). "Alcor A-1088 Case Report" (PDF). Alcor. 
  169. Drake, Aaron (January 2012). "Alcor A-1546 Case Report" (PDF). Alcor. 
  170. Brown, Emma (2011-06-24). "Robert Ettinger, founder of the cryonics movement, dies at 92". Retrieved 2019-01-22. 
  171. "21CM Cryopreservation Eval Page – The Brain Preservation Foundation". Retrieved 2019-02-03. 
  172. Fahy, Gregory M.; Guan, Na; de Graaf, Inge A. M.; Tan, Yuansheng; Griffin, Lenetta; Groothuis, Geny M. M. (2012-10-30). "Cryopreservation of precision-cut tissue slices". Xenobiotica. 43 (1): 113–132. ISSN 0049-8254. doi:10.3109/00498254.2012.728300. 
  173. "Scientists' Open Letter on Cryonics – Biostasis". Retrieved 2019-01-22. 
  174. Kutcher, Matthew; Forsythe, Raquel; Tisherman, Samuel. "Emergency preservation and resuscitation for cardiac arrest from trauma". Retrieved 2022-10-06. 
  175. "Oregon Cryonics - Pet Case Reports". www.oregoncryo.com. Retrieved 2019-01-22. 
  176. Vita-More, Natasha; Barranco, Daniel (October 2015). "Persistence of Long-Term Memory in Vitrified and Revived Caenorhabditis elegans". Rejuvenation Research. 18 (5): 458–463. ISSN 1549-1684. PMC 4620520Freely accessible. PMID 25867710. doi:10.1089/rej.2014.1636. 
  177. 177.0 177.1 177.2 177.3 "Oregon Cryonics - Cases". www.oregoncryo.com. Retrieved 2019-01-22. 
  178. Kanawaku, Yoshimasa; Someya, Satoka; Kobayashi, Tomoya; Hirakawa, Keiko; Shiotani, Seiji; Fukunaga, Tatsushige; Ohno, Youkichi; Kawakami, Saki; Kanetake, Jun (July 2014). "High-resolution 3D-MRI of postmortem brain specimens fixed by formalin and gadoteridol". Legal Medicine. 16 (4): 218–221. ISSN 1344-6223. doi:10.1016/j.legalmed.2014.03.003. 
  179. Shatil, Anwar S.; Uddin, Md Nasir; Matsuda, Kant M.; Figley, Chase R. (20 February 2018). "Quantitative Ex Vivo MRI Changes due to Progressive Formalin Fixation in Whole Human Brain Specimens: Longitudinal Characterization of Diffusion, Relaxometry, and Myelin Water Fraction Measurements at 3T". Frontiers in Medicine. 5. ISSN 2296-858X. PMC 5826187Freely accessible. PMID 29515998. doi:10.3389/fmed.2018.00031. 
  180. Yong-Hing, Charlotte J.; Obenaus, Andre; Stryker, Rodrick; Tong, Karen; Sarty, Gordon E. (August 2005). "Magnetic resonance imaging and mathematical modeling of progressive formalin fixation of the human brain". Magnetic Resonance in Medicine. 54 (2): 324–332. ISSN 0740-3194. PMID 16032673. doi:10.1002/mrm.20578. 
  181. admin (2015-10-06). "First cryonaut, is now the longest-surviving human being ever". Alcor News. Retrieved 2020-01-22. 
  182. McIntyre, Robert L.; Fahy, Gregory M. (1 December 2015). "Aldehyde-stabilized cryopreservation". Cryobiology. 71 (3): 448–458. ISSN 0011-2240. doi:10.1016/j.cryobiol.2015.09.003. 
  183. McIntyre, Robert L.; Fahy, Gregory M. (December 2015). "Aldehyde-stabilized cryopreservation". Cryobiology. 71 (3): 448–458. ISSN 1090-2392. PMID 26408851. doi:10.1016/j.cryobiol.2015.09.003. 
  184. "Large Mammal BPF Prize Winning Announcement – The Brain Preservation Foundation". Retrieved 2019-01-22. 
  185. "Cryogenics Human & Pet Freezing for Preservation and Revival". Osiris | Back to Life. Retrieved 2019-01-22. 
  186. 186.0 186.1 "Nectome". nectome.com. Retrieved 2019-01-22. 
  187. "Project Information - NIH RePORTER - NIH Research Portfolio Online Reporting Tools Expenditures and Results". projectreporter.nih.gov. Retrieved 2019-02-15. 
  188. "Why Cryonics Makes Sense - Wait But Why". web.archive.org. 2016-03-25. Retrieved 2019-02-04. 
  189. "Alcor Care Trust Supporting Organization". alcor.org. Retrieved 2019-01-22. 
  190. Manuchehrabadi, Navid; Gao, Zhe; Zhang, Jinjin; Ring, Hattie L.; Shao, Qi; Liu, Feng; McDermott, Michael; Fok, Alex; Rabin, Yoed (1 March 2017). "Improved tissue cryopreservation using inductive heating of magnetic nanoparticles". Science Translational Medicine. 9 (379). ISSN 1946-6242. PMC 5470364Freely accessible. PMID 28251904. doi:10.1126/scitranslmed.aah4586. 
  191. "Organ cryopreservation is becoming a reality – but bringing whole bodies back still 100 years away". International Business Times UK. 2017-03-01. Retrieved 2019-02-04. 
  192. Muehlhauser, Luke (2017-04-26). "Some Case Studies in Early Field Growth: Failure modes in cryonics and molecular nanotechnology". Open Philanthropy. Retrieved 2020-07-05. 
  193. Muehlhauser, Luke (2017-04-26). "New Report on Early Field Growth". Open Philanthropy. Retrieved 2020-07-05. 
  194. 李松. "Chinese woman's body frozen in advanced procedure - Chinadaily.com.cn". www.chinadaily.com.cn. Retrieved 2019-02-04. 
  195. Feng, Scott (2017-08-14). "Woman cryogenically frozen after death in hope of being resurrected in future". mirror. Retrieved 2020-01-12. 
  196. Darwin, Michael. "Preliminary Evaluation of Alcor Patient Cryogenic CT Scans". 
  197. Combinator, Y. "10 Companies From YC Winter 2018". Y Combinator. Retrieved 2019-01-22. 
  198. admin (2018-05-16). "The Alcor Endowment Trust Supporting Organization". Alcor News. Retrieved 2019-01-22. 
  199. "Alcor Case Summary: A-1990". alcor.org. Retrieved 2019-01-22. 
  200. "Society for Cryobiology Position Statement - Cryonics" (PDF). Society for Cryobiology. November 2018. Retrieved 2019-01-23. 
  201. "Aspirational Neuroscience Prize – The Brain Preservation Foundation". Retrieved 2019-08-06.